Development of constrained fuzzy logic for modeling biological regulatory networks and predicting contextual therapeutic effects by Morris, Melody K
Development of Constrained Fuzzy Logic for
Modeling Biological Regulatory Networks and
Predicting Contextual Therapeutic Effects ARCHIVES
by
Melody K. Morris
B.S., University of Kentucky (2007)
MASSACHUSETTS INST fTE
TECN OLOGY
L 7R R~
Submitted to the Department of Biological Engineering
in partial fulfillment of the requirements for the degree of
Doctor of Philosophy in Biological Engineering
at the
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
June 2012
© Massachusetts Institute of Technology 2012. All rights reserved.
Ahi (Ii [/ i A /
A uthor ........................... r - - .- - - - --
Departrnent of B ological Engineering
,~V41A
May 18, 2012
J -
Certified by..................
Douglas K. Lauffenburger
Professor
Thesis Stpervisor
Accepted by ............ ................ ................
Forest White
Chairman, Department Committee on Graduate Theses
2
This Doctoral Thesis has been examined by the following Thesis Committee:
Douglas A. Lauffenburger, Ph.D.
Professor of Biological Engineering
Massachusetts Institute of Technology
Ernest Fraenkel, Ph.D.
Thesis Committee Chair
Associate Professor of Biological Engineering
Massachusetts Institute of Technology
Peter K. Sorger, Ph.D.
Professor of Systems Biology
Havard Medical School and Massachusetts Institute of Technology
Anand Asthagiri, Ph.D.
Associate Professor of Chemical Engineering
Northeastern University
3
4
Development of Constrained Fuzzy Logic for Modeling
Biological Regulatory Networks and Predicting Contextual
Therapeutic Effects
by
Melody K. Morris
Submitted to the Department of Biological Engineering
on May 18, 2012, in partial fulfillment of the
requirements for the degree of
Doctor of Philosophy in Biological Engineering
Abstract
Upon exposure to enviromnental cues, protein modifications form a complex signaling
network that dictates cellular response. In this thesis, we develop methods for using
continuous logic-based models to aide our understanding of these signaling networks
and facilitate data interpretation. We present a novel modeling framework called
constrained fuzzy logic (cFL) that maintains a simple logic-based description of inter-
actions with AND, OR, and NOT gates, but allows for intermediate species activities
with mathematical functions relating input and output values (transfer functions).
We first train a prior knowledge network (PKN) to data with cFL, which reveals
what aspects of the dataset agree or disagree with prior knowledge. The cFL models
are trained to a dataset describing signaling proteins in a hepatocellular carcinoma
cell line after exposure to ligand cues in the presence or absence of small molecule
inhibitors. We find that multiple models with differing topology and parameters
explain the data equally well, and it is crucial to consider this non-identifiability
during model training and subsequence analysis. Our trained models generate new
biological understanding of network crosstalk as well as quantitative predictions of
signaling protein activation.
In our next applications of cFL, we explore the ability of models either constructed
based solely on prior knowledge or trained to dedicated biochemical data to make pre-
dictions that answer the following questions: 1) What perturbations to species in the
system are effective at accomplishing a clinical goal? and 2) In what environmen-
tal conditions are these perturbations effective? We find that we are able to make
accurate predictions in both cases. Thus, we offer cFL as a flexible modeling method-
ology to assist data interpretation and hypothesis generation for choice of therapeutic
targets.
Thesis Supervisor: Douglas A. Lauffenburger
Title: Professor
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Chapter 1
Introduction:Logic-based models
for the analysis of cell signaling
networks [103]
1.1 Summary
Computational models are increasingly used to analyze the operation of complex
biochemical networks, including those involved in cell signaling networks. Here we
review recent advances in applying logic-based modeling to mammalian cell biology.
Logic-based models represent biomolecular networks in a simple and intuitive manner
without describing the detailed biochemistry of each interaction. A brief description of
several logic-based modeling methods is followed by six case studies that demonstrate
biological questions recently addressed using logic-based models and point to potential
advances in model formalisms and training procedures that promise to enhance the
utility of logic-based methods for studying the relationship between environmental
inputs and phenotypic or signaling state outputs of complex signaling networks. We
then relate the work presented in the remainder of this thesis to that described in
this introduction.
1.2 Background
With accelerating pace, molecular biology and biochemistry are identifying complex
patterns of interactions among intracellular and extracellular biomolecules. With
respect to cell signaling in eukaryotes, the focus of this chapter, complex multi-
component networks involving many shared components govern how a cell will re-
spond to diverse environmental cues. Powerful experimental approaches now exist
for identifying components of these networks and for determining their biochem-
ical activities, but understanding the networks as an integrated whole is difficult
using intuition alone. Thus, mathematical and computational modeling is increas-
ingly playing a role in data interpretation and attempts to extract general biological
understanding [69, 46]. Depending on the network studied, the data available and
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the questions posed, a diverse spectrum of modeling approaches exists, ranging from
the highly abstract to the highly specified [59, 57]. The goal of this chapter is to
discuss logic-based modeling, an approach lying midway between the complexity and
precision of differential equations on one hand and data-driven regression approaches
on the other.
Within the spectrum of modeling methods currently being applied to cellular
biochemistry, models involving differential equations bear the closest relationship to
underlying biochemical rate laws. Sets of coupled ordinary differential equations
(ODEs) can effectively represent chemical reactions when the number of molecules is
large and mass action approximations are appropriate. Partial differential equations
(PDEs) add the ability to represent spatial gradients [4] and stochastic methods
make it possible to analyze systems in which the number of molecules is small[118].
Networks of differential equations can model the temporal and spatial dynamics of
biochemical processes in considerable detail, making it possible to study chemical
mechanism and predict network dynamics under various conditions. However, the
topology of ODE and PDE-based models (that is, patterns of interaction among the
species) must be specified in advance and model output is strongly dependent on the
values of free parameters (typically initial protein concentrations and rate constants).
Estimating these parameters is a computationally intensive task requiring substantial
data. As networks get larger, ODE modeling becomes more and more challenging,
and models that attempt to capture real biological data are currently limited to a
few dozen components.
At the other extreme, a very active field has emerged to compute graphical repre-
sentations of biological networks through literature analysis or identification of corre-
lations in high throughput data. In these graphs, termed protein interaction networks
(PINs or interactomes) or protein signaling networks (PSNs), genes and proteins are
represented by nodes and potential interactions by edges (links). The edges can be
directional or not and signed (inhibitory/activating) or not and typically represent
a wide range of interaction modes from direct physical binding to correlated gene
expression [8] or integrated database entries [121]. Graphs are an attractive way to
summarize diverse relationships among large number of biomolecules across multiple
organisms but they are not executable per se and cannot be used to compute input-
output relationships. Moreover, network graphs rarely take into account dynamic
changes in signaling activities, cell type-specific biochemistry or context-dependent
variations [64].
Here, we review logic-based models, which represent a compromise between highly
specified differential equation models and protein interaction graphs. Using logic-
based methods, it is possible to model interactions among large numbers of protein
species and perform model training, model validation and model-based prediction.
The first application of logic-based modeling to biological pathways is credited to
Kauffman, who used discrete logic to model the biological process of gene regulation
[66]. Subsequent work focused on delineating theoretical properties of logic-based
models of gene regulation [25, 147]. Huang and Ingber were among the first to
apply logic-based modeling to cell signaling networks, demonstrating that specific
cell phenotypes might correspond to dynamic steady states of a logic-based model
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of intracellular signaling species [53]. This example of linking environmental inputs
to phenotypic outputs via a logic-based model of a biochemical signaling network
has sparked considerable interest in the possibility of harnessing logic-based models
to understand the relationship between biochemical signaling network and cell state,
reflected in a large nmnber of studies over the past few years [53, 10, 3, 34, 41, 47,
55, 67, 82, 87, 96, 116, 128, 124, 129, 131, 159, 165, 168, 161, 134, 98].
This chapter is divided into two sections. In the first, we describe the fmdamen-
tals of logic-based modeling; in the second, we discuss six applications of logic-based
modeling to eukaryotic biology. We focus on logic-based models of biochemical signal-
ing networks and refer the reader to the literature for a more in-depth explanation of
theoretical considerations[148], applications of logic-based models to gene regulatory
networks [25] and models of intercellular communication [68, 145].
Figure 1-1 (facing page): Example logic-based network a. Protein signaling network. Bio-
chemical species are represented as nodes. The interactions between these nodes interact
is indicated with arrows. b. Logic Gate. Precisely how the nodes interact is specified
with a simple Boolean logic gate. c. Truth table specifying the output node given possible
combinations of its inputs nodes' values. d. Boolean logic gates an their truth tables. If
the gates are used in the example network, the interaction is shown on the right. We also
describe the AND NOT gate, which is used in the example network. We note that, in many
applications of logic-based modeling, OR and AND gates are not explicitly indicated with
their gate symbols. e. Example logic-based network structure. The model was simulated
with synchronous updating using custom MatLab (Mathworks, Inc.) code (available as
supplemental information). f. Network behavior with binary rules. Under initial conditions
with different ligand stimulations, the network response was identical because the logic rules
did not distinguish between EGF and HRG stimulation. g. Multi-state rule specification.
The truth tables are given for each modeled species. These rules specify multiple states.
The greater sensitivity of EGFR for EGF than HRG is encoded in the higher level it reaches
upon stimulation by EGF. Rules that are different from the binary rules are highlighted.
h. Network behavior with multi-state rules given in d. The rules specified that EGFR is
more sensitive to EGF than HRG. Thus, the behavior differed depending on the stimula-
tion condition. Under EGF or EGF and HRG stimulation, the states of ERK and AKT
stabilized whereas they oscillated under HRG stimulation alone. This is because the rules
specified that, with the highest activation level of EGFR (activation state two), the negative
feedback by ERK was did not effectively inhibit P13K, whereas with medium activation of
EGFR (activation state one accessed with only HRG was present), the negative feedback
was effective.
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1.3 Representing biochemical networks with logic-
based models
1.3.1 What is a logic-based model?
Consider the graphical representation of a signaling network common to protein in-
teraction networks (Figure 1-1a): the nodes in the graph represent proteins, and the
edges represent interactions. Such a graph depicts nodes that interact physically
or have correlated expression or genetic profiles (depending on the underlying data
source) but do not allow us to explicitly compute the state of activity of individual
nodes given different inputs or initial network states. Performing such a calculation
requires information on how each node reacts to the activities of its input nodes. In
logic-based models, these dependencies are specified by 'gates' (Figure 1-1b) which,
in Boolean logic, are specified by 'truth tables' that list output states for all possible
combinations of input states (Figure 1-1c). Figure 1-1d shows the truth tables of the
OR, AND, and NOT Boolean logic gates as well as a small network in which gates
are assembled to create the AND-NOT logic gate.
To illustrate how logic-based modeling can be applied to a biological network,
consider a hypothetical representation of epidermal growth factor receptor (EGFR)
and several downstream proteins (Figure 1-1e). This toy network is too simple to be
realistic but demonstrates several issues of importance when building a logic-based
model. Either epidermal growth factor (EGF) or heregulin (HRG) can bind to and
activate EGFR (Figure 1-1d,e). EGFR then stimulates the Raf/ERK and PI3K/AKT
pathways (the multitude of known biochemical interactions in this case are modeled
as a single 'activating' edge). ERK activity inhibits the EGFR-dependent P13K
activation whereas AKT positively regulates the Raf/ERK pathway (Figure 1-1d,e).
With this information it is possible to compute the response of the unperturbed
network to a given input as well as responses resulting from inhibition of a node (by a
drug for example). However, under all simulated conditions (EGF or HRG alone or in
combination, Figure 1-1f), the network response is the same. This is to be expected
because binary logic cannot encode the differential sensitivities of EGFR to EGF and
HRG, a point we return to below.
1.3.2 Modeling non-discrete processes using logic-based ap-
proaches
The assumption in Boolean logic that all species are either on or off (states 1 or 0) is
clearly an unrealistic way to represent binding curves or catalytic reactions. Fortu-
nately, logic-based modeling provides several approaches for modeling intermediate
states of activity (Figure 1-2a). Multi-state discrete models specify additional levels
between 0 and 1, whereas fuzzy logic allows for continuous node states. In fuzzy logic,
which has found wide utility in industrial control systems, a set of user-defined func-
tions transforms discrete logic statements into relationships between continuous in-
puts and output levels. Other methods of describing discrete or Boolean logic models
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Figure 1-2: Description of logic-based formalisms. a. Description of various forms of
logic-based models: All logic-based models describe species' interactions in terms of log-
ical statements (or rules). Discrete logic can specify two or more levels for each modeled
species whereas Boolean logic specifies only two levels of each species. In addition to these
logic-based formalisms, various methods of describing discrete or Boolean logic models with
piece-wise continuous equations [39] or logic-based ODEs [159] have been successfully im-
plemented to represent biochemical signaling networks. b. Approximation of input-output
relationship between hypothetical biological species (black solid line) with binary (red solid),
ternary (green dashed), and quaternary (blue dash-dot) discrete logic gates. Various thresh-
olds could be chosen for each discrete gate; chosen thresholds are purely hypothetical. c.
Plane of granularity in species' states and treatment of time: Regions containing various
logic-based modeling variants are denoted by shaded boxes. Boolean networks (blue region)
and some discrete logic-based networks (orange region) are binary but their treatment of
time ranges from logic steady state to discrete with delays. Discrete models with multiple
species state cover a similar range in possible treatments of time. Fuzzy logic models (green
region) describe a continuous range of species' states with the same range of time granu-
larity. Conversion of Boolean or discrete models into logic-based ODEs, piecewise linear,
and standardized qualitative dynamical system (purple region) result in models that are
continuous in both species' states and time. Each case study is placed on the landscape
according to how it represents the biological system of interest with a logic-based network.
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098
0.7 - - - - --
specis ineracoonseDiscrete Fuzzy *o&0*
logic models models 0o .s - ---------- jpctual response
-Binary representation
04 *- 3-level representation
0.3 4 4-level representation
Fuzzy logic of mxed
Limit to two states Specify multiple 02 iscrete-continuous
species states o t representation
02 03 0.4 0 o.e
I F IInput
Boolew M -stat. Sdy Di w
Formulate as
continuous model
Continuous ormixed
discrete-ontinuous
Detain
Species' ohm"
24
as continuous or mixed discrete-continuous have also been implemented successfully
(Figure 1-2a, dashed lines) [159, 39, 96].
How is a prototypical biological interaction approximated using discrete and non-
discrete logic formalisms? In Figure 1-2b, a sigmoidal relationship between input
and output level (e.g. a protein kinase acting on a substrate, black solid line) is
approximated by a binary (red solid), ternary (green dashed), and quaternary (blue
dash-dot) discrete logic functions. Fuzzy logic and mixed discrete-continuous logic
can closely approximate the real response (orange dashed). It is important to note
however, that the increased realism of multi-state or Fuzzy logic modeling comes
at the cost of increased complexity, typically in the form of a threshold or transfer
function having free parameters that must be estimated.
1.3.3 Treatment of time in a logic-based model
Figure 1-1g provides an example of how multi-state discrete logic can be used to
represent the differing states of activation of EGFR when exposed to EGF and HRG
stimulation, where an additional activation level of 'two' indicates that EGFR is
more sensitive to EGF than HRG. In the model, addition of HRG alone causes AKT
and ERK activity levels to oscillate (Figure 1-1h, right panel). These oscillations
are caused by the negative feedback between ERK and P13K. However, when either
EGF alone or both EGF and HRG are present (Figure 1-1h, left panel), EGFR is
in activation state two and the negative feedback inhibiting P13K is absent. Thus,
oscillations are not observed.
The presence of oscillations in this and other logic-based networks complicates
analysis, and the actual form that the oscillations take depends on the treatment of
time during the simulation. Logic-based models represent time with varying degrees
of detail. We present this concept graphically in Figure 1-2c, where each modeling
formalism is classified according to the detail in its representation in species' state
and time. Table 1.1 presents a comparison of the approaches in tabular form. The
activity of each species in discrete logic-based network simulations is determined by
its input node states at some previous time step. The order in which node states are
updated results in an implicit treatment of time scales.
Two primary node-updating schemes exist: synchronous and asynchronous [147,
146, 36]. Synchronous updating updates every node at each time step according to
the states of its input nodes at the previous time step whereas asynchronous updat-
ing updates node states in random order. In practical terms, asynchronous updating
involves updating an output node based on some of its input nodes at the current
and others at a previous time step. Variants of both synchronous and asynchronous
updating exist. Time delays can be specified with synchronous updating, allowing for
a more refined description of dynamics. A variant of asynchronous updating, mixed
asynchronous updating, allows some nodes be updated before others, making it pos-
sible to represent separation of time scales for fast (e.g., binding, phosphorylation)
and slow (e.g., degradation, transcription) reactions, similarly to time delays[71]. Re-
gardless of the updating scheme, it is frequently observed that logic-based models
will settle into an 'attractor state' in which states no longer change (logic steady
25
Table 1.1: Description of logic modeling variants. Discrete time steps could use synchronous
or asynchronous updating with or without delay or be examined at steady state. *Biochem-
ical signaling network +Genetic network
Logic Modeling Time Treat- Detail of Use in biologi-
Variant ment species' states cal modeling
Boolean Discrete time Binary *[53, 34, 41, 47,
steps 82, 124, 128, 98]
+[82, 15, 31, 81,
24]
Discrete logic Discrete time Multi-state; user- *[87, 161,134, 96]
steps defined +[161, 93, 94]
Fuzzy Logic
Piece-wise linear
Logic-based
ODEs
Standardized
qualitative dy-
namical systems
Discrete time
steps or time
can be treated
as a variable
Continuous
Continuous
Continuous
Multi-state; user-
defined and im-
plicit in calcu-
lation of output
state
Multi-state; user-
defined and im-
plicit in equations
Multi-state; im-
plicit in ODE
equations
Multi-state; im-
plicit in formal-
ism
*[10, 3, 55, 168]
+[15, 11]
*[159]
[116]
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state) or states cycle in a pattern of activity (the oscillations in the example network
are an example of a cyclic attractor state; Figure 1-1h). The continuous or mixed
discrete-continuous methods mentioned previously formulate discrete logic as ordi-
nary differential equations or piecewise-linear equations, respectively. This treatment
allows one to model both species' state and time as continuous (Figure 1-2c) but at the
cost of increased model complexity. Research into the influence of updating scheme
on the segment polarity network of Drosophila melanogaster [15] and mammalian cell
cycle [311 network have demonstrated that the different treatments of time can lead to
unique biological interpretations. Generally, the most appropriate updating scheme
is dependent on the type of model built as well as the questions that the model is
meant to address.
Another extension of logic-based modeling aims to incorporate probabilistic inter-
actions [137, 37]. This method allows one to account for uncertainty in knowledge of
signaling networks as well as stochasticity in biological systems. Also noteworthy are
a number of efforts to apply related formalisms such as Petri nets, cellular automata
etc. to biological networks [32]. In some cases, these formalisms can be reduced
to logic-based formalisms, and they provide an additional level of abstraction that
makes it possible to perform formal network analysis[1]. Because these probabilistic
and computational techniques involve slightly different considerations than previously
discussed, we do not describe them further and instead point the interested reader to
the references listed above.
This chapter focuses on a qualitative description of various logic-based formalisms.
For readers interested in the actual computational procedures involved in carrying
out these methods, an outline is provided Supplementary Figure A-1. Additionally,
several dedicated software packages have been developed for logic-based modeling of
biochemical signaling networks with varying degrees of detail and differing updating
schemes; some of these are listed in Table 1.2. We refer the interested reader to the
references in this table for descriptions of each simulation procedure, in particular the
quantitative approaches not described here.
1.4 Applications of logic-based models to biochem-
ical networks: Case Studies
Below we discuss six logic-based models of signal transduction as a means to highlight
different methods, biological questions and opportunities for future development; we
necessarily omit many details. Figure 1-3a shows a general workflow for applying
logic-based modeling to signaling networks and serves as a means to summarize the
key features of each case study: (i) Case studies 1 and 2 involve models built solely
from literature-based prior knowledge (Figure 1-3b); (ii) Case 3 involves a comparison
of models to data (Figure 1-3c); (iii) Cases 4 and 5 use manual refinement to fit
experimental data to a fuzzy (case 4) or Boolean (case 5) logic-based model (Figure
1-3d); and, (iv) Case 6 presents a formal method for model optimization based on
refining a literature-based Boolean model against high-throughput data (Figure 1-3e).
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Table 1.2: Tools available for the logic modeling of biochemical signaling networks
Tool
BooleanNet
Type
logic
of
Boolean
Functionality
Simulation and visu-
alization
Treatment
of time
Synchronous,
asynchronous,
or. piecewise-
continuous
GinSim Discrete Model building, sim- Synchronous, [14, 40]
(multi- ulation and analysis asynchronous,
state) or mixed
asynchronous
CellNet Ana- Boolean Network properties Logic-steady [71, 70]
lyzer (multi- analysis state
state)
CellNet Opti- Boolean Model refinement Logic-steady [124]
mizer state
Odefy Boolean Simulation and visu- Synchronous, [159]
and Logic- alization asynchronous,
based or continuous
ODEs
Genetic Piecewise- Model building and Continuous [26]
Network linear dif- simulation
Analyzer ferential
equations
ChemChains Boolean Model simulation, vi- Synchroos 5-
sualization, and anal- (with de-
ysis lays) or
asynchronous
MetaReg Discrete Simulation and visu- Logic steady [151]
(3 states) alization; model re- state
finement
SQUAD Standardize dModel simulation
qualita- and analysis
tive dy-
namical
systems
Continuous
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Ref
1 (56)
[95, 27]
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Figure 1-3: Workflow of application of logic-based models to answer biological questions. a.
General workflow. The workflow is divided into two phases: an initial model-building phase
(purple boxes) and model prediction phase (blue box). Hypotheses are made from models
built either from literature (box la) or from a comparison of a literature-based model with
data (boxes la-c). In some cases, the models are refined manually (box le) or optimized
formally (box If) with data and then used to make hypotheses (boxes la-f). b. Workflow
of case studies 1 and 2. These case studies analyze network properties of logic-based mod-
els built from the literature and use them to make experimentally testable predictions. c.
Workflow of case study 3. This case study compares the results of experiments to simula-
tion results of a logic-based network to make predictions. They also analyze the network
properties of their logic-based network. d. Workflow of case studies 4 and 5. Both case
studies manually refine their models based on experimental data and, prior to refining, case
study 5 first uses a model built from the literature to predict experimental outcome. e.
Workflow of case study 6. This case study compares logic-based models to experimental
data and presents a formal method of training a Boolean network model to data.
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1.4.1 Case Study 1: Boolean logic model of leukemic T cell
large granular lymphocytes [165]
Zhang et al. use a Boolean network model constructed from the literature to ask which
proteins in leukemic T cell large granular lymphocytes (T-LGL) should be inhibited
to induce apoptosis. Simulation of a 58-node logic model of the T-LGL survival-
signaling network is used to address the following questions (i) What are minimal
stimulation conditions that recapitulate observed deregulation of the T-LGL network
and (ii) What perturbations might reverse deregulation and promote apoptosis?
A literature survey and experimental observations were combined to assemble a
Boolean logic network describing signaling in T-LGL that affected cytoskeleton sig-
naling, apoptosis, and proliferation. Simulations were compared when all nodes were
free to vary and when some nodes were fixed (i.e. set to active or inactive and not
allowed to change during the asynchronous updates). When the appropriate nodes
were fixed, the model correctly recapitulated the situation in which leukemic T-LGL
failed to undergo activation-induced cell death. Model analysis predicted a niinimum
set of stimuli that would result in the deregulated survival signaling previously ob-
served in leukemic T-LGL. Experimental inhibition of this network state was shown
to induce apoptosis in leukemic but not normal peripheral blood mononuclear cells
(PBMCs). Intriguingly, the authors identified nodes whose activation or inactivation
caused the apoptosis node to be activated. These nodes are potential therapeutic
targets for induction of apoptosis in leukemic T-LGL. Chemical knockdown of two of
the identified nodes, Sphingosine kinase 1 and NFKB, did indeed result in increased
apoptosis in leukemic T-LGL but not normal PBMCs.
1.4.2 Case Study 2: Logic-based model of helper T cell dif-
ferentiation [96]
Mendoza used a literature-derived logic network model of interactions among five
cytokines and transcription factors in helper T Cells (Th Cells) to ask the following
questions. (i) Do the final states of a logic-based network correctly represent the
differentiation fates of the helper T cell (Th cell)? (ii) How do feedback loops in
cytokine signaling interact to generate specific cell fates? (iii) How does perturbing
nodes of the logic network change the differentiation fate of Th cells?
A 17-node logic-based model of the Th regulatory network was constructed from
published literature and simulated under all combinations of initial node states until
logic steady states were achieved. This analysis revealed four steady states: one
corresponding to ThO cells, one corresponding to Th2 cells, and two corresponding
to Th1 cells. The Th1 cell attractors differed in their level of secretion of IFN-y but
their level of IFNy receptor was the same, a result supported by the literature. The
feedback circuits that caused the network to reach these steady states were shown
to correspond to experimental conditions known to induce ThO cells to differentiate
into Th1 or Th2 cells. Moreover, literature data validated several predictions based
on single node perturbations that corresponded to deletion or over-expression.
This paper illustrates the utility of logic-based modeling when analyzing a network
30
involving many positive and negative interactions whose net effect is not intuitively
obvious. This type of model could be used to answer a number of interesting biological
questions. For example: After a cell has entered one steady state, what cytokines
or inhibitors must be present to switch it to another state? How might systemic
cytokine administration affect the Th cell population? Can manipulation of normal
nodes compensate for defects in nodes mutated in disease?
1.4.3 Case Study 3: Boolean logic model of ErbB receptor
phospho-protein signaling data [131]
In the examples cited above, no direct link exists between the construction of the logic-
based model and experimental data (Figure 1-3b). In contrast, Samaga et al. directly
compared the outputs of a Boolean logic model constructed from the literature to
data collected from cells (Figure 1-3c). The authors first developed a strategy for
converting a biochemical network into Boolean logic. They then used this method to
construct a complex Boolean logic model from a canonical graph of ErbB signaling
that has been assembled by Kitano and colleagues [108]. Finally, they asked: Is
the constructed Boolean model consistent with data from cells stimulated with ErbB
ligands?
Model construction and simulation in Samaga et al. [131] was performed using
the toolboxes ProMoT [127] and CellNetAnalyzer (CNA) [70] and data were obtained
by exposing HepG2 liver cancer cells and primary human hepatocyte to various ErbB
ligands in the presence and absence of specific small-molecule kinase inhibitors. In-
consistencies between model prediction and experimental observation generated a set
of eleven hypotheses regarding ErbB signaling in HepG2 and primary cells. Five of
the eleven were supported by literature (although not in the cell types used in this
study); five pointed to the need to remove or add interactions in the network; and
one suggested that a small molecule inhibitor did not have the expected specificity.
Significantly, this work successfully converted a biochemical map into an executable
logic-based model and then used experiments to explore model topology.
1.4.4 Case Study 4: Fuzzy logic model of protein signaling
data [3]
As a means to analyze a set of continuous data, Aldridge et al. [3] built a fuzzy logic
model of multiple growth factor and cytokine pathways based on prior literature
knowledge and then refined the model manually based on measurements of signaling
protein phosphorylation in cells treated with TNFa, EGF and insulin. During the
model-building process, the authors asked: What interactions between TNFa and
growth factors best explain experimental data?
This data consisted of total or phospho-protein levels for eleven signaling proteins
following exposure of cells to TNFa, EGF and Insulin individually or in combination
at thirteen time points from zero to 24 hours. Because Boolean logic was unable
to capture important intermediate states of protein modification in the data, fuzzy
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logic modeling was used. Fully-implemented fuzzy logic is much more flexible than
Boolean logic. Thus, the authors first selected a limited number of ways to represent
interactions. Manual data fitting was used to optimize the interactions in the model
and the shapes of the functions relating input and output species in the fuzzy logic
gates. Time was included as a variable ("early" or "late") and time delays were
included in the logical rules for several gates. Acceptable values for these delays were
determined manually. During the model-building process, the authors uncovered
unexpected interactions between ERK and IKK activities. This work demonstrates
that fuzzy logic can be used to model and gain insight into signaling data that was
not obvious from either inspection or partial least squares regression modeling. The
authors also note that because manual fitting of large datasets to a fuzzy logic model
is an arduous process, methods are required to automate the fitting process.
1.4.5 Case Study 5: Integration of logic-based modeling with
experimental study of Trastuzumab-resistant breast can-
cer [129]
Sahin et al. first used a literature-derived Boolean logic model of a chemotherapeutic
resistant cell line to ask the question: Knockdown of which molecular species will
result in increased drug sensitivity? Because the model was unable to accurately
predict experimental results, they attempted to deduce the network from experimental
data but concluded that the most reliable network was one that they had manually
refined (Figure 1-3c).
Trastuzumab is a monoclonal antibody against ErbB2 that has successfully treated
a subset of ErbB2 positive breast cancers. However, two thirds of patients are
Trastuzumab-resistant from the beginning of treatment. The authors hypothesize
that this resistance is conferred by an escape from G1 cell cycle arrest. A Boolean
logic network model of ErbB receptor regulation of the G1/S cell cycle transition
was constructed based on published literature. Only the ErbB receptor dimerization
events that were possible in the cell line model of Trastuzumab resistance were in-
cluded in the model and initial node states were set based on the biological activity
of the proteins in their experimental system, making the model specific to the experi-
mental system of interest, a clear benefit for modeling a context-sensitive phenomenon
such as Trastuzumab resistance, which is context sensitive.
The retinoblastona protein (Rb) is phosphorylated under conditions of constant
EGF stimulus and was postulated to allow cells to escape G1 cell cycle arrest. The
model was queried to identify those nodes whose inactivation under conditions of
constant EGF would result in pRb dephosphorylation and consequent G1 cell cycle
arrest (resulting in restoration of Trastuzunab sensitivity). RNAi knockdown of
all but two species in the network (including those not predicted a priori to confer
Trastuzumab sensitivity) was then used to test model-based predictions, several of
which were found to be correct. Manually refining a single logical rule substantially
improved accuracy, correctly predicting all but one RNAi knockdown result. The
authors attempted to reverse engineer the network using protein array data but were
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unable to explain this final inconsistency. Overall, this work nicely illustrates the
power of integrating experimental and logic-based modeling to gain a more complete
understanding of the system of interest. As with case study 4, it also points to a need
for more reliable methods of training of logic-based networks.
1.4.6 Case Study 6: Training a Boolean logic model of HepG2
signaling [124]
The primary advance in Saez-Rodriguez et al. [124] is the development of a formal
method for optimizing logic-based models against experimental data, implemented
in the CellNetOptimizer software. The data in this case was fairly extensive, com-
prising 1000 phospho-protein measurements of sixteen signaling proteins in tumor
cells stimulated with one of six growth factors or inflammatory cytokines (TGFa,
IGF1, TNFa, ILla, LPS, and IL6) in the presence or absence of one of seven small
molecule kinase inhibitors. The starting point for model construction was a signed
directed graph comprising 82 nodes and 116 interactions derived from pathways in
the Ingenuity IPA software. The authors then asked: (i) Can a formal training pro-
cess be developed to increase the predictive capacity of the nave model? (ii) Is the
number of interactions in an optimized network similar to or smaller than the number
in the nave model? (iii) Can interactions absent from the initial graph be indentified
that increase predictive power? It was observed that data-optimized models contain
many fewer interactions than the original network graph, suggesting the presence of
many false-positive interactions at least for the HepG2 cells under study. Moreover,
addition of a small number of links deduced directly from data improved predictive
capacity while increasing model size only modestly. Support for these links was subse-
quently found in the literature. This work represents a first step in using logic-based
models to generate executable models of network graphs and then refining the mod-
els to increase their reliability in specific cellular contexts. Direct extension of the
methods should make it possible to compare different cell types directly and perhaps
even identify drugs that affect diseased but not normal cells.
1.4.7 Outline of Thesis Work
In this chapter, we described how logic-based models can be used to represent bio-
chemical signaling networks and illustrate some of the questions that logic-based
modeling can address. The ability of discrete and fuzzy logic models to determine
the effects of protein over-expression or inhibition on phenotype, elucidate network
properties, and identify the network that best describes high-throughput experimen-
tal data has been illustrated with case studies. However, as illustrated by case studies
4 and 5, the ability to gain significant biological insights with the models was fre-
quently hampered by the lack of a method to rigorously train the logic model to data.
While this was accomplished in case study 6 for Boolean logic models, the inability
to accurately model intermediate values is a significant limitation of the approach.
In the following chapters of this thesis, we present a novel logic modeling formal-
ism called 'constrained fuzzy logic' (cFL) that retains the ability of traditional fuzzy
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logic to fit intermediate values but constrains the modeling flexibility such that it is
able to efficiently model biological systems. We first use cFL to train logic models to
data by altering the approach presented in case study 6 (Chapter 2). We demonstrate
the the ability of cFL to fit intermediate values was crucial for accurately determining
model topology and gaining important biological insights from our data. We perform
a preliminary investigation of the ability of cFL models to predict species states in
Chapter 2, and in Chapters 3 and 4 we significantly extend this capability by de-
veloping a complementary software tool called 'Querying Quantitative Logic Models'
(Q2LM) that uses cFL model simulation results to determine therapeutic perturba-
tions predicted to be effective at accomplishing a clinical goal in different contexts.
We use Q2LM to answer these questions with cFL models constructed based solely
on prior knowledge (Chapter 3) or trained to data (Chapter 4). Finally, we conclude
with an examination of further opportunities for development and application of this
modeling technique (Chapter 5).
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Chapter 2
Training a constrained fuzzy logic
model to data [102]
2.1 Summary
Predictive understanding of cell signaling network operation based on general prior
knowledge but consistent with empirical data in a specific environmental context is
a current challenge in computational biology. Recent work has demonstrated that
Boolean logic can be used to create context-specific networks models by training pro-
teomic pathway maps to dedicated biochemical data; however, that formalism is re-
stricted to characterizing protein species as either fully active or inactive. To advance
beyond this limitation, we propose a novel form of fuzzy logic sufficiently flexible to
model quantitative data but also sufficiently simple to efficiently construct the mod-
els by training pathway maps on dedicated experimental measurements. Our new
approach, termed constrained fuzzy logic (cFL), converts a prior knowledge network
(obtained from literature or interactome databases) into a computable model that
describes graded values of protein activation across multiple pathways. We train a
cFL-converted network to experimental data describing hepatocytic protein activation
by inflamnmatory cytokines and demonstrate the application of the resultant trained
models for three important purposes: (a) generating experimentally testable biological
hypotheses concerning pathway crosstalk, (b) establishing capability for quantitative
prediction of protein activity, and (c) prediction and understanding of the cytokine re-
lease phenotypic response. Our methodology systematically and quantitatively trains
a protein pathway map summarizing curated literature to context-specific biochemi-
cal data. This process generates a computable model yielding successful prediction of
new test data and offering biological insight into complex datasets that are difficult
to fully analyze by intuition alone.
2.2 Background
Signaling networks regulate cell phenotypic responses to stimuli present in the extra-
cellular environment [63]. High throughput 'interactome' data provide critical infor-
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mation on the composition of these networks [156, 112, 28], but understanding their
operation as signal processing systems is strongly advanced by direct interface with
dedicated experimental data representing measured responses of biochemical species
in the network (proteins, mRNA, miRNA, etc.) to stimulation by enviromnental cues
in the presence or absence of perturbation [38, 58, 97, 84]. Immediate early responses
are dominated by protein post-translational modifications (we focus here on phospho-
rylation), assembly of multi-protein complexes, and changes in protein stability and
localization. Such responses are typically highly context dependent, varying with cell
type and biological environment. A critical question for the field is how large scale
measurements of these responses can be combined with a signed, directed protein
signaling network (PSN) to better understand the operation of complex biochemical
systems [85].
PSNs are typically deduced by manual or automated annotation of the literature
(e.g. [65}) or directly from high-throughput experimental data (e.g. [143, 121, 139])
using a variety of computational techniques. PSNs are represented as node-edge
graphs [117], and although they provide high-level insight into the composition and
topology of regulatory networks [83, 30, 135, 13, 16, 111], as currently constituted
PSNs are not readily 'computable' in that they cannot be used to calculate activation
states of the key proteins in a pathway given a set of input cues, nor can quantitative
relationships between pathways be determined. This restricts the utility of PSNs for
explicit prediction of responses and makes it difficult to compare network represen-
tations to functional experimental data. A chief motivation of our current work is to
determine how information encoded in a PSN can be made computable and compared
to experimental data from a specific cell type, resulting in a context-specific network
model.
Logic-based models (e.g. [128, 96, 165, 129, 131, 12]; reviewed in [103, 157]) of-
fer one means for converting interaction maps into computable models. We have
previously used Boolean logic (BL) to convert a literature-derived signed, directed
PSN (comprising for this purpose a 'prior knowledge network' [PKN]) into a com-
putable model that could be compared to experimental data consisting largely of the
phospho-states of signal transduction proteins in the presence of different ligands and
drugs [124]. This approach allowed us to determine which links in the PKN were
supported by the data, and generated models that were useful in making predictions
about network topology [124, 125] and drug targets [98]. However, Boolean logic has
a significant limitation, since real biochemical interactions rarely have simple on-off
characteristics assumed by Boolean logic. Thus, we require a means to encode graded
responses and typical sigmoidal biological relationships in a logical framework.
One way to accomplish this is to apply traditional fuzzy logic [FL], as demon-
strated previously in modeling continuous input-output relationships to encode a
complex signaling network [10, 3, 55]. In the realm of control theory, FL modeling
is an established technique for predicting the outputs of complex industrial processes
when the influences of inputs cannot be characterized precisely [164, 149, 153]. A
central feature of FL is that it accounts for graded values of process states using a
virtually unlimited repertoire of relationships between model species or components.
However, for past application to biochemical signaling networks, the flexibility of con-
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ventional FL modeling necessitated that the network topology be fixed prior to either
manual [10, 3] or computational [55] parameter fitting, rendering a formal training of
network topology to experimental data infeasible.
In this chapter we develop and employ a new approach to fuzzy logic modeling of
biological networks that we term 'constrained fuzzy logic' [cFL] for descriptive pur-
poses. A key feature of cFL modeling is that it limits the repertoire of relationships be-
tween model species, enabling the formal training of a PKN to experimental data and
resulting in a quantitative network model. To maximize broad dissemination across
the computational biology community, we implement cFL in an exisiting software tool
CellNetOptimizer v2.0 (CellNOpt), significantly extended to accommodate the fur-
ther requirements of cFL while maintaining the BL analytic approach (freely available
at http://www.ebi.ac.uk/saezrodriguez/software.htnl). We demonstrate the value of
the CellNOpt-cFL method by elucidating new information from a recently published
experimental dataset describing phospho-protein signaling in HepG2 cells exposed to
a set of inflammatory cytokines [5]. We show that a cFL model can be trained against
a training dataset and then validated by successful a priori prediction of test data
absent from the training data. We also establish the benefits of cFL relative to BL
in three key areas: (a) generation of new biological understanding; (b) quantitative
prediction of signaling nodes; and (c) modeling quantitative relationships between
signaling and cytokine release nodes. Particular examples of validated biological pre-
dictions include: (i) TGFa-induced partial activation of the JNK pathway and (ii)
IL6-induced partial activation of multiple unexpected downstream species via the
MEK pathway. Our work demonstrates the technical feasibility of cFL in modeling
real biological data and generating new biological insights concerning the operation
of canonical signaling networks in specific cellular contexts.
2.3 Results
2.3.1 Constraining fuzzy logic
Fuzzy logic is a highly flexible methodology to transform linguistic observations into
quantitative specification of how the output of a gate depends on the values of the
inputs [164, 42, 107, 43]. For example, in the simplest, 'Sugeno' form of fuzzy logic,
one specifies the following quantities: 'membership functions' designating a variable
number of discrete categories ( 'low, medium, high' etc.) as well as what quantitative
value of a particular input belongs either wholly or partially to these categories; 'rules'
designating the logical relationships between the gate inputs and outputs; AND and
OR 'methods' designating the mathematical execution of each logical relationship;
'weights' designating the credence given any rule; and 'defuzzification' scheme desig-
nating how a final output value is determined from the evaluation of multiple rules
[140]. This flexibility is important in industrial process control [23], which aims to use
uncertain and subjective linguistic terms to predict how a controller should modulate
a process variable to achieve desired process outputs.
However, our goal is to train models on quantitative biological data that are in-
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evitably incomplete in the sense that (i) measurements are not obtained under all
possible conditions and (ii) available data are not sufficient to constrain both the
topology and quantitative parameters of the underlying networks. Accordingly, we
sought to develop a fuzzy logic system that minimizes the number of parameters to
avoid over-fitting and simplifies the logic structure to facilitate model interpretabil-
ity. Because we aim to represent relationships among proteins in enzymatic cascades,
mathematical relationships should be need biologically relevant. We therefore use a
simple Sugeno fuzzy logic gate with a defined form (see Supplementary Text B.1)
based on transfer functions (mathematical functions describing the relationship be-
tween input and output node values) that approximate the Hill functions of classical
enzymology.
Our 'constrained' fuzzy logic (cFL) framework uses a simplified fuzzy logic gate
that is best described by the mathematical representation in Figure 2-1. The value
of an output node of a one-input positive interaction is evaluated using a transfer
function. In this work, 'input-output' refers to the nodes of a specific cFL logic gate,
where 'node' are molecular species. We use 'model inputs' and 'model outputs' to
refer to the overall relationship between model inputs such as ligand stimulation of
cells and the collective output of the network (protein modifications or phenotypic
states in our application). The transfer function underlying cFL gates is a normal-
ized Hill function with two parameters: (1) the Hill coefficient, n, which determines
the sharpness of the sigmoidal transition between high and low output node values
and (2) the sensitivity parameter, k, which determines the midpoint of the function
(corresponding to the EC50 value in a dose-response curve, Figure 2-1a). A negative
interaction is represented similarly, except that the transfer function is subtracted
from one, effectively inverting it (Figure 2-1b). Varying these parameters allows
us to create a range of input-output transfer functions including linear, sigmoidal
and step-like (Figure 2-1a). Moreover, this transfer function is biologically relevant:
protein-protein interactions and enzymatic reactions can be described by Hill function
formulations to a good approximation [51, 155, 130].
In some cases, use of a normalized function is too restrictive for practical appli-
cation. For example, if model inputs are purely binary (values of either zero or one),
the output of a normalized function would also be zero or one, making it impossible
for a cFL gate to achieve intermediate states of activation. Accordingly, our cFL
method allows for alternative transfer functions. For example, although the method
is not limited to binary model inputs, the ligand inputs of our current work are binary
(either present or not). If we used normalized transfer functions to relate these model
inputs to downstream outputs, all model species would also be either zero or one.
Thus, for these transfer functions, we used a constant multiplied by the binary ligand
input value (see Materials and Methods 2.5).
If more than one input node influences an output node, this relationship is cat-
egorized as either an 'AND' or 'OR' interaction. An AND gate is used when both
input nodes must be active to activate the output node, whereas an OR gate is used
when either input node must be active. Mathematically, we represent AND behavior
by evaluating each input-output transfer function and selecting the minimal possible
output node value (i.e., applying the 'min' operator, Figure 2-1c) whereas we select
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Figure 2-1: Construction of gates with constrained fuzzy logic (cFL). When node C depends
only on node A, a normalized Hill function is used to calculate value of node C, 'c' given
value of node A, 'a' where n is Hill coefficient and k is the sensitivity parameter specifying
the EC 5 o for each gate. Several representative normalized Hill functions are shown for
activating (a) and inhibiting (b) cFL gates. When C has more than one input (A and B,
in this case), either an AND (c) or OR (d) gate must be used to model the interaction. In
the case of the AND gate, the minimum possible value of C calculated from the transfer
functions is used as the output node value. One possible response surface for levels of
C given different levels of A and B with two transfer functions is demonstrated (c). For
evaluation of an OR gate, the maximum value of C is used as the output node value, with
the corresponding response surface (d).
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the maximal value ( 'max' operator; Figure 2-1d) to evaluate an OR gate. Finally, if
both AND and OR gates are used to relate input nodes to an output node, our formal-
ism evaluates all AND gates prior to OR gates. This order of operations corresponds
to the disjunctive normal or sum of products form [71].
Use of cFL to understand experimental data in the context of a prior knowledge
network: CellNOpt-cFL The processing of training a cFL network (CellNOpt-cFL)
has two starting requirements. The first is a prior knowledge network (PKN; Fig-
ure 2-2, box A). A PKN depicts interactions among the nodes as a signed, directed
graph (such as a PSN) and can be obtained directly from the literature. Alternatively,
a large number of commercial (e.g., Ingenuity Systems: www.ingenuity.com; GeneGo:
www.genego.com) or academic (e.g., Pathway Commons: www.pathwaycommons.org,
reviewed in [8]) pathway databases as well as integrative tools (e.g. [78, 77]) can be
utilized to construct a PKN. The second requirement is a dataset describing exper-
imental measurements characterizing node activities following stimulation of and/or
perturbations in upstream nodes (ligand and inhibitor treatment in our example;
Figure 2-2, box B). CellNOpt-cFL is then used to systematically and quantitatively
compare the hypothesized PKN to the experimental dataset.
In practice, available experimental data is usually insufficient to fully constrain
both the parameters and topology of the cFL models, and CellNOpt-cFL recovers
many models that describe the data equally well. Due to this typical absence of
firm structural and parametric identifiability [124, 75, 113], we examine families of
models that fit the data equally well rather than attempting to identify a single
global best fit. Specifically, we examined interactions in the PKN that were either
retained or consistently removed by training. We also used individual models to
predict input-output characteristics. This treatment allowed us to calculate both an
average prediction as well as a standard deviation, which we show below was useful
for discrediting inaccurate predictions.
Our method comprises three main stages (Figure 2-2): (1) structure processing
converts a PKN into a cFL model; (2) model training trains the model to experimental
data; and (3) model reduction and refinement simplifies trained models. To illustrate
CellNOpt-cFL, we examine a simple toy problem of training a PKN of the phospho-
protein signaling network response to TGFa and TNFa (Figure 2-2a.i) to in silico
data of activation of several downstream kinases in response to these ligands in the
presence or absence of P13K or MEK inhibition (Figure 2-2a.ii).
2.3.2 PKN Processing
In the first step, we streamline the network to contain only measured and perturbed
nodes as well as any other nodes necessary to preserve logical consistency between
those that were measured or perturbed ([124]; Figure 2-2, Step 1), resulting in a
compressed PKN (Figure 2-2 box C). In our example, many nodes that were in the
original PKN were neither measured nor perturbed experimentally. Because these
nodes can be removed without causing logical inconsistencies, they are not explicitly
included in the compressed network (Figure 2-2b).
In the second step, we expand the network into the multiple logical relationships
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(combinations of AND and OR gates) that can relate output nodes to their input
nodes (Figure 2-2, Step 2). For example, our toy PKN was expanded to include all
possible two-input AND gates governing the response of nodes with more than one
possible input node (Figure 2-2c).
Figure 2-2 (facing page): Right side: Workflow (Boxes A through G and Steps 1-6) The
methodology requires a dataset that describes some species in the prior knowledge network
(PKN; Box A). Based on the data structure of the dataset (Box B), the map is compressed
to contain only nodes measured (blue nodes), perturbed (green stimulated nodes and orange
inhibited nodes), or necessary to maintain logical consistency between nodes (Step 1). The
resultant compressed network (Box C) is then expanded to contain multiple possible logic
descriptions of gates connecting more than one input node to a single output node (Step
2). The resultant expanded network (Box D) is compared to the data values (Box E) using
several independent runs of a discrete genetic algorithm to minimize MSE (Step 3). Each
independent run results in an unprocessed cFL models represented with a grey triangle.
This results in a family of unprocessed cFL models (Box F). The result of each indepen-
dent optimization run is now represented with a different colored triangle. Each individual
unprocessed model is reduced with several reduction thresholds (Step 4), resulting in sev-
eral reduced models (different triangles shadings). The parameters of each reduced model
are then refined (Step 5), resulting in reduced-refined models (triangles outlined in black).
Finally, one model is chosen to represent each original unprocessed model using a selection
threshold (Step 6), resulting in a family of filtered models (Box G). Left side: Application
to a toy model (panels a to e). A PKN was hypothesized from the Ingenuity Systems
database (www.ingenuity.com) (a.i.) and compared to an in silico dataset generated by a
simulation of a cFL model with known topology and parameters (a.ii.). The PKN contains
15 molecular species represented as nodes that are believed to positively (arrows) or nega-
tively (blunt arrows) affect others species. These intermediate nodes summarize the possible
paths between experimentally stimulated ligands (green) and measured (blue) or inhibited
(orange) species. The model was compressed as described in [124] (b) and then expanded
to contain all possible two-input AND gates (c). The expanded network was compared to
the in silico dataset with twenty independent runs of the discrete genetic algorithm. The
topologies of the resultant models were identical except in the case of the gate describing
activation of MEK (d), with sixteen models modeling this interaction with an activating
gate (brown, dashed gate) and four models using an AND-NOT gate (green, dashed gate).
The TNFa JNK cFL gate was removed from all unprocessed models, reflecting that this
interaction was inconsistent with the in silico data. The reduction process (Figure 2-3)
showed that the AND-NOT cFL gate could be described more simply without significantly
affecting the MSE, resulting in a family of filtered models (e). We have labeled each gate
with the sensitivity of the gate (defined in Materials and Methods 2.5), where sensitivity is
scaled between zero and one and a higher sensitivity indicates that the output node is more
active at lower input node values. All maps and the graphs of cFL models were generated
by a CellNOpt routine using the graphviz visualization engine (www.graphviz.org) followed
by manual annotation in Adobe Illustrator.
41
TGFa Stktmiation TNFa Stimulation
MEK
10.8
ERK o8
Akt .6
JNKo.
o.2
// //
1. Compress network based
on experimental design
VC. Compressed network
2. Expand into logic gates
(of optional complexity)
D. Expanded network E. Data Vaue
3. Discrete genetic algorithm
to minimize MSE
v v v
F. Family of unprocessed locally
optimal constrained fuzzy logic models
4. Reduction
(via Reducton Threshold)
5. Refinement
6. Fiter Reduced Refined Models(via Seleclon Threshold)
v v v
ERK JN pm
------o Urd not Identilled by
Boolean kloc mnetiodoiogy 1 G. Family of filtered locally optimalconstrained fuzzy logic modelsthat fit data well
42
a) j.
b)
C)
d)
Structure
Processing
Model
Training
e)
Model
teduction an
Refinement
I
2.3.3 Model T raining
In the third step, we train the cFL models to the data (Figure 2-2, Step 3). We start
by limiting the possible parameter combinations to a subset of discrete parameter
values that specify seven allowed transfer functions as well as the possibility that the
input does not affect the output node (i.e. the cFL gate is not present). A discrete
genetic algorithm determines transfer functions and a network topology that fit the
data well by minimizing the mean squared error (MSE, defined in Materials and
Methods 2.5) with respect to the experimental data.
Due to the stochastic nature of genetic algorithms, multiple optimization runs
return models with slightly different topologies and transfer function parameters that
result in a range of MSEs. Models with an MSE significantly higher than the best
models are simply eliminated from further consideration. Models with similar MSEs
but different topology and parameters result from the insufficiency of the data to con-
strain the model such that each model fits the data well albeit with slightly different
features. We consider each individual in this family as a viable model, and all are
included for subsequent analysis. Thus, after multiple independent optimization runs
using the discrete genetic algorithm to train the expanded PKN against the data, a
family of models with transfer functions chosen from a discrete number of possibilities
is obtained.
For each of these models, we generate unprocessed models (Figure 2-2, box F) by
removing all cFL gates that are logically redundant with other cFL gates (e.g., in the
gate '(B AND C) OR B activate D', the AND gate is logically redundant with the 'B
activates D' gate). These gates are removed because they increase model complexity
by using multiple logic gates to encode a logic relationship that can be encoded in a
simpler gate.
In our toy example, a family of twenty unprocessed models was obtained by train-
ing the expanded map (Figure 2-2c) to in silico data (Figure 2-2a.ii.) using the
discrete genetic algorithm. The unprocessed models from different optimization runs
had similar topologies with the exception of the gate describing the relationship of
MEK to its input nodes: TGFa and Akt (Figure 2-2d, brown and green dashed
gates). Sixteen of the unprocessed models described the activation of MEK as de-
pending only on TGFa (brown, dashed gate) whereas four described activation using
the AND NOT gate (green, dashed gate).
2.3.4 Model Reduction and Refinement
In the model reduction and refinement stage (Steps 4-6), we determine which gates
can be removed altogether as well as AND gates that can be replaced with one-input
cFL gates without significantly affecting MSE. We implemented the non-exhaustive
heuristic search procedure described below on each unprocessed model and illustrate
its application to our toy example (Figure 2-3).
In the fourth step, we remove or replace all gates for which the alteration does
not increase the MSE of the unprocessed model over some threshold, which we term
the 'reduction threshold'. We use a range of reduction thresholds such that each
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Figure 2-3: Reduction of Tained cFL models. The unprocessed models resulting from
twenty independent runs of the discrete genetic algorithm to compare the expanded network
to an in silico dataset were reduced using several reductions thresholds and subsequently
refined. The behavior of three representative models is shown (a). To develop a criterion for
our model selection, we note that each individual model exhibits a drastic increase in refined
MSE when reduced at some reduction threshold. For our toy model, the MSEs of some
reduced-refined models increase significantly (AMSE of 7.7 x 10-3) at a reduction threshold
of greater than 5 x 10-3 (a., magenta line), whereas the MSEs of others only increase at a
reduction threshold greater than 7 x 10~3 (a., green line). In our toy example, this increase
in MSE of 7.7 x 10-3 is deemed significant because it corresponds to the models no longer
fitting the in silico data of Akt and JNK under TGFa stimulation (the remaining data are
still well fit). For each unprocessed model, we refer to the reduction threshold above which
a significant increase in MSE is observed as the 'filter point' of the model. Each individual
model has a filter point that is determined based on the amount that the reduced-refined
models' MSE is allowed to increase. We term this allowable increase in MSE the 'selection
threshold'. For example, one model of our toy example (black line) could be described as
having a filter point of 1 x 10-3 or 5 x 10-3, depending on the amount of increase in MSE
allowed by the selection threshold. To choose a selection threshold, we compare the average
increase in final MSE to the average decrease in the number of parameters in the resultant
filtered family of models (b) and note that, at a selection threshold of 7.7 x 10-3, the average
MSE increases while at a selection threshold of 5 x 10-, average number of parameters
decreases. Thus, a selection threshold of 5 x 10-4 to 7.6 x 10-3 results in the models at the
'filter points' noted in (a).
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unprocessed model results in several models, one for each reduction threshold used.
Following this step, the resultant models are considered reduced models.
In the fifth step, we fix the model topology to that obtained during Step 4 and
treat the transfer function parameters in each reduced model (Figure 2-2, Step 5) as
continuous parameters rather than the discrete set of transfer function parameters
required for use of the discrete genetic algorithm. We use a Sequential Quadratic
Programming method (Supplementary Text B.1) to refine the model parameters and
further improve the fit of the models to the experimental data. The resulting models
are termed reduced-refined models, which have a range of MSEs depending on the
reduction threshold used (Figure 2-3a).
In the sixth and final step, we specify a reduced-refined model to represent each
unprocessed model (Figure 2-2, Step 6). For each unprocessed model, we choose
the reduced-refined model that has the fewest number of fitted transfer function
parameters without increasing the MSE above a defined 'selection threshold'. The
selection threshold is chosen by comparing the average number of parameters in the
family of models to the average MSE of the models (Figure 2-3b). The net result is a
set of reduced-refined-filtered models (hereafter referred to as filtered models, Figure
2-2, Box G).
In our toy example, the filtered models have identical topology and in no case does
Akt inhibit MEK activation (Figure 2-2e). This topology is, in fact, the topology from
which the in silico data was derived. The ability of cFL to fit intermediate values
made it possible to recover the correct model topology, whereas BL did not identify the
correct model, and a gate linking TGFa to P13K was consistently missing (Figure 2-
2e, dashed arrow). Specifically, BL was unable to return the correct topology because
nodes downstream of P13K (Akt and JNK) were partially activated (0.32 and 0.19,
respectively) under conditions of TGFa stimulation, and a BL model that included
the TGFa to P13K gate had a higher error (MSE = 0.56) than a model that omitted
the interaction (MSE = 0.07). In contrast, the improved ability of cFL to model
graded activities made it possible to recover the true network topology.
2.3.5 Adjusting the complexity of CellNOpt-cFL model train-
ing
While the expansion step (Figure 2-2, step 2) captures the many possible combinations
of AND and OR logic relationships between nodes, it also increases the complexity
of the network, resulting in an increase in the size of the optimization problem.
Depending on the biological network of interest, some or most of these AND gates
might not be biologically relevant. For example, it is unlikely that six receptors must
be active in order to activate another species, as would be the case for a six-input
AND gate (instead, it is more likely to be a OR gate). A profusion of AND gates
also makes the resultant networks difficult to interpret because most AND gates are
in only a few models whereas the majority of models contain single-input and OR
gates. Thus, the AND gates can effectively appear as system 'noise', interfering with
visual assessment as well as computational analysis of the model topologies. Because
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of these potential complications, the expansion step can be limited to include only
AND gates with a few inputs, depending on the complexity one would like to capture
with the trained network models.
In the current chapter, we have limited the search in the discrete genetic algo-
rithm to a set of seven transfer functions in the discrete genetic algorithm. Use of
more or fewer transfer functions is possible, but we found that seven transfer func-
tions allowed us to represent a variety of input-output relationships without unduly
increasing problem complexity to the point that the discrete genetic algorithm no
longer consistently returned models that fit the data well (see Materials and Methods
2.5).
2.3.6 Applying CellNOpt-cFL to protein signaling data from
HepG2 cells
To test the ability of cFL modeling to analyze real biological data, we modeled a
set of measurements describing the response of HepG2 hepatocellular carcinoma cell
line to various pro-survival, pro-death, or inflammatory cytokines in the presence
or absence of specific small molecule kinase inhibitors. This dataset was used to
construct a recent BL model [124]. Here we ran an independent analysis using the
cFL approach and compare the results to the BL previously reported. The dataset
comprises measurement of phosphorylation states as a marker of activation of 15
intracellular proteins before and 30 minutes after stimulation by one of six cytokines
in the presence or absence of seven specific small molecule kinase inhibitors (Figure
2-4a, Supplementary Figure B-1). The measurements were normalized to continuous
values between zero and one using a routine implemented in the MatLab toolbox
DataRail [126], as previously described ([124], see Supplementary Text B.1).
The HepG2 dataset was trained to several related PKNs which are enumerated in
Table 2.1 and Supplementary Figure B-2 . These PKNs were derived, with various
extensions, from the Ingenuity Systems database (www.ingenuity.com) with manual
addition of literature data about IRS1 that was obviously missing from the Ingenuity
database [124]. The first PKN, termed PKNO was identical the one used previously
for BL modeling [124]. In the course of our analysis, we found it necessary to search
the literature for interactions missing in PKNO but supported by the data, resulting
in several PKNs (Table 2.1 ). Furthermore, we limited the manner in which the PKNs
were expanded in two ways: (1) expansion into all possible two-input AND gates or
(2) expansion into a two-input AND gate only when one input was inhibitory. In the
second case, the expansion of inhibitory gates was necessary because, in logic terms,
an inhibitory gate indicates that the output node is active when the input node is not
present. In biological networks, this is true if the output node is constitutively active,
which was not observed in the normalized HepG2 data. Thus, in order to accurately
model the inhibitory effect, it had to occur in conjunction with activation by some
other input node, which is captured with an AND gate. If a PKN was processed with
both types of expansion, we include a superscript to differentiate between the two
cases (i.e., PKN1" for the expansion of all gates and PKN1' for the expansion of only
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the inhibitory case).
2.3.7 CellNOpt-cFL Training of PKNO
PKNO was expanded to include all possible two-input AND gates and trained to the
HepG2 dataset with CellNOpt-cFL (Supplementary Figure B-2 ). The 90 unprocessed
cFL models obtained after training showed that PKNO exhibited a poor fit to ILla-
induced protein phosphorylation (Supplementary Figure B-3 ), a result we had also
observed with BL analysis [124], confirming that the poor fit of BL was due to errors
in the topology of PKNO and not the inability of Boolean logic to fit intermediate
values.
An inspection of systematic model/data disparity (Supplementary Figure B-3 )
inunediately indicated that the models did not fit ILla-induced phosphorylation of
IRS1, MEK and several species known to be modulated by the MEK pathway. In
PKNO, no paths between ILa and MEK or IRS1 were present. Based on careful
reading of the literature, we added two links to PKNO: a TRAF6 MEK link [119],
and an ERK IRS1 link [162]. These links had been inferred by the BL framework
[124] and were supported by further literature evidence. To add a link that provided a
path between ILla and MEK in the absence of BL inference results, for simplicity one
Figure 2-4 (facing page): Training a family of cFL models to the HepG2 dataset. (a)
Experimental design of a dataset describing the measured signaling response of the HepG2
cell line to six ligand stimulations in the presence or absence of inhibition of seven species.
This dataset was used to train the PKNs (Supplementary Figure B-2 ) with CellNOpt-cFL.
(b) The fraction of edges indicated were randomly removed from (solid line) or added to
(dashed line) PKN1' to result in at least 90 altered PKNs, which were subsequently trained
to the HepG2 data. The average MSEs of the altered PKNs indicates that removal of edges
reduced the ability of the trained models to fit the data (solid line). Because CellNOpt-cFL
does not add links to the model, this result is as expected. The addition of edges to the
PKN did not reduce the ability of the trained models to fit the data (dashed line) since
edges that were inconsistent with the data could be removed during the training process
(Supplementary Figure B-6 ). (c) Results of ten-fold cross-validation in which the data
was randomly divided into ten subsets and the optimization procedure performed to obtain
a family of at least 57 models from training data comprising nine of the ten subsets; the
remaining subset was considered a test set. We thus obtained ten families of trained models,
one family from the use of each subset as a test set. The fit of these families of models
to their respective training and test sets was then plotted as a function of the selection
threshold. As expected, on average the ability of the trained models to fit the test sets was
slightly worse than, but comparable to, the ability to fit the training sets, suggesting that
the models were predictive. The difference between MSEs of the test versus training sets
did not change as a function of the selection threshold, suggesting that the models were not
overfit, even at very low selection thresholds. (d) A comparison of the average final MSE
with the average final number of parameters was used to determine a range of selection
thresholds (1 x 10- through 7.5 x 10-3) where the family of models has a slightly lower
average number of parameters without greatly increasing the MSE.
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Table 2.1: Prior knowledge networks trained to HepG2 dataset. PKNO: Initial PKN shown
to be insufficient for fitting HepG2 data. PKN1: Extended PKN used to compare two
expansion limitations; PKN1 was used for the majority of subsequent analysis. PKN2:
PKNs used to determine mechanism of IL6-induced protein phosphorylation. PKN3: PKN
further extended to model cytokine release.
Model ID PKNO PKN1a PKN1' A B C D PKN3
ERK to IRS1 [162] X X X X X X X
TRAF6 to MEK X X X X X X X
[119]
Assay to P13K X X X X X
IL6R to PI3K [44] X X X X
IL6R to Ras [44] X X X
Protein Signals to X
Cytokine Release
Gates expanded All All Only Only Only Only Only Only
into all possible Inhib Inhib Inhib Inhib Inhib Inhib
2-input AND
gates (Step 2)
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should first consider links from species that ILla is already known to activate. In this
case, TRAF6 is the most upstream species which experimental evidence suggests can
activate MEK [119]. In the case of IRS1 signal activation, the specific phosphorylation
site measured should be considered. Our data included measurements of phospho-
S636/639, and S636 is a known phosphorylation site of ERK2 [162].
A novel finding from CellNOpt-cFL analysis of the HepG2 data was that IL6
treatment led to phosphorylation of several downstream proteins. Similarly to the
links just considered, PKN0 included no paths between IL6 stimulation and these
downstream proteins, resulting in an inability to fit this pattern of phosphorylation.
Importantly, however, BL analysis would not have recognized this partial activation
due to its inability to fit intermediate activation values (as illustrated in our earlier
toy example). Because IL6 was observed to partially activate Akt in the data and
known mechanisms exist for this activation [44], we added a prospective IL6R -+
P13K link to the PKN, thus providing an extended PKN (PKN1) that we use below
for subsequent CellNOpt-cFL analysis.
2.3.8 CellNOpt-cFL T'raining of PKN1
PKN1 was expanded to include all possible two-input AND gates (PKN14) for a total
of 170 discrete parameters corresponding to 105 logic gates. The resultant network
was trained to the HepG2 data. Reduction of the PKN1a-derived models indicated
that almost all AND gates could be removed or replaced by single-input gates. Since
the AND gates appeared to add unnecessary complexity to the cFL models, we also
expanded PKN1 to only include AND gates if an input node was inhibitory (PKN1';
Table 2.1), resulting in only 60 discrete parameters corresponding to 56 logic gates.
We then compared the PKN1a- and PKN1i-derived cFL models.
The comparison of these two PKN-derived model families revealed a clear tradeoff
between model fit and complexity. The more complex PKN1a-derived models were
able to fit the data slightly better than the PKN1L-derived models (average unpro-
cessed model MSE of 0.032 ± 0.002 compared to 0.035 t 0.002, p < 0.001). However,
the more complex PKN14-derived models contained many more parameters than the
PKN1t-derived models both before and after optimization (170 compared to 60 dis-
crete parameters before optimization and an average of 72.8 ± 4.9 compared to 66.6
± 3.9 continuous parameters after optimization (p < 0.001); Supplementary Figure
B-4 ). The simpler PKN1'-derived models used fewer initial and final parameters
to arrive at a fit to the data only 9% worse than PKN1a-derived models. Since the
9% deviation is in the range of error in the normalized data (error estimated to be
10% by comparing similar stimulation conditions), we focused subsequent analysis
on the simpler PKN1'-derived models. For completeness, we include the results of
PKN14-derived models as supplemental information (Supplementary Figure B-5 ).
2.3.9 Statistical significance of cFL models trained to PKN1
To determine the statistical significance of our results, we compared the family of 243
unprocessed models with unprocessed models obtained from either training PKN1P to
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randomized data or training a randomized PKN1P to the data (Supplementary Table
B.1). Data was randomized by pairwise exchange of all data values while network
topologies were randomized either by generation of an entirely random topology or
by random pairwise exchange of gate inputs, gate outputs, or nodes' inputs [124].
When compared to the results of all types of randomization, models trained to the
real data and PKN1 were highly significant (p < 0.001, Supplementary Table B.1),
indicating that the family of trained cFL models fit the data better than expected by
random chance.
To probe the dependence of the CellNOpt-cFL training process on the quality of
the PKN used, we randomly added links to or removed links from the PKN and trained
the resultant PKN to the data. As expected, the models derived from PKNs with
links randomly removed had a poorer fit to data than those derived from the complete
PKN1P (Figure 2-4b, solid line). Conversely, when links were randomly added to
the PKN, cFL-CellNOpt effectively removed the links (Supplementary Figure B-6 ),
resulting in models with similar goodness of fit as models derived from PKN1 (Figure
2-4b, dashed line). We thus conclude that an incomplete PKN degrades the ability of
CelNOpt-cFL to fit the data whereas models derived from a PKN with extraneous
links retain the ability to fit the data.
As an initial investigation of model predictive capacity to check for over-fitting,
we performed a ten-fold cross-validation by randomly dividing the HepG2 data into
ten subsets and, for each subset, reserving one as a test set while training with the
remaining nine data subsets. The similar fits of the training and test data provided
evidence that the family of models obtained from this procedure were predictive, and
the difference in test and training MSEs did not depend on selection threshold, a
measure of model size, suggesting that the models were not over-fit (Figure 2-4c).
Analysis of this cross-validation result combined with a plot of average filtered
model size and fit (MSE) as a function of selection threshold (Figure 2-4d) suggested
that a selection threshold in the range 1 x 10-3 - 1 x 10-2 would result in a family
of models that contain slightly fewer number of parameters than lower thresholds
(Figure 2-4d, dashed line) while retaining the ability to fit the data well (Figure 2-4d,
solid line). We used a threshold of 5.0 x 10- for the remainder of our analysis unless
otherwise noted.
Finally, we obtain a fanily of 243 filtered models for further analysis (Figure 2-5).
By taking note of which cFL gates are removed during the CellNOpt-cFL training
and reduction processes, one can generate hypotheses regarding these gates. Table
2.2 summarizes a set of biological hypotheses readily suggested by our cFL model
topologies.
2.3.10 Validated Biological Hypothesis 1: Crosstalk from
TGFa to the JNK pathway
Analysis of error between the family of cFL models and experimental data (Supple-
mentary Figure B-7 ) highlighted consistent error in TGFa-induced partial activation
of c-Jun. Both PKNO and PKN1 allowed for TGFa-induced activation of c-Jun by
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Figure 2-5: Results of training PKN1t to HepG2 dataset. Topologies of the family of
filtered cFL models trained to the HepG2 dataset. Unprocessed cFL models can be found
in Supplementary Figure B-6 and fit of the filtered models to the data in Supplementary
Figure B-7. Nodes represent proteins that were either ligand stimulations (green), inhibited
(orange), measured by a phospho-specific bead-based antibody assay (blue), or could not
be removed without introducing potential logical inconsistency (white). The grey/black
intensity scale of the gates corresponds to the proportion of individual models within the
family that include that gate. Thus, links colored black were present in all models whereas
links colored grey were present in a fraction of the models. Where visually feasible, cFL gates
are labeled with a numerical value that corresponds to a quantitative sensitivity of the input-
output relationship. Sensitivity is calculated as described in the Materials and Methods 2.5.
The larger this value, the lower the level of the input nodes' activity required for generating
significant output node activity (i.e. a gate with a high sensitivity indicates that the output
node is sensitive to a low value of its input node). The uncertainties in these values arise
from the various best-fit EC50 for each family member in the refinement step. The graph
of the cFL models was generated by a CelNOpt routine using the graphviz visualization
engine (www.graphviz.org) followed by manual annotation in Adobe Illustrator.
IRS1s p70s6 STAT3
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Table 2.2: Biological hypotheses about signaling network operation. Hypotheses suggested
by gates removed during CellNOpt-cFL analysis
Hypothesis
Akt
crosstalk
consistent
the data.
IKk
is in-
with
Crosstalk from
the growth and
survival pathways
(MEK/ERK and
PI3K/Akt) to
the inflammatory
pathways (Nfsb,
JNK, and p38) is
not necessary to
fit the data well.
Crosstalk from
the MEK/ERK
pathway is not
necessary to
describe Hsp27
phosphorylation.
HistH3 data is
not well described
by PKN1.
LPS does not
activate the mea-
sured signaling
nodes.
Evidence
Models
in cFL
Akt - Isk gate is not
present in unprocessed
models (Supplementary
Figure B-6 )
Akt I k gate is
not present in unpro-
cessed models and fre-
quencies of other rele-
vant crosstalk gates (Ras
MAP3K1 and P13K
- MAP3K1) are low in
unprocessed models and
decrease in filtered mod-
els.
MEK - Hp27 gate is
not present in unpro-
cessed models.
Frequency of MSK1/2
- HistH3 gate is low
in unprocessed models
and decreases in filtered
models and models do
not fit HistH3 data well
(Supplementary Figure
B-7 )
Frequency of LPS
TRAF6 gate is low in
unprocessed models and
decreases in filtered
models.
Evidence in data
Phosphorylation of Akt and
IKb are not positively corre-
lated (correlation coefficient
of -0.24).
Phosphorylation of MIEK
and Hsp27 is not strongly
correlated (correlation coef-
ficient of 0.43) but phospho-
rylation of JNK and Hsp27
is strongly correlated (corre-
lation coefficient of 0.91)
Phosphorylation of HistH3
and neither MEK nor p38
are strongly correlated (cor-
relation coefficients of 0.55
and 0.47, respectively)
The only protein that is con-
sistently phosphorylated un-
der LPS stimulation is Akt
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the JNK pathway via crosstalk from Ras or P13K to MAP3K1. In the BL methodol-
ogy, this crosstalk was removed due to the inability to fit partial activation, and no
BL model allowed for activation of c-Jun after TGFa stimulation. However, we found
that a subset of cFL models accounted for this c-Jun partial activation by including
crosstalk between Ras or P13K and MAP3K1. These models also partially activated
JNK after TGFa stimulation, a feature that was inconsistent with the training data
(Supplementary Figure B-8 ). Thus, these models predict that JNK was actually
phosphorylated under conditions of TGFa stimulation, but our measurements did
not detect it.
To test this prediction directly, we undertook de novo measurement of JNK and c-
Jun phosphorylation following stimulation with different doses of TGFa (Figure 2-6a).
These new data show that JNK does indeed become phosphorylated upon stimulation
of HepG2 cells with TGFa. Thus, the cFL models containing crosstalk from Ras or
P13K to MAP3K1 were the correct models. Combined with Table 2.2, this analysis
highlighted the partial activation of the JNK pathway after TGFa stimulation as
a singular instance of crosstalk from a pro-growth ligand to an inflammatory path-
way. In support of the significance of our finding here, we note that TGFa-induced
JNK activation has been shown to be important for hepatic regeneration [158] and
stimulation of DNA synthesis [7] in primary rat hepatocytes.
2.3.11 Validated Biological Hypothesis 2: Mechanism of IL6-
Induced Protein Phosphorylation
As previously mentioned, PKNO was unable to fit IL6-induced protein phosphory-
lation (a feature of the data unappreciated by the BL methodology). Because Akt
was observed to be partially phosphorylated under these conditions and we found
literature evidence for a prospective IL6R -+ P13K link, we added the link to PKN1.
However, the media-only condition also induced partial phosphorylation of Akt. Dis-
covery of the partial activation of Akt in the media-only control led us to consider
that perhaps the IL6-induced phosphorylation of Akt was simply an assay artifact.
Thus, we inserted an Assay -+ P13K link into the PKN. This 'Assay' node represents
cell stress arising from changing environmental conditions during the assay (media
change, etc.); it is postulated to activate P13K because only Akt is consistently active
in the untreated control. Having accounted for the potential that IL6-induced partial
phosphorylation of Akt was an artifact, we undertook a series of computational exper-
iments to determine the mechanism of IL6-induced phosphorylation of downstream
proteins.
Upon exposure to IL6, SHP2 has been reported to bind to gp130, a subunit of the
IL6 receptor complex. SHP2 is then phosphorylated in a JAK1-dependent manner.
This phosphorylation can lead to PI3K/Akt pathway activation through interactions
with Gab-1 or IRS1 or Ras/MEK/ERK pathway activation through Grb2 or Gab1
[44]. Thus, our computational experiments were designed to infer which pathway
(PI3K/Akt or Ras/MEK/ERK) was mediating the IL6-induced protein phosphoryla-
tion. Four families of 150 filtered models were examined, all of which were obtained
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Figure 2-6: Validation of cFL crosstalk predictions. (a) Analysis of systematic error as well
as the topologies of the family of trained cFL models (Figure 2-5) indicated that c-Jun was
partially activated after TGFa stimulation. Models with crosstalk from Ras or P13K to
Map3K1 predicted that JNK was partially activated under these experimental conditions
even though it was not partially activated in the dataset. We tested whether JNK was
actually partially activated under these conditions by stimulating HepG2 cells with TGFO
and measuring levels of phosphorylated JNK and c-Jun by a bead-based antibody assay
after 30 minutes. Fold increase in measured phosphorylation over un-stimulated control for
c-Jun (black) and JNK (red) is shown. Where available, biological replicates are indicated
with filled circles. Solid lines indicate the averages of the replicates. This experiment
indicates that JNK was partially phosphorylated under TGFa stimulation and the cFL
models with crosstalk from Ras or PI3K to MAP3K1 were correct. (b) CFL analysis
of the topologies and fit of the HepG2 training dataset to several PKNs suggested that
IL6 activated downstream nodes through the Ras/MEK pathway (Table 3). To test this
prediction, a validation dataset was examined [5]. This validation dataset showed that
the activation of nodes other than STAT3 that responded robustly to 1L6 stimulation was
ablated by pretreatment with a small molecule MEK inhibitor but not other inhibitors,
demonstrating that the Ras/Raf/MEK pathway mediates this crosstalk.
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Table 2.3: Results of cFL training of various prior knowledge networks for the investigation
of IL6 crosstalk
PKN Assay to 13K[ IL6R to PI3K? _IL6R to Ras? MSEIL6
_ _PKN1 100_ 
- 0.040 ± 0.004
PKN2A 100% - - 0.052 i 0.004
PKN2B 97% _ _56% - 0.046 ± 0.008
PKN2C 99% 40% 95% 0.028 ± 0.004
PKN2D 99% - 98% 0.028 ± 0.004
after training a new PKN to the normalized HepG2 dataset (Table 2.3 , PKN2A
through PKN2D). The inability of PKN2A-derived cFL models with only the Assay
-- P13K link to fit well the IL6-induced protein phosphorylation data suggested that
some other link was necessary to fit this data. In our trained networks, the IL6R -
P13K link was present in only a fraction of the relevant trained models (PKN2B and
PKN2C), but the IL6R -- Ras link was present in more than 90% of relevant trained
models (PKN2C and PKN2D). Additionally, models with IL6R -+ Ras links were
better able to fit the IL6-induced protein phosphorylation. Consequently, our cFL
results supported the hypothesis that IL6R activates downstream proteins through
the Ras/Raf pathway. This hypothesis is supported by an independent dataset [124],
where the IL6-induced protein phosphorylation response was more robust than in the
training data (Supplementary Figures B-1 and B-9). Inhibition of MEK either alone
or in combination with other inhibitors resulted in ablation of downstream protein
activation whereas inhibition of P13K did not (Figure 2-6b). Thus, we infer that IL6-
induced protein phosphorylation was not an assay artifact and was instead mediated
by the Ras/Raf pathway.
2.3.12 Predicting node-to-node transfer functions
CFL relates nodes in a network with transfer functions that describe quantitative
input-output relationships between protein species represented as network nodes. To
investigate the ability of the cFL models to predict these transfer functions, we sim-
ulated the PKN1'-derived, filtered cFL models to determine the activation state of a
specified node under many theoretical combinations of its input nodes. We then plot-
ted the model predictions of quantitative input-output relationships. As one instance,
Figure 2-7 shows the predicted average and standard deviation of the quantitative
values of CREB phosphorylation as a function of the activation of its input nodes,
p38 and MEK1/2. The resulting plots indicated that we were able to predict the
activation response of CREB to the entire range of p38 and MEK1/2 although train-
ing set measurements were limited to a few values of these nodes (Figure 2-7, black
circles).
We tested this prediction using a set of data with combinations of ligands and in-
hibitors not present in the training data ([124], Supplementary Figure B-9 ). Roughly
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Figure 2-7: Transfer functions predicted by trained cFL models. The output value of the
CREB node was predicted by computationally simulating each individual model in the fam-
ily of cFL models with 441 combinations of p38 and MEK1/2. Three-dimensional plots were
generated in MatLab showing the average prediction (opaque surface) as well as the average
prediction plus or minus the standard deviation of the predicted value (semi-transparent
surfaces). The training data (black circles) and validation data (green diamonds) are also
plotted. The 3-D plots have been rotated to highlight the influence of either (a) p38 or (b)
MEK1/2. The predicted transfer functions agree with the validation data reasonably well
except for the overestimation of CREB activation for conditions with TGFa stimulation as
one of the ligands.
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20% of the test conditions were also present in the training data set, allowing us to
control for differences between both data sets. When we compared this dataset to
the predicted transfer functions, we observed that most of the data fell within one
standard deviation of the predicted value (Figure 2-7, green diamonds) with excep-
tion of overestimation under conditions of TGFa stimulation. This overestimation
is expected, as a comparison of common conditions between the training and test
dataset indicated that the normalized experimental values of CREB in the validation
dataset were 38±4% lower than that in the training set.
This result demonstrates the ability of the trained cFL models to predict the
quantitative relationship between nodes in the network. We also found that the family
of cFL models was able to fit the phospho-protein signaling response in the validation
dataset well, which we demonstrate as supplementary information (Supplementary
Figure B-9 ).
2.3.13 Predictive capability of a cFL model family
We performed a series of nineteen cross-validation experiments to further investigate
the ability of our methodology to predict signaling response under conditions that
were not represented in the training data. For each experiment, we used training data
from which we had removed the phosphorylation data of a specific protein signal, s,
under a single ligand stimulation condition and all inhibitor treatments. Nineteen
signal/stimulation combinations were chosen to be test sets according to two criteria:
(1) s is at least partially activated under the stimulation condition of interest and (2) s
is at least partially activated under some other stimulation condition (Supplementary
Table B.2). These criteria ensured that the remaining training data contained some
information regarding the activation of s but it did not contain information regarding
the activation of s under the stimulation condition of interest. This procedure is a
more stringent test for predictive capability than a random cross-validation procedure
because training sets from which random data is removed might retain other data with
the same information as the removed data (e.g., based on the network topology, Akt
phosphorylation in the absence of MEK inhibition is the same as Akt phosphorylation
with MEK inhibition, so removing only one of these data points is not a stringent
test of predictive capacity of the other).
We examined the ability of models trained on reduced training sets (n > 45 for
each case) to predict phosphorylation of the test protein signals. Because we used
each individual in the family of models to predict the test signal, we could determine
if the models were constrained in their predictions by examining the coefficient of
variance (CV; standard deviation divided by mean) of the prediction. If the CV was
high, the models were not constrained to a specific prediction (i.e. the prediction
was imprecise), and the average prediction should be discounted. Thus, for these
cross-validation results, we compared the precision (CV) and accuracy (MSE) of the
models' predictions, where precise and accurate predictions exhibited both a low CV
and low MSE (Figure 2-8a).
We found that the families of models trained on these reduced training sets were
able to precisely predict phosphorylation of the test protein signals in twelve of the
57
Figure 2-8: Accuracy vs. precision of cross-validation experiments. (a) Model predictions
can be assessed based on both how well the family of models agree on a prediction (precision)
as well as their accuracy. If a prediction is imprecise (i.e. the models do not agree),
the models are not constrained to any single prediction. Thus, precision can be used to
discredit predictions. Predictions can be both precise and accurate (green field), imprecise
but accurate on average (yellow field), imprecise and inaccurate (blue field), or precise
but inaccurate (orange field). Predictions that are precise and accurate (green field) are
preferred. (b) The importance of considering the precision of a prediction amongst a family
of models was demonstrated by a cross-validation study in which a signal under a single
ligand stimulation condition in the presence or absence of any inhibitor was removed from
the training data set. The mean coefficient of variance (CV) as a function of the error in the
prediction (MSE) is plotted for all tests. One prediction was highly inaccurate. However, it
was also imprecise (blue field), whereas no predictions were precise and inaccurate (orange
field), demonstrating that taking the precision of a prediction into account can help to
discredit inaccurate predictions. (c) The grey-boxed subset of (b) highlights the test sets
that were precisely and accurately predicted by the family of cFL models.
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nineteen cases (Figure 2-8b and c, green field). In six of the test sets, the models
did not agree, although their average prediction was reasonably accurate (Figure 2-
8b and c, yellow field). We observed no test sets for which the training sets agreed
about an inaccurate prediction (Figure 2-8b, orange field). In one case (prediction
of IKb signaling under TNFa stimulation), the predicted phosphorylation state was
highly inaccurate (MSE > 0.20). However, this prediction was also very imprecise
(CV > 0.25), indicating that the average prediction was unreliable (Figure 2-8b, blue
field). Thus, by taking the precision of the models' predictions into account, we were
able to discredit an inaccurate prediction. This result underscores the importance of
considering consensus among the family of models rather than examining the results
of only one cFL model.
2.3.14 Using cFL models to relate phospho-protein signaling
to cell phenotypic response
The ability to quantitatively model protein signal activation with cFL offers the
prospect of predicting phenotypic response upon exposure to stimuli and inhibitors.
To investigate the ability of cFL to model phenotypic data, we turned to data de-
scribing cytokine release three hours after stimulation under the same conditions as
the phosphorylation data [5]. As a first approach, we linked the output of our family
of cFL models to a partial least squares regression model [58] obtained by regressing
normalized data of release of five cytokines (IL1B, IL4, G-CSF, IFNg, and SDF1a)
to the normalized protein phosphorylation measurements (see Supplementary Text
B.1).
The cFL models linked to a PLSR model were able to model phenotypic response
with an accuracy of R2 = 0.79, near that of the PLSR model (R2 = 0.81; see Suppe-
mentary Figure B-10). However, we found that the correlation indicated by regression
coefficients did not lead to easily interpretable insights about phenotype because pro-
teins in the same pathway were also highly correlated with each other.
To obtain a more interpretable model, we utilized a second approach where we
included nodes specifying cytokine release in the PKN and linked them to a few
protein signaling nodes. These nodes were chosen based on principle component
analysis: if protein signals in a pathway clustered together in principle component
space, the signal most downstream in the pathway was linked to cytokine release.
Based on this analysis, the following protein signaling nodes were linked to each
cytokine release node: MEK1/2, CREB, GSK3, c-Jun, Hsp27, IKb, and STAT3 (Table
2.1, PKN3). We then trained a family of cFL models to the normalized dataset
comprised of cytokine release at three hours and protein signaling at thirty minutes.
The models resulting from cFL method were able to fit the cytokine release data
reasonably well (R 2 = 0.78 for the average predicted by a subset of best-fitting mod-
els). Furthermore, the low frequency of several gates in the resultant family of cFL
models (Supplementary Figure B-11 , Supplementary Table B.3) indicated that, al-
though the promoters of several of the modeled cytokines contained binding sites of
transcription factors are known to be modulated by the MEK1/2, GSK3, and CREB
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pathways (Supplementary Table BA), activation of these nodes did not predict cy-
tokine release. Thus, we altered our previous PKN by removing the links between
these protein signaling and cytokine release nodes and trained it to the data. The re-
sultant family of cFL models (Figure 2-9) indicated that STAT3 activation explained
cytokine release after IL6 stimulation and other signals (Ib, c-Jun, and Hsp27) ex-
plained cytokine release three hours after TNFa or ILla stimulation.
2.4 Discussion
In this chapter, we have described cFL for formal training of a prior knowledge net-
work obtained from a protein interaction or signaling network map to experimental
data and demonstrated that the ability of cFL to fit intermediate activities was crucial
for understanding key features of a biological network. We validated two important
biological insights concerning network operation in the HepG2 cells under inflaminma-
tory cytokine and growth factor treatment: (i) identification of c-Jun as a downstream
locus of crosstalk between growth factor and inflammatory cytokine treatments and
(ii) the Ras/Raf/MEK pathway as an avenue for activation of key downstream pro-
teins following exposure of cells to IL6. Both of these insights were dependent on
the ability of our cFL models to fit partial protein activation and were thus not
appreciated by BL modeling.
We note that the ability of cFL to model intermediate activity data comes at the
cost of increased model complexity. This complexity calls into question the identifia-
bility of a cFL model (i.e. ability of the CellNOpt-cFL training process to train both
parameters and topology given limited data). To address this concern, we considered
families of models where each individual model predicted signaling states and the
resulting predictions had an average and standard deviation. The standard deviation
provided a metric for discrediting predictions for which the models were not con-
strained. With regard to topology, we considered how often a gate was present in the
trained cFL models. This allowed us to determine hypothesized links (those present
in the PKN) that were either inconsistent with the data (cFL gates removed from
unprocessed models) or only marginally important for fitting the data (cFL gates re-
moved from filtered models). Thus, the consideration of consensus and variation in an
ensemble of models allowed us to account for the non-identifiability of any individual
model.
We also illustrated the use of CellNOpt-cFL to (i) predict quantitative phenotypic
response data with the same quality as a regression-based approach and (ii) increase
the biological understanding of a phenotypic response by generating hypotheses re-
garding protein signaling pathways that lead to cytokine release. Transcriptional
and/or non-transcriptional mechanisms could underlie the biological link between
the signaling network activation and cytokine release profiles. We investigated pre-
dicted and known transcription factor binding sites in the promoters of relevant genes
(Supplementary Table B.4), finding that several transcription factors hypothesized
by CellNOpt-cFL to drive cytokine release (STAT3 and Nfsb) could, in concert with
IRF1, potentially lead to the production and secretion of the observed cytokines.
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Figure 2-9: Trained cFL models linking ligand cues, phospho-protein signals, and cytokine
release phenotypic responses. A dataset describing release of five cytokines after three hours
under conditions identical to those under which protein phosphorylation was measured af-
ter thirty minutes was combined with the phospho-protein dataset. PKN2D was further
extended to include links from protein signals that occupied unique principle component
space (Supplementary Text B.1) to nodes of cytokine release after three hours. Training
this network to the data indicated that the growth and survival pathways were not needed
to describe cytokine release. Thus, the PKN was revised to link only Stat3, NfKb, c-Jun,
and Hsp27 to the cytokine release nodes, and this PKN was trained to the experimental
dataset of both cytokine release and protein phosphorylation. In contrast to the cFL mod-
els describing only signaling activation, we found that the family of 141 cFL models fit the
cytokine response data with a wider distribution of MSE. The resultant sub-family of seven
filtered cFL models that fit the data with a MSE less than the average plus one standard
deviation of the family MSE is shown. Nodes represent proteins that were either ligand
stimulations (green), inhibited (orange), phosphorylation states measured (blue), cytokine
secretion measured (yellow) or could not be removed without introducing potential logical
inconsistency (white). The grey/black intensity scale of the gates corresponds to the pro-
portion of individual models within the family that include that gate. The graph of the
cFL models was generated by a CelNOpt routine using the graphviz visualization engine
(www.graphviz.org) followed by manual annotation in Adobe Illustrator.
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Our subsequent test of this notion by qRT-PCR measurement, however, yielded a
negative result; expression of the HepG2-secreted proteins were not significantly up-
regulated by IL6 stimulation (data not shown). Thus, it appears more likely that
non-transcriptional mechanisms, such as exocytosis of secretory vesicles [122, 105] or
proteolytic cleavage of pro-forms at the cell plasma membrane [9, 89], was responsible
for the cytokine release observations.
We have shown that CellNOpt-cFL is useful for systematically and quantitatively
comparing experimental datasets to a PKN that summarizes decades of dedicated
biochemical studies. However, our aim in this work is not to argue for exclusive use
of cFL modeling instead of BL or other modeling approaches, but rather to delineate
key advantages of cFL modeling for addressing data with intermediate activity values.
Training with CellNOpt-cFL is a more difficult optimization problem that is not effi-
ciently solved for networks much larger than those in this work. The BL optimization
problem scales as 2', where w is the number of gates in the processed PKN, whereas
the CellNOpt-cFL optimization problem scales as (1 + a)h, where a is the number of
transfer function in the set chosen by the genetic algorithm ((1 + a) 2; (1 + a) = 8
as formulated here) and h is the number of possible input-output transfer functions
in the network (h > w). Additionally, as was the case with the reformulation of
the BL optimization problem with Integer Linear Programming [98], we acknowledge
that there may be more efficient, rigorous ways to solve the optimization problem
presented by CellNOpt-cFL.
When training a prior knowledge network to data, we often encountered the need
to add links to the prior knowledge network in order to fully describe the data. In this
study, this was done manually simply by searching the literature. In the absence of
such information, one should automate the process of testing many candidate links.
A simple heuristic procedure such as the one we employed for the BL methodology
based on mismatches between the best-fit models and data is one option [124]. Alter-
natively, more complex reverse engineering techniques could be used. The additional
complexity of cFL modeling poses significant complications for the implementation
of a simple heuristic or reverse engineering technique, but future efforts should inves-
tigate best practices for the automation of this process.
An additional prospective application of CellNOpt-cFL is to use a trained cFL
model to inform the construction of a model with a different mathematical formal-
ism. One intriguing possibility is that the CellNOpt-cFL methodology might be used
to determine topologies to translate into a system of ordinary differential equations
(ODEs) with methods such as that presented in [159]. The precise relationship be-
tween cFL and ODE parameters is unclear, but the ease of translating from one
formalism to the other might be facilitated through the use of continuous AND and
OR operators rather than the Min/Max operators utilized in this study. As a first
step, we have retrained one of our main results (that presented in Figure 2-5) us-
ing the product of possible outputs to evaluate AND gates and the sum of possible
outputs to evaluate OR gates. The models resulting from this procedure (Supple-
mentary Figure B-13 ) were similar to those obtained previously (Figures 2-4c, 2-5),
demonstrating the flexibility of this approach to accommodate different AND and
OR operators as well as transfer function forms. Such flexibility should aid future
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attempts to translate CellNOpt-cFL results into other mathematical formalisms.
Finally, the dataset used here was gathered for training a BL model. This dataset
was explicitly designed to maximally stimulate or inhibit pathways through the ap-
plication of saturating doses of ligand and drugs. However, cells in vivo face a much
more subtle and interesting situation in which ligands are present in combination,
often at very different levels. Because cFL can model the graded activation of cell
signaling pathways, we suspect that CellNOpt-cFL should prove particularly useful
with signaling data collected under more physiological conditions. Our laboratories
are currently pursuing experimental studies in this direction.
2.5 Materials and Methods
2.5.1 Optimization Procedure
Model compression and expansion was performed with CellNOpt as previously de-
scribed [124]. The discrete genetic algorithm in the CellNOpt-BL variant was adapted
so that discrete variables specified a transfer function rather than the gate type. Be-
cause our datasets (toy example and HepG2) only contained saturating concentrations
of ligand stimulation, the normalized values of ligand model inputs were one or zero.
In this instance, using normalized Hill functions to model interactions downstream
of these zero or one inputs would result in all downstream nodes also reaching lev-
els of zero or one (a Boolean simulation). To circumvent this issue, we represented
interactions linking a ligand input to a downstream component with linear transfer
functions with a y-intercept of zero and possible values of slope of 0.2, 0.3, 0.4, 0.5,
0.6, 0.7, and 0.8 as well as the absence of the interaction. All other interactions were
modeled with the normalized Hill function described in Figure 2-1 where the follow-
ing transfer functions were possible: gate not active, approximately linear transfer
function (n = 1.01, k = 68.5098 chosen for computation efficiency and numerical
stability), or sigmoidal transfer function (n = 3) with an EC50 of 0.2, 0.3, 0.4, 0.5,
0.6, or 0.7 (Supplementary Figure B-14 ). These transfer functions were chosen be-
cause the models resulting from the training represented many different topologies
while still fitting the data well. We found that including a subset of three to five
of the aforementioned transfer functions would have also succeeded in this case, but
a family of models obtained when ten transfer functions were used contained some
models that did not fit the data well. This necessitated the addition of a step to
choose a subset of well-fitted models from the family of trained models; this subset
of well-fitted models did not significantly differ from the family of models obtained
with fewer possible transfer functions. Given that more transfer functions allow to
more accurately represent parameter space, this implied that the genetic algorithm
was converging to poorly-fit local minima because the search space was too large. We
therefore concluded that usage of eight transfer functions (seven transfer functions
and the possibility of no interaction) balanced coverage of search space and ability to
identify well-fitting models.
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2.5.2 Sensitivity of a cFL gate
Sensitivity is calculated as (1 - ECo) for cFL gates modeled with normalized Hill
functions and (0.5 x slope) for cFL gates modeled with linear transfer functions.
2.5.3 Calculation of MSE
Mean squared error was calculated with the following formula
1 Naig Natim Ninhib
MSE=N Z E (k- ijk
i=1 j=1 k=1
where N is the total number of data points, Nsig is the number of protein signals
measured, Nstim is the number of cytokine or growth factor stimulations, Ninhib
is the number of inhibition conditions used, and zGped and x? b are the predicted'ij,k art te reice
and observed protein level of the ith protein signal under the jth stimulation and
kth inhibition condition, respectively. In some cases, only the MSE of a subset of
the data points is calculated for more specific error analysis. In these instances, the
previous formula holds, but signal and/or stimulation conditions are constant and
indicated with subscripts (e.g. MSEIL6 is the MSE of all signal measurements under
all inhibition conditions and IL6 stimulation).
2.5.4 Measurement of protein phosphorylation and cytokine
release
Protein phosphorylation and cytokine release were measured as described in [5].
Briefly, cells were incubated with small molecule inhibitor before exposure to ligand.
Luminex bead-based bioassays were used to determine protein phosphorylation in cell
lysate collected immediately before and 30 minutes after ligand exposure. Three hours
after ligand exposure, supernatant was collected and Luminex bead-based bioassay
used to measure the amount of cytokine that had been secreted.
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Chapter 3
Q2LM analysis of cFL models
based solely on prior knowledge
[104]
3.1 Summary
Using intuition alone to predict the response of a complex biological system to per-
turbation is difficult, even when individual processes comprising the system are well
understood. Mathematical models have substantially improved our ability to predict
these responses, but their use is typically limited by difficulty in specifying model
topology and parameter values. Additionally, incorporating entities across different
scales ranging from molecular to organismal in the same model is not trivial. Here,
we present an open source MATLAB framework that we call 'querying quantitative
logic models' (Q2LM) for building and asking questions of constrained fuzzy logic
(cFL) models. CFL is a recently developed modeling formalism that uses logic gates
to describe influences among entities, with transfer functions to describe quantitative
dependencies. Q2LM does not rely on dedicated data to train the parameters of the
transfer functions, and it permits straight-forward incorporation of entities at multiple
biological scales. The Q2LM framework can be employed to ask application-oriented
questions about the system, such as: Which potential therapeutic perturbations ac-
complish a designated goal, and under what environmental conditions will these per-
turbations be effective? We demonstrate the utility of this framework for generating
testable hypotheses in two diverse examples: (a) a model for intracellular signaling
network regulation of transcription factor activity; and (b) a model for physiological
pharmacokinetics and pharmacodynamics of cell/cytokinie interactions; in the latter,
we validate hypotheses concerning molecular design of granulocyte colony stimulat-
ing factor with the goal of enhancing neutrophil production from hematopoietic stem
cells.
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3.2 Background
Based on current understanding of a biological system, bioengineers predict how the
system will respond to designed perturbations. One important manifestation of this
process is predicting whether exposing a patient to a drug with a pre-defined target
will result in a favorable clinical outcome. This approach works well when few relevant
components of the system are considered. However, it is more difficult to propagate
possible effects through a complex system using intuition alone, which hinders the
capability for reliable prediction.
To aid intuition, a broad spectrum of mathematical and computational models
have been developed [57]. For example, 'theory-driven' differential equations (DEs)
based on physico-chemical mechanisms have been used to model and make predictions
in biological systems ranging from virus population dynamics in a host organism [114]
to receptor trafficking through cellular compartments [49] to enzymatic phosphory-
lation cascades [45]; at the other end of the continuum, 'data-driven' algebraic and
statistical algorithms have been used to understand the integrated influence of mul-
tiple signaling pathways on cell phenotypic outcomes [58, 160]. While these various
approaches have proven useful in biological and pharmaceutical contexts, their ability
to make reliable predictions depends heavily on a large amount of appropriate exper-
imental data for determining relationships, topologies, and parameter values. This
critical dependence creates a high barrier-to-entry for using mathematical models to
guide scientific decisions on a day-to-day basis. Furthermore, using these methods to
describe relationships between different biological scales, such as the exchange of a
molecule from tissues to individual cells and subsequent molecular interactions within
the cell, is a significant challenge and an active area of research [56, 154, 20].
Logic-based models are an attractive intermediate alternative on the continuum
of mathematical/computational approaches because they are readily derivable from
either theory-driven or data-driven foundation [103], and they have been successfully
used to predict the response of a biological system to perturbation (e.g. [165, 124]).
A deficiency of discrete (e.g. Boolean) logic models, in which all species are found
categorically in one of a few levels of activity, is that they are often too simple to ad-
equately describe biological systems. Furthermore, increasing the number of possible
species levels beyond two or three generally causes the process of specifying the gates
in a logic model to become unwieldy. Recently, some have proposed transforming
discrete logic models into either ordinary or piecewise linear differential equations
[39, 96, 159]. While some software tools for building and simulating models of these
types exist (reviewed in [103]), changes to parameters of such models affect the differ-
ential equations governing each species, and it is not immediately evident how such
changes affect the quantitative relationships among the species in the system. More-
over, use of these tools to determine the effect of perturbation to species or parameters
requires familiarity with the particular software and is not straightforward.
To alleviate these difficulties, we present here a new analysis framework for asking
questions of logic-based models, which we term 'querying quantitative logic models'
(Q2LM). We use the constrained fuzzy logic (cFL) formalism recently developed for
training a logic model to data [102], but here demonstrate the Q2LM approach on
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models based solely on prior knowledge of the biological system. This logic formalism
allows species in a biological system to be modeled with a continuous range between
zero and one using mathematical functions that directly relate input and output
species (transfer functions). The transfer functions contain parameters with distinct
interpretations, allowing for the direct exploration of the effect of these mathemati-
cal relationships on model predictions. Importantly, the Q2LM approach facilitates
querying of these models for more efficiently making predictions about the behav-
ior of biological systems in response to perturbation. Q2LM is freely available at
http://sites.google. com/site/saezrodriguez/software.
Because we use a simple logic-based framework, Q2LM is flexible enough to con-
comitantly incorporate multiple scales of biology-from molecular species to whole
organisms. We illustrate the use of Q2LM to build and query a logic model with
a simple example intracellular signaling model. Subsequently, we investigate a logic
model of multiscale pharmacokinetics and pharmacodynamics of granulocyte colony
stimulating factor (GCSF) with the objective of predicting the molecular-level alter-
ations to the system that would best stimulate maturation of precursor neutrophils.
3.3 Methods
3.3.1 What is a constrained fuzzy logic model?
In a constrained fuzzy logic (cFL) model, the relationship between species is described
by logic gates with transfer functions, from 'upstream' parent node(s) to 'downstream
child node. In the simplest logic gate, one input parent species activates an output
species, designated by an arrow between the two (Figure 3-1a). In cFL, this activating
relationship is represented with a transfer function, which is simply a mathematical
function used to evaluate the value of the output species given the value of the input
species (Figure 3-1b).
In the current implementation, each transfer function is a normalized Hill func-
tion with a gain, where the gain, g, is a constant between zero and one, n is the
Hill Coefficient, and k is the parameter that determines the ECo of the function. If
the input species inhibits the output species (a NOT gate in traditional logic mod-
eling, Figure 3-1a), the transfer function is subtracted from one, effectively inverting
it. We have found this transfer function form to be useful because it is simple yet
flexible enough to accommodate a variety of biologically relevant functional relation-
ships including linear, sigmoidal, and digital. Furthermore, each parameter of the
transfer function determines a specific aspect of the function shape: g determines the
maximum value that the output species reaches given maximal input species value;
k determines the value of input species necessary for the output to reach activation
at half of its maximum (E05 o), and i determines whether the shape is linear or sig-
moidal. Thus, changing any of these parameters changes the transfer function shape
in a predictable manner (Figure 3-1b).
Transfer functions are specified for every relationship between species and pro-
vide the basis for all quantitative relationships between species in a cFL model. If
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Figure 3-1: Description of constrained fuzzy logic. (a) Constrained fuzzy logic describes
interactions between biological species with logic gates. The logic gates are evaluated based
on the output of the transfer function (f) that quantitatively relates the input and output
species. In this example, AND gates are evaluated with the PROD operator and OR gates
are evaluated with the SUM operator. Evaluation of the AND and OR gates with the
MIN and MAX operators, respectively, is also possible, and Q2LM supports both types of
operators. Note that the SUM operator is not identical to arithmetic sum, but rather, the
logical sum of two possible values is equal to the first plus the second minus the product of
the two (i.e. V1 + V2 - V1V2, where V1 is the value of one possible output and V2 is the
value of the other). (b) The quantitative relationship between any two species is specified
with a transfer function. In this work, we use a normalized hill function multiplied by a
gain as the transfer function, although other functional forms can easily be imagined.
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an output species has more than one input species, multiple transfer functions are
evaluated for each input-output relationship, resulting in multiple possible values for
the output species. The final value for the output species is then determined based on
these possible values as well as the logic of the interactions. For example, if an output
species has two inputs species, both could be necessary to affect the output species
(an AND gate) or they could affect the output species independently of one another
(an OR gate). If both AND and OR gates are used to relate inputs species to an out-
put species, AND gates are evaluated before the OR gates (i.e. the sum-of-products
formalism, Figure 3-1a).
3.3.2 Building a cFL model
To build a logic-based model, one must first identify the species in the biological
system of interest to be included in the model. These species might be intra- or
extra-cellular molecules, specific cell types, or the 'state' of a molecule or cell; thus,
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within the model a single entity can be represented by several species (e.g. ligand-
bound and unbound cell receptors, differentiated or undifferentiated hematopoietic
cells), where the name of the species is used to distinguish among various states of a
single entity. Denoting various species names to identify any sort of entities enables
a logic model to concomitantly incorporate processes at multiple biological scales.
The next step for building a logic model is to specify the interactions between
species both in terms with what species interact as well as whether the interaction is
activating or inhibitory. Knowledge of these interactions can come from a variety of
sources. An expert may have accumulated enough knowledge to build such a model
using intuition alone. Additionally, a wealth of databases exists that contain such
interactions [8]. It is important to document sources used during the model building
process so that, if discrepancies arise between the model simulations and what is
known about the system, the knowledge basis of the model can easily be revisited.
The most challenging aspect of building a logic model is specifying AND or OR
logic gates for species with more than one input parent species. While in previous
work we used the CellNOpt software to train logic gates to dedicated experimental
data [124, 102], in this work we rely on prior knowledge to determine the logic of
the relationships. An AND gate should be used if the input species 'work together'
to affect the output. Alternatively, one can identify an AND gate by asking 'Should
the output be affected with only that input, or are other species necessary?' If other
species are necessary, an AND gate should be used. For example, a molecular binding
event is represented with an AND gate because both binding partners are necessary
to form the bound species.
The final step is to write the model in a form readable by the software. For Q2LM,
this involves making a spreadsheet that specifies the interactions and parameters of
the transfer functions used to evaluate the effect (Figure 3-2c).
3.3.3 Simulating a cFL model
Q2LM simulates a cFL model with synchronous updating by calculating species values
at each simulation step based on the values of their input species at the previous step.
The simulation terminates when either the values of all species stabilize (the so-called
'logic steady-state') or once a pre-defined maximum number of steps has been reached.
Species that have been designated as 'stimuli' are maintained at the stimulated value
or, if its input species specify it to be a larger value during simulation, it is assigned
the maximum of the stimulated and calculated values. The value of an inhibited
species is multiplied by the percent inhibition at each simulation step. The initial
values of all non-stimuli species is designated as Not-a-Number (NaN) and are ignored
until their values have been specified by an upstream interacting species.
3.3.4 Querying a cFL model
We demonstrate Q2LM here by posing the following example questions: 1) What
perturbations to species in the system result in a desired outcome? and 2) In what en-
vironmental conditions are these perturbations effective? To answer these questions,
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one must provide environmental conditions (the 'environment'), the perturbations
('experiments') and the desired outcome (the 'criteria'). Environmental conditions
are considered invariant while experimental perturbations are varied and the effect
of the experimental perturbation on each environmental condition determined. This
effect is then compared to the criteria to reveal if the experimental perturbation 'met'
the criteria. Strictly speaking, only an environment is required to simulate the model
while experiments and criteria are used to answer a specific query. We will consider
two vignettes motivated by previous studies by the Lauffenburger laboratory with
various collaborators: one on the relationship of inflammatory cytokine and growth
factor signaling to transcription factor regulation, and the other on systemic phar-
macokinetic and pharmacodynamic behavior of neutrophilic cells to hematopoietic
factors.
3.4 Results
3.4.1 Logic-based model of intracellular signaling network
We first investigate potential crosstalk between TNFa- and TGFa-induced signal-
ing pathways in activating downstream transcription factor activation with a highly
simplified network. In a cFL model trained to intracellular signaling data from
HepG2 cells, we previously noticed that both TNFa and TGFa stimulation of HepG2
cells activated the JNK/c-Jun pathway while only TGFa stimulation activated the
MEK/ERK pathway [102]. These two pathways activate a variety of transcriptional
programs; here, we focused on API transcription factor activation, which involves the
oligomerization of c-Jun and Fos, and IKK-mediated activation of the NFKB transcrip-
tion factor. We postulated from literature evidence that ERK phosphorylates Fos,
which facilitates its dimerization with c-Jun, thus forming AP1 heterodimers. Alter-
natively, c-Jun can be phosphorylated via the JNK pathway and dimerize to form
AP1 homodimers [19, 152, 50]. For our Q2LM analysis, we focus on questioning
whether inhibiting the activation of MEK, ERK, or JNK would increase the amount
of AP1 homodimers.
From our understanding of this simple biological system, we specified the interac-
tions between species in the network (Figure 3-2a). In most cases, increasing the value
of the input species increased the value, or activity, of the output species. However,
there were a few cases of inhibitory interactions: IKB sequesters and inhibits the ac-
tivity of NFKB, and increased activity of IKK decreases the ability of IB to sequester
NFcB. For this example, we also assumed that there was limited c-Jun available in
the system which resulted in stoichiometry-driven inhibitory relationships between
API hetero- and homo-dimers because the presence of one dimer form indicated that
there was less c-Jun available to form the other.
To convert these interactions into a logic model (Figure 3-2b), we considered
species with more than one parent inpu species as possible AND gates. JNK has
more than one parent input ( TGFa and TNFa), but TGFa and TNFa activate
JNK independently of one another. Thus this gate is an OR gate and not an AND
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Figure 3-2: Converting posited interactions of intracellular signaling into a logic model. (a)
The relationship between species in an intracellular signaling network is depicted. These
relationships are based on a model trained to biochemical data of HepG2 signaling protein
activation after exposure to extracellular ligands [102] with additional links to AP1 homo-
and hetero-dimerization based on [19, 152, 50]. (b) To convert the posited interactions in
(a) into a logic model, we consider if the logic describing the relationship between input
and output species should include an AND gate for species with more than one input,
and find that two AND gates are necessary (see text for details). (c) The logic model is
recorded as a spreadsheet to be loaded into the Querying Quantitative Logic Model (Q2LM)
software. The first three columns specify which species interact as well as the logic of these
relationships. An AND gate is specified by 'linking together' input and output species with
a 'dummy' species indicated with 'and' followed by a number identifier. The last three
columns specify the parameters of the transfer functions of the interaction indicated by
that row. (d) The Q2LM software has been specifically designed to ask academically and
industrially relevant questions.
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Figure 3-3: Files to use Q2LM to examine intracellular signaling logic model. (a) Example
of a scenario file that Q2LM imports to simulate experimental perturbations in a variety
of environmental conditions. A detailed description of all file types is provided in the
software's manual. In this case, environments with partial or full stimulation of TNFa and
TGFa alone or in combination will be simulated with inhibition of the 'Expt' species JNK,
ERK, and MEK at levels listed in the 'Values' column alone or in combination, where the
maximum number of species to inhibit at any one time is listed in the 'MaxNum' column.
(b) Example of a criteria file that Q2LM imports. Simulation results from environments
with perturbation are compared to environments without perturbation and Q2LM calculates
if the criteria have been met. In this case, the criteria is that the APIhomoDim species
increase in value by at least 0.1 with perturbation compared to without. (c) Example of
a Results file Q2LM outputs to indicate, for each environment, the values of perturbation
that met the criteria in (b) and in what fraction of models they were effective.
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gate. The AP1 heterdimers species also has more than one parent input species (c-
Jun, Fos, and NOT AP1 homodimers). Because a heterodimer consists of both c-Jun
and Fos, both are necessary to increase the amount of heterodimer, and an AND gate
was used to model their logic. The presence of AP1 homodimer limits the amount of
AP1 heterodimer, but only when c-Jun and Fos are present to make a heterodimer.
Thus, it is also a parent input for the AND gate.
Finally, we wrote our logic model in a spreadsheet compatible with Q2LM (Figure
3-2c). TGFa did not activate the JNK pathway as strongly as TNFa in our initial
dataset [102], but since we were not certain of the relative activating potentials we
made several models, each with a different gain parameter for this interaction. This
was indicated in the spreadsheet by including an array of gain parameters in the
corresponding entry (Figure 3-2c). Additionally, when we loaded the model, we added
normally distributed noise to each parameter to simulate biological noise.
We queried our intracellular signaling model to determine if inhibiting MEK, ERK,
and JNK alone or in combination would increase AP1 homodimers in specific environ-
ments composed of varying levels of TNFa and TGFa alone or in combination. We
simulated these environments with partial or complete inhibition of MEK, ERK, and
JNK and then compared the resulting levels of AP1 homodimers with the levels that
resulted without inhibition. This information was encoded in two input files: (1) the
Scenario file included the environments and species to perturb with inhibition (Figure
3-3a) and (2) the Criteria file specified that the software should return experimental
conditions that increase AP1 homodimers (Figure 3-3b).
Q2LM results revealed perturbations that increased the values of AP1 homodimers
(Figure 3-3c), which corresponded to our criteria. These perturbations were stored
in a separate file. We found that partially or completely inhibitting ERK and/or
MEK increased AP1 homodimers in enviromnents featuring high values of TGFa
stimulation, but had minimal effect in those featuring low values of TGFa stimulation.
Furthermore, this result implied that inhibiting JNK was not an effective strategy for
increasing AP1 homodimer levels. However, inhibiting ERK and MEK either alone
or in combination increased homodimers only if the network was fully stimulated by
TGFa. Because this example served only to illustrate the use of Q2LM, a test of
this hypothesis was out of the scope of this work. However, we note that because the
software asked questions of the model in a manner analogous to experimental queries,
experimental tests are easy to specify. For this example, a follow-up experiment to
test this hypothesis would be to stimulate cells with low and high concentrations of
TGFa in the presence or absence of ERK or MEK inhibition and to measure the
resulting AP1 homodimer levels.
We next investigated how the system evolved during model simulation (Figure 3-
4). It was apparent that the values of the AP1 homo- and hetero-dimers oscillated in
several inhibition conditions. This is a common occurrence in models with feedback
that have been simulated with discrete updating [39]. Q2LM offers two alternative
treatments for environment/perturbation combinations that exhibit oscillations: 1)
they can be ignored when delineating conditions that meet the designated criteria,
or 2) the average value calculated over some pre-defined number of simulation steps
can be used as the representative value for that species. In this case, we used the av-
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Figure 3-4: Species values as a function of simulation step during simulation of intracellular
signaling model. a) For each indicated species, the median value for all models at the final
19 simulation steps is shown (Q2LM does not save all simulation steps when memory is a
limitation). Upper and lower error bars indicate the third and first quartile, respectively.
Simulation conditions: TGFa = 1; TNFa = 1; Perturbation with different combinations of
JNK, MEK, and ERK inhibition is indicated by different line color. Different line styles rep-
resent different models. b) Median value for AP1 homo- or hetero-dimers with no inhibitor
perturbations. c) Median value for AP1 homo- or hetero-dimers for inhibitor combinations
that met criteria of increasing the value of APlHomDimer by at least 0.1 in at least 2% of
the models.
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erage to analyze oscillations. Because the interpretation of a condition that produces
oscillations might differ from that of a condition that does not, it is important to
plot the simulation evolution. In this case, the oscillations did not hinder our inter-
pretation. In the absence of perturbation, AP1 homo- and hetero-dimers oscillated
due to the negative feedback between them (Figure 3-4b). Thus, these two species
were calculated to have values of 0.5 based on the average of their values over mul-
tiple stimulation steps. In inhibitor combinations that met the designated criteria,
no oscillations were observed (Figure 3-4c). Instead, the values of the homo- and
hetero-dimer species approached unity and zero, respectively. Thus, these conditions
increased homodimers because they were no longer limited by negative feedback from
heterodimers. By examining the system evolution, we confirmed that the conditions
met our criteria by directly considering oscillations.
3.4.2 Logic-based modeling of pharmacokinetics of GCSF
For our second example, we investigated whether Q2LM could be useful for multi-
scale models of physiological significance by using it to address the pharmacokinet-
ics and pharmacodynamics of GCSF (Figure 3-5a). GCSF is used clinically to re-
store neutrophil levels to normal in situations generating neutropenia, such as cancer
chemotherapy treatment. It is administered intravenously to stimulate the matura-
tion of precursor neutrophils. After binding its receptor, it is internalized and either
degraded in endosomes or recycled back into the bloodstream. Additionally, GCSF
is cleared from the blood through non-specific clearance mechanisms, primarily renal
clearance. Sarkar et al. used a DE model for GCSF PK/PD to ascertain a finding
that when non-specific mechanisms are not the dominant mechanism of clearance, de-
creasing the rate of endosomal degradation of GCSF is more effective in stimulating
neutrophil maturation than increasing the binding affinity of GCSF to its receptor
[132]. This insight was consistent with the effects of engineerd GCSF variants in vitro
[133] but had not been verified in vivo. Here, we examined whether a simpler cFL
model would allow us to reach comparable conclusions without the requirement of
estimating model parameter value for a complicated mechanistic DE model.
We built a logic model of the GCSF system by converting the linguistic description
above (Figure 3-5a) into our cFL framework (Figure 3-5b). Although no dedicated
experimental data were used to train this model in a traditional sense, it was derived
from literature knowledge describing PK/PD of GCSF [115, 76]. Rather than us-
ing kinetic parameters to describe intracellular trafficking and non-specific clearance
mechanisms, we use an AND gate to model these processes as limiting the amount
of GCSF available in the bloodstream. The logic description therefore allowed us to
easily relate tissue level phenomena to cellular- and molecular-level phenomena.
To explore system behavior predicted by the cFL model, we simulated model be-
havior under several conditions and plotted the species' values at each simulation
step. We found that with decreasing clearance, the maximum value of both mature
neutrophil (N) and GCSF in the blood (bloodGCSF) species values increased (Figure
3-5c). Although these species eventually reached a value of zero due to GCSF be-
ing degraded via receptor-mediated endocytic uptake, in some cases these decreases
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occurred at later simulation steps. This result agrees with how we understand the
system to behave: a decrease in rate of clearance leads to an increase in total amount
of GCSF that reaches precursor neutrophils due to increased half-life, but GCSF is
nevertheless eventually cleared from the system. From this analysis, we identified two
criteria to consider for assessing the impact of a perturbation on the N and blood-
GCSF species: 1) maximum value attained; and 2) the number of simulation steps
during which the nodes were at a value greater than zero.
Having established that the model was recapitulating known behavior, we used
it to explore the effects of altering GCSF properties on physiological effectiveness,
as measured by N and bloodGCSF levels. In particular, we calculated the above
criteria under two conditions: 1) diminished degradation modeled by multiplying
the pNdegGCSF and NdegGCSF species by a percent inhibition; or 2) enhanced
binding modeled by increasing the minimal value of the boundGCSF species. We
then compared the values of criteria under these conditions to those from simulations
with no such perturbation (Figure 3-6a and b). Our results indicated that when
the degradation nodes (pNdegGCSF and NdegGCSF) were inhibited by more than
50% at low values of clearance, there was a substantial increase in the number of
simulation steps for the bloodGCSF species to reach zero. However, there was no
effect on maximal value of N or bloodGCSF (Figure 3-6a). On the other hand,
Figure 3-5 (facing page): GCSF administration as a logic model. (a) Depiction of GCSF
pharmacokinetics at the tissue, cellular, and molecular level. Altered from [132]. (b) Logic
model based on (a). All transfer functions have the parameters g = 1; n = 3; and EC 0
= 0.5. Normally distributed noise with a standard deviation of five percent was added to
each parameter 100 times to generate 100 models. Further analysis indicated adding noise
with a standard deviation of up to 25 percent led to identical conclusions. Arrow labels
indicate the following steps of the pharmacokinetics of the molecule: (1) When GCSF is
administered intravenously (doseGCSF), it enters the bloodstream where it is subject to
(2) nonspecific clearance (mainly renal clearance; clearance). (3) Precursor neutrophils
(pN) possess receptors (pNR), which (4) bind GCSF in the blood (pNboundGCSF). (5)
Bound GCSF can be degraded (pNdegGCSF), and (6) what is not degraded is recycled
back into the bloodstream (pNrecGCSF). (7) Bound GCSF also stimulates proliferation and
differentiation into mature neutrophils (N). (8) Mature neutrophils possess receptors (NR)
that can (9) bind GCSF (NboundGCSF). Bound GCSF is then (10) degraded (NdegGCSF)
or (11) recycled (NrecGCSF). (12) Value of GCSF in the blood (bloodGCSF) is limited by
the dose, clearance, and amount recycled. (13) An additional species bodyGCSF represents
the exchange of GCSF from the blood to the body cavity and is necessary in the logic
model to ensure that the bloodGCSF node is also limited by its own value. (c) The GCSF
logic model was simulated under non-limiting precursor neutrophils and dose conditions
(pN = 1 and doseGCSF = 1) with multiple levels of clearance (0, 0.1, 0.2, etc.). Median
value of the neutrophil and GCSF levels in the blood nodes (N and bloodGCSF) were
plotted as a function of simulation step, with error bars indicating the first and third
quartile of predictions of 100 models with noise added to the parameters. As levels of
clearance decreased, maximal values of N and bloodGCSF increased as well as the number
of simulation steps until the species values decreased to zero.
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increasing binding by setting the minimum of the pNboundGCSF species to a value
greater than zero resulted in no decay of the N node (i.e., a logic steady state value
greater than zero, Figure 3-6b). This result was expected because the pNboundGCSF
species directly activated the N species, so fixing the minimum value of one should
directly affect the value of the other. This effect was also reflected in an increase in
the maximum value that the N species attained. However, the maximal value of the
bloodCSF species did not increase, and in fact the number of simulation steps for the
bloodCSF species to reach zero decreased in many conditions (Figure 3-6b). These
results provide a first indication that inhibiting degradation is the better strategy for
increasing numbers of mature neutrophils.
As a complementary approach for exploring whether increasing binding affinity or
decreasing endosomal degradation would be more effective, we examined the effect of
varying the parameters controlling the processes of binding and degradation (Figure
3-6c and d). We varied the gain parameter of the boundGCSF-to-degGCSF transfer
function to represent varying the fraction of boundGCSF that was degraded, and
found that these results recapitulated those obtained when the degradation nodes
were inhibited: steps to decay of bloodGCSF and N increased with no effect on the
maximal level of these species (Figure 3-6c). We also decreased the EC 50 parameter
of bloodGCSF to pNboundGCSF to represent an increase in binding afnfmity. By defi-
nition, decreasing the EC 50 results in an increase in the value of pNboundGCSF for a
given value of bloodGCSF. This perturbation led to a corresponding increase in max-
imum value of N while the value of bloodGCSF remained constant for intermediate
values of clearance (Figure 3-6d). At high or low values of clearance, this effect was
not observed, pointing to another interesting aspect of our system: at high values of
clearance, bloodGCSF never reached a value large enough to activate the pNbound-
GCSF and N nodes while at low values of clearance, the N species reached a large
value at the default EC50 (Figure 3-5c), so only minimal effects were observed when
affinity was further increased. Changing these parameter values had no substantial
Figure 3-6 (facing page): In all parts, perturbations to species (a,b) or model parameters
(c,d) were made when the GCSF logic model was simulated under non-limiting precursor
neutrophils and dose conditions (i.e. pN = 1 and doseGCSF = 1) with multiple levels
of clearance (0, 0.1, 0.2, etc.), with each color and line style corresponding to a different
fixed value of the clearance species as shown in the legend in the rightmost panel for each
part. a) The median effect of increasing inhibition of the pNdegGCSF and NdegGCSF
nodes on each criteria is plotted, with error bars indicating the first and third quartile of
predictions of 100 models. b) The median effect of varying the minimal possible value of the
pNboundGCSF node, with error bars indicating the first and third quartile of predictions of
100 models. Because the N species was not observed to decay in these simulation, the first
panel is the increase in logic steady state value of N, not steps until decay. c) The median
effect of changing the gain of the transfer function relating pNboundGCSF to pNdegGCSF
and NboundGCSF to NdegGCSF on each criteria is plotted, with error bars indicating the
first and third quartile of predictions of 100 models. d) The effect of changing the EC 50 of
the bloodGCSF to pNboundGCSF interaction, with error bars indicating the first and third
quartile of predictions of 100 models.
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Figure 3-7: in vivo increase in WBC associated with decreased GCSF degradation. Veh
denotes the VVBC count in animals sham treated with PBS. Animals (n = 5) were treated
with 5FU (a drug that acts on the bone marrow and inhibits haematopoiesis, administered
at 150 mg/kg). T'reatment with the colony stimulating factor was started 24 h after the
administration of 5FU, and continued for 9 days. Animals were sacrificed and blood col-
lected by cardiac puncture. WBCs were concentrated after hemolysing the RBCs using a
RBC lysis solution. Cell count was performed using a Coulter counter. *p < 0.001 versus
vehicle-treated controls.
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effects on the number of simulation steps until decay.
In summary, these results indicated that while increasing the binding affinity of
GCSF to its receptor might result in an increase in N for a given level of bloodGCSF
(Figure 3-7b), this effect occured only in a limited range of clearance values, and an
increase in bound receptor also had the deleterious effect of decreasing the number of
simulation steps required for decay of bloodGCSF (Figure 3-6b). In contrast, decreas-
ing the amount of degradation consistently increased the number of simulation steps
required for decay of bloodGCSF (Figure 3-6a and c). We therefore concluded that
decreasing degradation of GCSF is the superior strategy for stimulating neutrophil
maturation.
Thus far, we have used in silico logic model simulations to generate hypotheses
about optimization of GCSF potency in living systems. This work suggests decreasing
degradation of receptor bound GCSF is an effective strategy for improving potency in
vivo. In previous work, a mutant GCSF with weaker receptor binding affinity at the
endosomal pH exhibited decreased degradation in vitro through increased recycling
of internalized receptor, resulting in increased potency of the molecule in vitro [133].
To examine whether decreased degradation had any effect in an in vivo setting, we
determined white blood cell (WBC) counts in mice following treatment with wild-
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type GCSF or mutant GCSF engineered for increase dissociation at an endosomal
pH (mutant D113H). Mice were first treated with 5-Fluorouracil (5FU) for 24 hours
to inhibit haematopoiesis followed by administration of either wild-type or mutant
GCSF. The mutant was more effective in increasing WBC count than wild-type GCSF
(Figure 3-7) . This result illustrates that cFL models can faithfully represent com-
plex multi-scale systems and that the hypotheses generated from the Q2LM analysis
presented here are relevant in both in vitro and in vivo settings.
3.5 Discussion
In this work we presented Q2LM as a means for generating insights from a cFL model
of a biological system based on literature knowledge. We queried the model to ad-
dress two questions highly relevant to translational research: 1) which therapeutic
perturbation of a system will result in a pre-defined clinical goal and 2) in which
environments will this perturbation be effective? We used this software framework
to explore two biological systems of different scales. With the first, an intracellu-
lar signaling model, we illustrated how the software can be used to make testable
hypotheses. With the second, a multi-scale model of GCSF administration, we gen-
erated and tested hypotheses to show that a logic model was able to recapitulate
the experimentally validated results of a mechanistic ordinary differential equation
without the prerequisite of estimating a multitude of kinetic parameters.
Building a logic model requires converting. a linguistic description into logic gates,
which requires a significant amount of abstraction of the system. Logic models are a
natural framework for modeling intracellular signaling networks because relationships
between proteins are commonly described in terms of their influence (e.g. 'Phospho-
rylation by JNK activates c-Jun' and ' TGFQ stimulation activates the MEK/ERK
pathway'). However, building a logic model of a biological system describing inter-
actions between species at the tissue, cellular, and molecular level is arguably less
intuitive, in part because the relationships between these types of interactions and
logic gats are less obvious (e.g. it is initially unclear how 'binding a receptor' and
'intracellular degradation' can be described with logic gates; these considerations are
further explored in Supplementary Text C). Nevertheless, with our logic model of
GCSF we demonstrated that transforming such linguistic descriptions into a logic
model can provide valuable insights into the operation of a system.
Along with abstracting the relationships between species by describing them as
logic gates, the concepts of time and amount are also abstracted in a logic model.
The plots presented in Figure 3-4 and 3-5 are similar in appearance to time courses.
However, the values of species were plotted as a function of simulation step, not time.
Thus, these plots allow one to directly 'follow the logic' of environmental conditions
and perturbations, which is not equivalent to examining the value of a species as
a function of time. The exact relationship between simulation steps and time can-
not be ascertained without additional information regarding the dynamic behavior of
the system. Similarly, the meaning of the values of species in relation to a physical
descriptor such as concentration is unclear without additional information. Neverthe-
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less, the relative values of species in simulations of the same model carry interpretable
information regarding the qualitative effect of perturbations (e.g., the value of N is
nonzero for more simulation steps when degradation is inhibited than when it is
not) from which we can form a testable hypotheses (e.g., inhibiting degradation will
increase the process of neutrophil maturation).
Because the quantities resulting from cFL models are abstract, it raises the ques-
tion of whether modeling with ostensibly simpler Boolean or discrete logic would be
sufficient for the analysis we present here. Indeed, cFL models use traditional AND,
OR, and NOT gates to specify the topology of a network, such that tools developed
for either analysis are readily interchangeable. However, the use of cFL is justified
for several reasons. First, discrete models lack transfer functions such that analyses
similar to that shown in Figure 3-7 could not easily be performed with a discrete
model. Furthermore, analysis with cFL is no more difficult than one with discrete
logic because of the simplicity of the cFL formalism and ease of specifying a model
and its transfer functions in Q2LM. Moreover, cFL modeling allows one to explorethe
effects of a number of additional parameters, such as the amount of perturbation, dif-
ferent implementations of perturbations, and the effect ofnoise in the transfer function
parameters. Such explorations allow one to ascertain whether the predictions are ro-
bust to variations of the model, which if confirmed, increases the confidence in their
reliability.
One of the main results of this work is a novel 'seamless' approach to multi-scale
modeling, exemplified by our logic model of GCSF administration that integrates
ligand/receptor binding and endocytic trafficking at the molecular level, the transition
between differentiation states at the cellular level, and systemic pharmacokinetics at
the tissue level. The insights from this model were validated both in vitro and in
vivo. Thus, the relevance of this model to the therapeutic administration of other
receptor agonists should be considered. Because intracellular trafficking is important
for cellular responses to other stimulatory ligands such as EGF and IL2 [80], it is
likely that the insights from this model will be applicable to the administration of
these molecules. More broadly, these results may be applicable to therapeutics for
which endosomal degradation is an important mechanism for clearance, underscoring
the importance of understanding intracellular trafficking when administering receptor
agonists as therapeutics [61, 163].
From this work overall, we submit that our Q2LM framework holds promise for
effective use toward generating testable hypotheses of interest in academic as well
as industrial settings. Additionally, the further development of cFL will enable the
prediction of perturbation effects on a complex system without requiring a large
amount of experimental data, thereby facilitating the use of mathematical models for
guiding scientific decisions.
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Chapter 4
Investigation of the ability of
trained cFL models to make
precise predictions with Q2LM
4.1 Background
In previous chapters, we have developed a formalism for modeling quantitative rela-
tionships between species called constrained fuzzy logic (cFL) and demonstrated its
use for enhancing insights gleaned when training logic models of signaling networks
[102]. We have also used cFL to make predictions regarding context-specific ther-
apeutic effects with logic models built entirely based on prior knowledge (i.e. not
trained to data) using the software framework Querying Quantitative Logic Models
(Q2LM) [104]. However, the ability of cFL models trained to data to make these
predictions has not been fully investigated.
In this work, we adapt Q2LM to make predictions with models trained to data.
We divide our results into three main sections: (1) Model training and Q2LM Predic-
tion; (2) Examination of conditions in our initial data set useful for training models
that will make precise predictions; and (3) Experimental design for suggesting more
informative conditions. We first train logic models to a new dataset describing the
signaling response of HepG2 cells to various environmental stimuli. We train multi-
ple models (a 'family' of models) because the data is not sufficient to constrain both
the topology and parameters of the models, a non-identifiability problem common in
training biological network models [75]. We then use the trained models and Q2LM
to ask: (1) What therapeutic or combination of therapeutics will result in a desired
outcome? and (2) In what environmental contexts will the therapeutics be effective?
We experimentally test several of these predictions and find that these predictions are
highly accurate in a statistical sense. However, in the course of making predictions, we
find that some were ambivalent, in that half of the models predict a therapeutic will
be effective whereas the other half do not. Such ambivalent predictions indicate that
the data did not sufficiently constrain the models to be able to make all predictions
of interest. Thus, we undertake a series of computational analyses to determine if we
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can suggest experiments that would better constrain our models. We find that inclu-
sion of ligand doses is particularly important for training models that will have few
ambivalent predictions. Additionally, we are able to suggest conditions predicted to
be informative, but they are not helpful in producing more precise predictions. Thus,
in the absence of a principled method of ensuring constrained models and precise
predictions, we emphasize the importance of considering model ambivalence during
model training and analysis.
4.2 Results
4.2.1 Model training and Q2LM Prediction
We first gathered a dataset of phosphorylation of seventeen intracellular proteins in
HepG2 cells exposed to one of several small molecule inhibitors followed by stimulation
with a growth factor or inflammatory cytokine, all at various doses (Figure 4-2a).
Briefly, cells were incubated with small molecule inhibitor for 30 minutes prior to
exposure to ligand. For the initial dataset (Figure 4-2), BioPlex bead-based bioassays
were used to determine protein phosphorylation in cell lysate collected prior to any
perturbation (inhibition or ligand exposure) as well as a pooled lysate collected 10
and 30 minutes after ligand exposure. For the validation data sets (Supplementary
Figures D-7 and D-7), protein phosphorylation was measured with BioPlex in cell
lysate collected before perturbation as well as 30 minutes after ligand exposure.
For the initial dataset, each data point was normalized using the 'Booleanizer'
method described previously [1243. Briefly, this method calculated the relative fold
change of each signal upon stimulation and transformed it using a hill function to
smooth the output. A noise penalty was then applied by multiplying the resultant
relative fold change by the Langmuir transformation of the value of the signal relative
to the maximmn value observed in the experiment. Importantly, in this work when
calculating the relative fold change, we used the basal value of the signal adjusted
for vehicle effects. We defined 'basal value' as the value of the signal before either
stimulation or inhibition had occurred. Thus, if a signal decreased due to inhibition
of an upstream node, and the stimulation condition did not activate the signal, its
normalized value would be negative. This property had important implications to
model simulation.
In order to correctly model our normalized data, an alternative simulation proce-
dure was used. In this simulation procedure, the constrained fuzzy logic formalism
using min/max operators for AND and OR gates described in Figure 4-1a and b was
used. This formalism is equivalent to that in Chapter 2, Figure 2-1 with the excep-
tions that negative inputs are supported and inhibitory effects were modeled using
the formula output = -f(input). To simulate the behavior of the network, effects
of inhibitors on the basal level of downstream proteins were evaluated (Figure 4-1c
through e). Next, effect of stimuli on the signal was evaluated by propagating the
activating effect of the ligand to downstream nodes without considering the effect of
the inhibitor on basal level. Finally, the effect of the inhibitor on the ability of the
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stimuli to activate downstream species was evaluated by using the values from the
previous step as the initial points for this step. The inhibition amount was subtracted
from inhibited nodes' values and this effect was propagated to downstream nodes. To
obtain the simulated species' values, the effect of the inhibitor on basal levels was
added to values from the last step (Figure 4-1e). This simulation procedure allowed
the inhibition effects on basal values to be modeled separately from effects on the
ability of a stimulation condition to activate its downstream species.
A prior knowledge network (PKN) was constructed using that from [102] as a
basis. However, this PKN modeled species as one single 'activity' (e.g. "Mek activates
Erk") rather than incorporating knowledge of the influence of phosphorylation of
specific sites on catalytic activity of the kinase (e.g. "serine phosphorylation of Mek
results in increased phosphorylation of the activation loop of Erk). Because we were
measuring the phosphorylation of these specific sites and not activity as a whole,
we extended the PKN to include information describing phosphorylation of different
protein domains. Different domains were included as additional nodes in the network,
and their phosphorylation by upstream kinases and influence on activity of the protein
encoded as interactions deduced from a variety of sources [166, 167, 60, 62, 6, 34, 2,
52, 74, 109, 92, 138, 141]. This PKN (Supplementary Figure D-1) was then trained
to the data.
Model training followed the procedure described in Chapter 2 with the addition of
a PKN processing step that added nodes and interactions to allow for the training to
capture affects of inhibition on basal signal value. Additionally, in the first training
step in which transfer functions are chosen from a predefined suite of possible transfer
functions using a genetic algorithm, the suite of transfer functions was different than
that used in Chapter 2. In the current application, the same suite was used for all
interactions and consisted of nine transfer functions with fixed hill coefficient (n = 3)
and all combinations of EC5o = 0.3, 0.5,0.7 and g = 0.3,0.7,1 for a total of nine
possible transfer functions.
The CellNOpt training process was repeated 993 times, resulting in 993 con-
strained fuzzy logic (cFL) models. Of these, we used 120 models that fit the data
Figure 4-1 (facing page): Alteration to cFL methodology and simulation to allow for normal-
izing to basal value. (a) The modeling formalism for evaluating logic gates. (b) Transfer
function used to evaluate negative effects. For example plot shown, g = 1, n = 3, and
EC5o = 0.5. (c) Network model used to demonstrate simulation procedure. Note that
inhibited species are represented by two nodes, one that participates in the signaling net-
work as activated by upstream stimuli, and one marked with a 'B' that only affects basal
levels upon inhibition. (d) Data that the model in (c) produces upon various stimulation
and perturbation conditions. (e) Simulation procedure for each condition in (d). Effect of
inhibition on basal values is determined (Step 1) by propogating the effects on inhibition
on the inhibitted species' nodes marked with a 'B'. In step 2, the effects of stimulation are
determined without considering basal level effects. In step 3, the effects of inhibition of the
nodes participating in the network are determined based on the results of step 2. To obtain
the final species' values, the basal affect is added to the effect of the stimuli and inhibitor
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2. Stim Effect 0.9 0.6 0
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1. Inhib Basal Effect -0.7 0 0
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Condition: IGF1 = 1, MTORCI inhibition
Akt p70s6k p9ORSK
1. Inhib Basal Effect 0 0 -0.7
2. Stim Effect 0.9 0.6 0
3. Inhib & Stim Effect 0.9 0 0
Final Value (Step 1 + 3) 0.9 0 -0.7
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within 6.6 percent of the best fit for subsequent analysis (see Supplementary Figure
D-5 for dependence of kept models' features on solution pool size). The fit of these
models to the data and their topology is summarized in Figure 4-2c and d. The
results of 10-fold cross validation (Supplementary Figure D-6) provided a first indi-
cation that cFL modeling of this data resulted models that were predictive and not
over-fit.
While the topology and fit of the trained models yielded interesting hypotheses
regarding the network structure (Supplemental Table D.1), we focused our analysis
here on the ability of these models to predict species state. We first extended the
software package Querying Quantitative Logic Models (Q2LM) to allow for simulation
of cFL models trained to data. We then used Q2LM to predict the values of species
in our models in three scenarios.
Q2LM predictions in this chapter are made using three components: (1) cFL
models trained to data; (2) "Scenario" file specifying environmental conditions and
perturbations; and (3) an optional "Criteria" file indicating the species to be com-
pared across conditions. The scenario file was used to generate indicated combinations
of stimuli and inhibitors. Each 'simulation project' was then simulated with the cFL
models. If a criteria was provided, the simulation results in the perturbed conditions
were compared to those without perturbation and the relevant criteria evaluated
(Figure 4-3).
To specify a scenario, we specified two components: enviromnents and pertur-
bations. Environments were considered independent aspects of the cellular milieu
whereas perturbations were the inhibitors or stimuli we proposed to expose to the
cells in order to result in a desired outcome. This semantic distinction was used to
set up the problem efficiently recognizing that, in some instances, a species might be
an environmental species whereas in others, it might be a perturbation.
The scenarios used in this work contained different 'environmental' stimulation
conditions and the same perturbation conditions: varying inhibition of Map3k7, p38,
IKK, P13K, or Mek at various doses alone or in combination. The environmental
stimulation conditions were chosen to approximate growth, inflammatory, and mixed
environments, as described in Table 4.1.
To evaluate the simulation predictions, we assessed how constrained they were
by evaluating the inner quartile range (IQR) of each predicted species value across
all models. For example, if a prediction had a small IQR across all models, it was
constrained in that the models were able to precisely predict its value (Figure 4-
4a). Conversely, if it a large IQR across models, it was unconstrained in that the
models did not agree to a precise prediction of its value (Figure 4-4a). A plot of the
distribution of IQR for all predictions indicated that between 65 and 80 percent of
the predictions for each scenario were predicted with an IQR of less than 0.2 and were
thus fairly well constrained (Figure 4-4b and c).
We next simulated our models to address our main question of interest: Which in-
hibition conditions (perturbations) met a criteria and in which stimulation conditions
(environments) were they effective? We focused on inhibition of various downstream
'effecter' proteins with eight criteria described in Table 4.2. To determine if an in-
hibition condition met our criteria, we evaluated whether the relative fold change of
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Figure 4-2: Training cFL models to dataset of HepG2 signaling response. The prior knowl-
edge network in (a) was processed and trained to the dataset in (b) as described in Chapter
2. This analysis yielded the family of models shown in (c) where the grey/black intensity
scale of the gates corresponds to the proportion of individual models within the family that
include that gate. Thus, links colored black were present in all models whereas links colored
grey were present in a fraction of the models. The fit of the models to the experimental
data is shown in (d) where the average simulation result is shown with a dashed blue line
and the absolute difference in measured and average simulated signal level is indicated with
a background color ranging from green (good fit) to red (bad fit). Larger views of all figures
can be found in Supplementary Figures D-1 through D-4
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Figure 4-3: Workflow for use of Q2LM for species value prediction and criteria evaluation.
Steps on the left side (colored black with sold outlines) were necessary for species' predic-
tions. Steps on the right side (colored grey with dashed outlines) were only necessary if a
criteria was to be evaluated.
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Figure 4-4: The inner quartile range as an indication of the precision of predictions. (a)
Hypothetical distributions of three species' value predictions for one condition across the
102 models. A lower inner quartile range (IQR) indicates the predictions were more precise
(Hsp27 and Erk plots) while a higher IQR indicates the models were not constrained in
their prediction of the species' value (Map3kl plot). (b) Cumulative distribution of IQR
of predictions across models. The distribution for each prediction scenario (Table 4.1) is
indicated with a dotted line whereas a black line indicates the distribution for the conditions
that the models were fit to. For the prediction scenarios, 65 - 80% of the predictions had an
IQR across models of < 0.2, indicating that they were precisely predictions. (c) To simplify
visualization of these types of distributions, we will present bar graphs of the percent of
predictions that were reasonably well constrained (i.e. IQR < 0.2). As expected, a higher
fraction of predicted species' values for fitted conditions had an IQR of < 0.2.
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Table 4.1: Scenarios simulated by Q2LM for predicting therapeutic effects
Inflammatory Sce-
nario
Growth Scenario
"Environmental"
Stimuli (partial
full activation)
and
TNFa and IL1a
alone or in combina-
tion
TGFa and IGF1
alone or in combina-
tion
Inhibitor "Perturba-
tions" (partial or full
single inhibitors and
all pairs)
Map3k7, p3 8 ,
P13K, MEK
IKK,
Map3k7, p38, IKK,
P13K, MEK
Mixed TGFa in combina- Map3k7, p38, IKK,
Growth/Inflammator tion with TNFa or P13K, MEK
Scenario ILla
the species of interest decreased by at least 50 percent with perturbation compared
to without (i.e. stimulation and inhibition compared to stimulation alone) for each
model simulated. We then determined the fraction of models that predicted that
the condition met our criteria. Perturbation conditions that met the criteria in a
high fraction of models were considered good therapeutic candidates for their specific
environments whereas those that met the criteria in a low fraction of models were
not. Inhibition conditions that met the criteria in an intermediate fraction of models
could not be categorized because the models were ambivalent as to whether or not
they would be effective. The results of this analysis is summarized for all predictions
in Table 4.3. Overall, we found that 16% of predictions were ambivalent.
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Table 4.2: Therapeutic effect criteria evaluated by Q2LM
Criteria Species that should
decrease by a relative
change of 50%
1 cJun
2 Hsp27
3 Creb
4 s6
5 cJun, Hsp7
6 Creb, s6
7 cJun, Hsp27, IB
8 Creb, s6, p70s6k
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Table 4.3: Summary of Q2LM Evaluation of Criteria across Conditions. The first four
columns contain the number of perturbation conditions that the indicated fractions of
models predicted to be effective. The last column contains the fraction of 'ambivalent'
predictions (i.e. the faction of perturbations
80% of models).
predicted to be effective in between 20 and
Criteria Species Scenario Zero | Between Betweei Greater Fraction
Per- Zero 20 and than Am-
cent and 80% 80% bivalent
20%
cJun Inflam 1628 47 996 44 0.37
Growth 1695 136 272 612 0.10
Mixed 2084 349 764 51 0.23
Hsp27 Inflam 196 144 684 1620 0.25
Growth 555 1360 01800 0.00
__ ___Mixed {179 1428 832,- 1819 0.26
Creb Inflain 175 308 434 1798 0.16
Growth 1 591 216 612 1296 0.23
Mixed 866 313 966 1113 0.30
s6 Inflam 299 1052 344 1020 0.13
Growth 915 780 0 1020 0.00
Mixed 828 1206 0 1224 0.00
cJun, Hsp27 Inflam 1628 47 996 44 0.37
Growth 1695 136 272 612 0.10
Mixed 2086 393 728 51 0.22
Creb, s6 Inflam 549 1082 64 1020 0.02
Growth 919 776 234 786 0.09
Mixed 1061 973 624 600 0.19
cun, Hsp27, IjB Inflam 1731 182 758 44 0.28
Growth 1695 604 128 288 0.05
Mixed 2240 428 566 24 0.17
Creb, s6, p7Os6k Inflam 613 1082 52 968 0.02
Growth 919 776 273 747 0.10
Mixed 1290 744 792 432 0.24
Sum 26456 12624 11391 19033 0.16
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We experimentally tested a few conditions of interest that the models suggested
would be effective for decreasing phosphorylation of either cJun, Hsp27, and InB
or Creb, s6, and p70s6k (experimental data shown in Supplementary Figure D-7).
Although we were initially interested in Map3k7 (TAK1) inhibition alone, off target
effects of the inhibitor used (5Z-7-Oxozeaenol) were evident in a subsequent dataset
(Figure 4-12) and cited as possible from the literature [106], so we considered appli-
cation of this inhibitor to inhibit both Map3k7 and Mek.
Relative fold decrease for the experimental data and model predictions is de-
picted in Figure 4-5c and d). We found that, for most protein signals, the models
correctly predicted whether or not the signal would decrease (Figure 4-5a and b).
The computed accuracy of the predictions was dependent on the exact threshold for
considering a decrease significant, but for a reasonable choice of thresholds (average
model value decreasing by 50% and average experimental value decreasing by 40%),
the true positive rate was 86% and false positive rate was 44%. The contingency table
associated with these thresholds for decreases was statistically signifiant (p = 0.0028)
determined with a fisher exact test.
This analysis also yielded the observation that, for some conditions and signals,
model predictions were ambivalent (i.e. some predicted that a signal would sub-
stantially decrease whereas others did not; marked with an asterisk in Figure 4-5d),
leading to a bimodal predicted response of cJum in conditions with ILla stimulation
and Map3k7 inhibition (Figure 4-5e). To determine differences in models that were
driving these predictions, we classified each model as either predicting that the signal
would decrease or not and plotted the fraction of models in each set that contained
each interaction in the processed PKN (Figure 4-5f). We found that all models that
predicted cJun would not decrease in the relevant conditions contained an interac-
tion linking ILla and Map3kl whereas only a few models that predicted cJun would
Figure 4-5 (facing page): Experimental validation of Q2LM predictions. The computed
accuracy of the predictions was dependent on the exact threshold for considering a decrease
significant. Here, we varied the threshold for considering an experimental or simulated value
decrease significant and calculated the true positive rate (TPR) and false positive rate (FPR)
for each threshold pair. The resultant Receiver Operator Characteristic Curve (ROC)
indicated that model predictions behaved as expected and accurately predicted significant
decreases in phosphorylation of (a) single and (b) pairs of signals for a reasonable choice of
thresholds that determined if a decrease is deemed significant. The ROC for predicting if
three signals would decrease was similar to that for pairs (not shown). For the thresholds
indicated by the arrow in (a), the magnitude of the decrease in signal is depicted in (c)
for the experimental data and (d) for average model prediction. The colors in (c) and (d)
indicate if the change is classified as significant (blue for yes, white for no). In (d), the
species marked with an asterisk were predicted to decrease in some models but remain the
same in others, resulting in a bimodal distribution of predictions (demonstrated in (e) for
species marked with a yellow asterisk). (f) For the case in (e), we divided the models into
two sets: those that did and did not predict cJun phosphorylation would decrease and
plotted the fraction of models containing each interaction in the processed PKN fore each
set.
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Table 4.4: Structural elements of trained models with a correlation coefficient of at least
0.6 in filtered models
Positively Correlating Interactions
1. erkl2loop=p90rskhmsites with map3k1=mkk4
2. mtorclB=p90rskhmsites with map3kl=mkk4
3. p90rskntkd=gsk3s with pi3k=p9Orskntkd
4. aktact=gsk3s with pi3k=aktact
5. mtorc1B=p70s6kact with p70s6kact=s6s236
6. pi3kB=aktact with aktact=tscl2act
7. mtorclB=p9Orskhmsites with erkl2loop=p9Orskhmsites
8. pi3kB=p90rskntkd with p90rskntkd=tscl2act
Negatively Correlating Interactions
9. tgfa=pi3k with grb2=pi3k
10. igfl=grb2 with pi3k=mekls
11. p90rskntkd=s6s236 with pi3k=p53s15
12. erk12loop=p53s15 with mtorc2=p53s15
13. pi3kB=ntorc2 with mtorcl=p90rskhmsitest
decrease contained this interaction. The fact that cJun did decrease in the experi-
mental test of this prediction (Figure 4-5c) indicated that models that did not contain
this interaction were correct. While additional experimental controls are necessary
to verify this aspect of the network, it would be a particularly interesting feature
because it implicates Map3k1 as a key node in the network allowing growth factors
to activate some inflammatory pathways while decoupling that activation from the
action of inflammatory stimuli, which seem to signal primarily through Map3k7.
The finding that in some cases there were topological distinctions between models
making specific predictions(Figure 4-5) led us to determine if a more general analy-
sis of structural features would yield such insights. Thus, we clustered the trained
models based on whether or not they contained each interaction and calculated the
correlation between structural features of the network. We found that, while no dis-
tinct patterns emerged from the clustering results (Supplementary Figure D-8), the
correlation matrix pointed to interesting relationships between interactions (Table
4.4 and Supplementary Figure D-9). While some positively correlated pathways were
coincidental (Numbers 1 and 2), those between successive interactions in pathways
(Numbers 3 - 9) indicated that if the one interaction was included to fit the data
during training, the other was also necessary. The pathways that were negatively
correlated demonstrated pathways that were redundant (Numbers 9 - 13). All in
all, this analysis provided initial insights into the general structural features of the
trained models, but it did not immediately point out differences that would result in
the bimodal distributions of predictions described above.
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Table 4.5: Subsets of original dataset used to query what aspect of initial training set was
useful in constraining the models' topology and predictions.
Sl etName_ Iaa Neinov e d Data Remaining
All None All
No-Combs Combinations (Combs) Single Lig Doses + Inhib Doses
LigDose Combs + Inhib Doses Single Lig Doses + Full Inhib
InhibDose Combs + Lig Doses Full Single Lig + Inhib Doses
NoDose Combs + Lig Doses + Inhib Doses Full Single Lig + Fill Inhib
4.2.2 Evaluating original conditions for usefulness in con-
straining predictions
Given that we had initially conducted and experiment of 49 conditions and found
that the resultant models still led to some ambivalent predictions, we wondered how
many of the original 49 conditions were useful in training the models. Thus, we
created four subsets of our original dataset, and trained the models to the reduced
datasets (Table 4.5). To our surprise, we found only negligible differences between
the distribution of topology and parameters of the family of models resulting from
training to each subset (Supplementary Figure D-10). Furthermore, an analysis of
the precision of model predictions indicated that while inhibitor doses were also useful
in producing models that made fewer ambivalent criteria predictions, they did not
constrain the species' value predictions overall as much as ligand doses. Thus, the
main determinant in making constrained predictions was whether or not the dataset
contained conditions with ligand doses (Figure 4-6a).
97
Figure 4-6: Original Training Conditions Necessary to Constrain Models. (a) Experimental
data. Cumulative distribution functions for IQR of predictions as an indication of prediction
precision. Training to subsets 'NoCombs' and 'LigDose' resulted in predictions that were as
precise as those from training to the full training set ('All'). However, training to 'InhibDose'
and 'NoDose' resulted in less precise predictions in general. These two subsets did not
contain ligand doses, indicating that the ligand dose conditions were useful in training
models that would result in precise predictions. (b) The analysis in part a. was repeated
with in silico data that did not contain biological or technical noise. Thus, a comparison of
a. and b. revealed the influence of noise in part a. This result indicated that noise was the
likely cause of more data being detrimental for making constrained predictions as evidenced
by the smaller fraction of precise predicted for the 'All' and 'NoCombs' subsets than the
'LigDose' subset. However, this result did not reveal why ligand doses were especially
helpful in making precise predictions. (c) The ability of the models trained to each subset
to fit the data left out of that subset indicates that there was overlapping information in
the data remaining in the subsets and the data left out.
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From Figure 4-6a, we noticed two important features: (1) more data was some-
times detrimental for making precise predictions as evidenced by the smaller fraction
of precise predictions for the 'All' and 'NoCombs' subsets than the 'LigDose' sub-
set and (2) the inclusion of ligand dose data was most important for making precise
predictions. For the former, we believed that the subsets with more data were less
successful at constraining the models due to inherent noise in the data. We tested this
hypothesis by training models to data sets of the same composition using 'perfect'
in silico data obtained by simulating one of our trained models (Figure 4-6b). The
removal of noise indicated that more data was not detrimental in constraining the
model predictions, and we concluded that the cause of more data being detrimental in
the model training was due to noise in the experimental data. However, for the latter,
we obtained the same general result: the only major difference was in the utility of
ligand doses for making precise predictions (Supplementary Figure D-11).
Because noise in the data did not explain the additional utility of the ligand
dose conditions, we hypothesized that some conditions were not useful because of
redundancy of information contained in the new conditions. We first tested for this
effect by determining if the models trained to the subsets could predict the data
removed. If so, the models already contained the information regarding the value
of signals under the removed conditions. Thus, we would not expect that adding
the data to the training set would be helpful in constraining the models. Figure 4-
6c indicated models trained to each subset were reasonably successful at predicting
the value of those removed from the subset, suggesting that the reason additional
conditions were not always informative was indeed that the information contained in
the removed conditions was redundant with those kept.
To further investigate if conditions removed from each subset contained informa-
tion that was redundant with those kept, we first quantified information lost when
creating data subsets by computing the minimum distance between signal values of
conditions removed and kept from each data subset using the correlation distance
metric (Figure 4-7). We found that, when compared to randomly chosen condi-
tions of the same size, conditions removed from the subset 'InhibDose' contained
significantly higher distances between kept conditions (Figure 4-8) indicating that
conditions removed from the subset (i.e. the ligand dose and combination conditions)
contained more unique information than expected by random chance. Unfortunately,
this metric was a relative metric that was only meaningful when compared to random
subsets of the same size. Thus, we sought an absolute quantity indicating how much
information was lost upon removal of conditions from the subsets.
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Figure 4-7 (facing page): Use of relative distance metric for determining information lost
upon removal of conditions. The data was first split into subsets either randomly or by
choice. A standard distance metric (in this case correlation) was used to compute the
distance between all kept and removed conditions. The minimum distance between each
removed condition and kept conditions represented how 'unique' the removed condition
was compared the kept conditions. The more unique (higher minimum distance), the more
information that was removed. To interpret the distances, they were compared to those
obtained by randomly creating subsets of the same size. If the minimum distances were
larger for the chosen than random, more information was removed than expected by random
chance.
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Figure 4-8: Relative distance metric for determining information in data subsets. Cor-
relation distance metric as an indication whether or not more information was lost than
expected by random chance. p-value calculated with a t-test
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We first attempted to quantify this information with a quantity from information
theory, joint information entropy. However, we found that this quantity was not
flexible enough for our purposes for two reasons: (1) the requirement that the data
first be discretized led to a strong dependency the discretization protocol employed
and (2) most conditions differed by at least one discretized signal level. Thus, they
were unique and joint entropy was maximized for all sets. We defined a more general
metric for lost information by answering the following questions: Did several signal
measurements in removed conditions significantly differ from kept conditions? If
so, the removed condition contained information that was 'lost' from the remaining
data (Figure 4-9). In this metric, there were two thresholds: (1) how much should the
signals differ quantitatively to be considered different and (2) how many species should
be different to consider the condition to have contained additional information? We
calculated the number of conditions containing lost information for several threshold
combinations and (Figure 4-10) and found that indeed more conditions contained lost
information in the subsets that did not contain ligand dose conditions than those that
did.
As a whole, our analysis here indicated that additional data was not particularly
helpful in constraining model topology and parameters, but the addition of ligand dose
conditions resulted in models that made precise predictions. Noise in the data was not
the sole reason that more data did not result in more constrained models. Rather, the
information content of the data was a major determinant of how helpful a particular
set of conditions would be. We found that some conditions contained redundant
information, such that their removal did not adversely affect model training.
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Figure 4-9: Metric for quantifying information lost upon removal of conditions. To quantify
the absolute number of conditions removed from a subset that contained lost information,
we defined a metric by determining if several signal measurements in removed conditions
significantly differ from kept conditions based on two thresholds (t and n).
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Figure 4-10: Quantification of data lost from subsets. Titles indicate parameters used in
discretization protocol. The first number in title is threshold for difference in signal value
for measurement to be considered different, and the second number is how many species
had to be different for the condition to have contained lost information. If more or less
removed conditions contained lost information than expected by random chance (p <; 0.1),
it is indicated above the bars.
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4.2.3 Experimental Design for more precise predictions
Determining conditions to distinguish between trained models
The finding that many of our initially chosen conditions were not useful in training
constrained models for making precise predictions led us to question if further exper-
iments could better constrain the models. To determine these experiments, we first
simulated a set of models with a multitude of conditions. Conditions for which the
models predicted very different values for any measured species were considered to
be good candidates for further experiments because they would allow us to distin-
guish between the models. We further extended Q2LM to suggest combinations of
experiments that would allow us to discriminate between many models based on the
simulation predictions (Figure 4-11, left side).
Based on this analysis, we conducted an experiment of 9 additional conditions
(Supplementary Table D.2) that were predicted to differentiate between models for
5116 of 5151 pairs (99.3%) of 102 models initially trained to all conditions (in later
analysis, we discovered that the genetic algorithm had not converged when we ini-
tially trained our models. We had based this analysis on these models, but all other
analysis in this chapter is based on models trained subsequently to convergence.) Our
experiment also contained several control conditions to allow for comparison between
experiments. Unfortunately, the results of this experiment indicated that day-to-day
variability was high and could not be adjusted for with our experimental controls,
such that models that fit the discriminating conditions well were mainly fitting the
discrepancy between the quantitative values of the two experiments rather than the
specific protein signals whose response to these specific conditions was intended to
discriminate between models. This result underscores the importance of controlling
Figure 4-11 (facing page): Workflow for use of Q2LM for experimental design (dQLM). Left
Side: In the case of dQLM for conditions to distinguish between trained models, predictions
for conditions contained in scenario files were evaluated to determine if they were able to
distinguish between models. DQLM evaluated the difference between all model predictions
of all measured species for all conditions. If the condition resulted in predictions of any
measured species that differed by more than a predefined threshold (0.5 in this case), it was
said to be able to distinguish between the two models. DQLM then used a greedy search
to determine the simplest sets of experiments that distinguished between as many models
as possible. Right Side: In the case of dQLM for a priori experimental design, the prior
knowledge network was first processed as described in Chapter 2 based on proposed stimuli,
inhibitors, and measured species. User-specified interactions were excluded from the general
scaffold, and other specified interactions were varied systematically. The resultant Boolean
models were then simulated with the scenario conditions, and conditions that resulted in
different predictions for measured species defined as able to distinguish between two models.
In this case, we assumed that the basis for any design would be a factorial design in which
cells were exposed to all stimuli and inhibitors alone and in combination. DQLM then
used a greedy search to determine the simplest sets experiments containing combinations
of stimuli or inhibitors (or both) that distinguished between as many additional models as
possible
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for day-to-day variability when integrating new conditions.
Experimental design a priori
Because so few of the conditions in our initial experiment were useful in constraining
the trained models and incorporation of new experiments was complicated by the
need for many experimental controls, we wondered if we could use Q2LM a priori to
determine conditions that would allow us to distinguish between models within our
prior knowledge network. To make this challenge tractable, we used Boolean simula-
tion to focus on full stimulation and inhibition conditions that distinguished between
different topologies in the prior knowledge network. Additionally, we reasoned that
the basis for any design would be a standard one-level factorial design (single stimuli
in the presence or absence of single inhibitors). Thus, we only considered conditions
with combinations of either stimuli or inhibitors that would allow us to distinguish
between more models than a standard one-level factorial design.
We first specified which aspects of the topology we would like to distinguish be-
tween and the species that we could stimulate, inhibit, or measure. Regarding the
specification of aspects of topology to distinguish between, we could either specify
that we would like to determine if a specific edge was present or what edges linking
to a given model species were present (i.e. what logic gate controlled the species' ac-
tivation). We chose the latter for this analysis. The software then simulated different
conditions with all models and suggested combinations of experiments that would
allow us to distinguish between many models based on the simulation predictions
(Figure 4-11). In total, this analysis involved the simulation of 176 conditions in
377,408 models. The results of this analysis (Table 4.6) pointed to a set of ten con-
ditions that would allow us to distinguish between at least ten specified model pairs
in at least one of the PKN-derived model topology combinations specified. It was
possible to suggest more conditions by adding conditions that distinguished between
fewer than ten model pairs, but we chose a 'model pair' threshold of ten based on the
ability to distinguish between many models without drastically adding experimental
complexity (Supplementary Figure D-12).
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Table 4.6: Combination conditions in addition to a single-level factorial design predicted to
differentiate between additional models in PKN
ILla ± TNFa p3 8
109
stimuli Inhibitors
TNFa Map3k7 + P13K
IGF1 + ILla
IGF1 + ILla Map3k7
IGF1 + ILla p38
IGF1 + TGFa
IGF1 + TGFa p38
ILla + TGFa
ILla + TNFa
ILla + TNFa Map3k7
We performed an in silico experiment with these conditions by simulating one of
our trained models with the conditions chosen by the experimental design process as
well as randomly chosen conditions for comparison. We also considered conditions
with ligand doses since they had previously been demonstrated to be useful (see
Figure 4-12 for experimental design). As before, we found that models trained to the
various subsets did not differ significantly in how constrained the model topologies
were. A few subsets did differ in terms of how constrained the parameters were
and featured more constrained EC50 parameters but less constrained Hill coefficients
(Supplementary Figure D-14). These subsets also different in terms of how precise the
predicted species values were (Figure 4-13a), and, as before, the sole determinant of
how constrained the predictions were was whether or not the models contained ligand
doses. Because no beneficial effect was observed for subsets additionally containing
the designed conditions, this result demonstrated that the experimental design process
was not useful in constraining the models.
Nevertheless, we performed a wet lab experiment with these conditions (Figure
4-12 and Supplementary Figure D-13). To our surprise, we found that the results
differed from the in silico result, and the designed conditions appeared to result in
models that yielded more precise predictions (Figure 4-13b). However, the evalua-
tion of criteria using models trained to the designed conditions were actually more
ambivalent than those without these conditions (Figure 4-13b). When compared
to randomly chosen subsets of the same size as the designed conditions, we found
that predictions with models trained to the designed conditions were slightly more
constrained than those trained to randomly chosen conditions, but the effect was neg-
ligible. Additionally, models trained to randomly chosen conditions resulted in fewer
ambivalent predictions when evaluating criteria (Figure 4-13c).
We suspected that the disparity between the success of the experimental design
in silico versus experimental data was due to the noise inherent in biological data as
well as the inability of the PKN to account for all aspects of the experimental data.
This hypothesis was supported by the fact that models trained to all of the data
were less precise for the conditions and species to which they were actually fit (Figure
4-13d). To further investigate the data and model features underlying imprecise
model fit, we visualized the species that were fit imprecisely and the conditions for
which the models' fits were imprecise (Figure 4-14). We found that p70s6K and
IRS1 phosphorylation were imprecisely fit for many conditions. Specifically, IRS1
was imprecisely fit in conditions with IL10a stimulation and either MEK or MTORC1
inhibition. To examine structural features underlying this result, we divided the
models into two sets: those that predicted the first quartile of values (bottom 25%)
and those that predicted the fourth quartile of values (top 25%). We then plotted
the fraction of interactions in the processed PKN (Figure 4-14). We found that
structural features underpinning the imprecise fits weren't obvious for the conditions
with MTORC inhibition, but for cases with MEK inhibition, the pathway contained
in the models that was used to activate the TSC complex resulted in differing IRS1
predictions.
From this analysis, we concluded that ligand doses were of utmost importance
in training models that would make constrained predictions. While we were able to
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Figure 4-12: Experimental Test of Effectiveness of Experimental Design. Conditions used
in test of designed experiments. Because of off-target effects evident in the data and cited as
possible from the literature [1061, the Map3k7 inhibitor actually inhibited both Map3k7 and
Mek . Thus, Map3k7 inhibition was changed to Map3k7 + Mek inhibition in any condition
it was included in both the real and in silico data sets, and the in silico result was verified
to be the same when this substitution was not made.
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Figure 4-13: Effectiveness of Experimental Design. No significant differences between
topologies and parameters were observed for models trained to different subsets. However,
differences in the ability to make constrained predictions were observed.
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predict a reasonably small set of experiments predicted to better constrain the model
predictions, they were not helpful when tested with in silico data. Experimental data
indicated that some subsets of conditions might have been helpful in constraining the
model predictions, but subsequent analysis suggested that this effect was mainly due
to inclusion of data that the model training was unable to reconcile either due to
noise in the data or lack of appropriate edges in the PKN.
Figure 4-14 (facing page): Analysis of model variability. (a) Data values that the trained
models fit imprecisely (i.e. with an IQR of more than 0.25) are colored red. (b) By dividing
the models into two sets: those that predicted the first quartile of values (bottom 25%) and
those that predicted the fourth quartile of values (top 25%), and plotting the fraction of
interactions in the processed PKN, we were able to observe structural features underpinning
the imprecise fits in some cases. We show a few examples here. For IRSI phosphorylation
under conditions with MEK inhibition, were were able to see the disparity in fits was due to
differences in which pathways were used to activate MTORC1 (which then activated IRS1).
For IRS1 phosphorylation under conditions with MTORC1 inhibition, no obvious trends
emerged, although similar pathways seemed to be involved.
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4.3 Conclusions
In this work we trained a family of constrained fuzzy logic models to a dataset de-
scribing signaling response. In order to train our models to data normalized to pre-
inhibited basal level, we introduced a new simulation engine that modeled the effects
of inhibitors to basal value of signals separately from the effect on ability of species to
be activated upon stimulation. Additionally, we explicitly modeled the biochemistry
of the sites actually measured by phospho-specific antibodies through incorporation
of nodes describing different protein domains into the prior knowledge network. We
subsequently investigated the ability of the models to make predictions that efficiently
screened for what therapeutic or combination of therapeutics would result in a desired
outcome and in what environmental contexts they would be effective. We assessed
the predictions in terms of both accuracy and precision and discovered interesting
facets of model topology.
The evaluation of a trained logic model both in terms of accuracy and precision of
predictions is a concept introduced in [124] and explored for constrained fuzzy logic in
Chapter 2 [102]. In this work, we further demonstrated the utility of this concept by
determining the accuracy of several predictions (Figure 4-5a and b) and further exam-
ining differences in models that predicted different responses for the signals (Figure
4-5e and f). We found that examining the topological features underpinning differ-
ent predictions yielded further insight into network topology that was not discernible
from a more general clustering and correlation analysis (Table 4.4 and Supplemen-
tary Figures D-8 and D-9). Thus, we concluded that differences in model topology
should be considered and examined throughout use of the models to make predictions
because a general approach, while useful, did not present a complete picture of the
implications of topological disparities.
As described in [102], a family of models was trained to the data because avail-
able data did not completely constrain both model topology and transfer function
parameters. While considering this lack of identifiability was useful when making
predictions, it would be preferable to obtain data that better constrained the model
predictions. We addressed this issue in two ways: (1) investigating what subset of the
data we originally obtained was useful in constraining the models and (2) develop-
ing methods to determine experimental conditions that would allow us to distinguish
between models.
In our investigation of what portion of the data was useful in constraining the
models, we found that inclusion of ligand dose data was important for training models
that would make precise predictions (Figure 4-6a). It remains to be seen if this
will be true for other data sets, but it stands to reason that inhibitor doses will
generally add less information than ligand doses. In the case of partial inhibition of
downstream nodes, other conditions could contain information regarding the effect of
partial activity of that node due to differential activation under other experimental
conditions. However, information regarding effects of partial activity of the most
upstream nodes (the ligand stimuli) could not be contained in any condition other
than one featuring partial stimulation of that species. Thus, the ligand dose condition
would be necessary to determine this effect.
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Our efforts to quantify the information content of the data subsets led us to
propose a new metric for data information that wasn't reliant on a comparison with
randomly chosen conditions. We developed a new metric to determine if removal
of a condition resulted in 'lost' information and found that it allowed us to better
determine how many conditions removed in each subset contained lost information.
However, future work should aim to use this metric in a variety of data sets of various
size and composition to ensure its general usefulness and applicability.
Toward the goal of developing a method to determine informative experimental
conditions, we performed the design analysis both to distinguish between our trained
models (Table D.2) and to suggest experiments a priori that distinguished between
models derived from the prior knowledge network (Figure 4-11). We found that
we were able to propose a set of experiments a fraction of the size of that tested
(less than 10% of conditions tested were found to be informative). In our test of
conditions predicted to distinguish between trained models, we found that day-to-
day experimental variability prevented us from being able to use these experiments
as planned. We had allowed the software to propose experiments that contained
different doses of ligands. The use of these smaller doses exacerbated the effect
of day-to-day variability, as small differences in seeding density could lead to large
differences in the number of molecules of ligand stimulation per cell, which has been
shown to greatly affect cellular response [21]. The variability was systematic in that
the observed dose response for the ligands appeared shifted. Thus, we could not
correct for the appearance of this experimental noise nor could we have accounted
for it during our design calculations. If we had included dose response conditions of
each ligand and inhibitor as part of the validation study, we could have corrected
for the noise. Alternatively, we could limit this effect by only considering conditions
that contain full stimulation and inhibition. An example design incorporating this
limitation is shown in Supplementary Table D.3.
In our test of a priori design for conditions that distinguished between models
derived from the prior knowledge network, we found that while we were able to suggest
conditions that were predicted to be informative, a test of the ability of models trained
to these additional conditions in making constrained predictions indicated that the
designed conditions were not additionally informative for in silico data. For real
data, some conditions appeared to be helpful in constraining the resultant models'
predictions. However, on closer inspection, the success of the designed conditions
seemed to be due to noise in other conditions and not the actual information content of
the data. This noise (or, in some cases, differing responses in similar but not identical
conditions) led to imprecise models because the training process could not rectify the
data in terms of the prior knowledge network, which caused the models to choose one
of several reasonable explanations for the data and led to ambivalent models. Because
the success of the designed conditions was attributable to experimental noise rather
than the information content of the data, we concluded that the experimental design
procedure was not successful. In this procedure, we assumed that potential stimuli,
inhibitors, and measured species were known. In order to obtain an effective design
strategy in future work, it might be beneficial to also consider what species it would
be most informative to additionally measure or perturb.
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We concluded that, because we are currently unable to design experiments that
will not result in a single model that fits the data rather than a family of models,
we should consider ways to investigate model 'ambivalence' during entire modeling
process: from training to topology analysis to making predictions. We demonstrated
several strategies for such analysis of model ambivalence. Initially, we trained many
models individually and used the resultant family of well-fit models for further anal-
ysis. By exploring what is kept and removed in many models, we determined aspects
of our prior knowledge network that were inconsistent with or unnecessary to fit the
data well. Additionally, we performed correlation analysis to determine interactions
that are correlated, resulting in a deeper understanding of the ambivalence in the
topology of the models. Importantly, we also considered model ambivalence when
making predictions. We used each model to predict if a condition would meet our
criteria, and then determined the fraction of models that predicted a conditions would
be effective. If many models predicted that it would be effective while many others
predicted it would not, the prediction was ambivalent. In such cases, we demonstrated
that by considering differences between structural features in each group of models,
we gained further insight into the regulatory network dictating cellular response.
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Chapter 5
Conclusions and Perspectives
5.1 Summary of thesis contents
Signaling networks contain many protein species with many interactions between
them, all of which could play a role in eliciting a cellular response. The complicated
nature of these signaling networks leads to difficulty in predicting their response using
intuition alone. Rather, mathematical models can aide in probing network proper-
ties and interpreting data describing signal activation under specified environmental
conditions.
In this thesis, we developed methods for using continuous logic-based models to
aide our understanding of biological systems and facilitate data interpretation (Figure
5-1). Chapter One describes various types of logic models as well as how they have
been applied to biological networks in the past [103]. A logic-based network model
encodes observations of how molecular species interact with logic rules comprised of
AND, OR, and NOT gates. The simplest and most common form of logic is Boolean
logic, where species are described as either active or inactive. However, in biological
networks, proteins often access a range of intermediate activation states. Aldridge
et al manually determined fuzzy logic relationships and tuned parameters to fit the
model to the data. During the training process, the authors made interesting ob-
servations regarding interactions in the signaling network. However, the necessity to
manually fit the both the topology (in the form of fuzzy logic rules) and parame-
ters was quite cumbersome, pointing to the need to simplify the formalism in order
to enable automation of the model training [3]. Thus, we have developed a logic
framework called constrained fuzzy logic (cFL) that maintains the simple description
of interactions with AND, OR, and NOT gates, but allows for intermediate species
activities through the use of mathematical functions relating input and output values
(transfer functions).
In Chapter Two, we used cFL to train a prior knowledge network (PKN) to data,
which revealed what aspects of the dataset agreed or disagreed with prior knowledge
[102]. The PKN represented how we expected the signals to interact and was con-
structed from the literature or curated databases. To train the PKN to data, we
employed a strategy previously developed to train Boolean logic models by enumer-
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ating possible logic gates from the PKN and testing the ability of models containing
a subset of those gates to fit the data [124, 125]. We extended this strategy to train
cFL models by testing models containing a subset of logic gates as well as transfer
functions chosen from a list of possible functions. We implemented our approach as
a significant extension of the publicly available software CellNetOptimizer [101].
In our first application to data in Chapter Two, we trained cFL models to a
dataset describing fifteen signaling proteins in the HepG2 liver cancer cell line after
exposure to six extracellular ligand cues in the presence or absence of seven small
molecule inhibitors. We demonstrated that the ability to capture intermediate infor-
mation is essential for full understanding of the network structure. Furthermore, our
trained models generated new biological understanding of network behavior as well as
quantitative predictions of signaling protein activation. Specifically, we learned that
the ligand cue TGFa induced partial activation of the JNK pathway and that IL6
induced partial activation of multiple unexpected downstream species via the MEK
pathway.
In addition to training a cFL model, in Chapter Three, we developed a tool
called Querying Quantitative Logic Models (Q2LM) to quickly and easily construct
a cFL model from existing knowledge of a biological system [104]. No dedicated
data was gathered in these cases. Rather, we described the logic of the system
based on observations made from diverse studies of the system. The model was
then queried to determine if a prediction made using intuition alone was consistent
with the current understanding of the system. We also varied the parameters of
the model to determine if a prediction was consistent with many possible models, or
only models with certain parameter values. Furthermore, this tool was specifically
designed to screen for the effectiveness of combinations of therapeutics across posited
extracellular environments. These two features are of utmost importance because
cellular response can vary greatly across different environments, and combinations
of inhibitors are often needed to elicit the correct response since many paths can
activate the same signal in these networks. We used this platform for the analysis of
a multiscale model of GCSF pharmacokinetics and pharmacodynamics and discovered
that the cFL model was able to predict behavior that was reflected of the system in
vivo.
We also explored the ability of cFL to model multiple stages of a biological re-
sponse - from environmental cues to protein activation to subsequent transcriptional
response (Appendix E). We collected datasets of both early protein phosphorylation
and later mRNA transcription of the HepG2 cell line response to various ligand stimu-
lation conditions, and explored means to train a cFL model to the diverse information
contained in these datasets. We concluded that cFL training of a prior knowledge
network linking protein and transcriptional regulation was useful for systematically
determining if condition specific hypotheses were consistent with a general picture,
but further development is necessary to fully evaluate the ability of this methodology
to provide additional insight to this type of analysis.
In our final application of trained cFL models, we investigated the ability of these
models to predict therapeutics that would be effective at accomplishing a clinical goal
in different cellular environments. We first trained a PKN to a new dataset describing
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activation of sixteen signaling proteins in the HepG2 cell line after exposure to several
doses of four extracellular ligand cues and four small molecule inhibitors. As is often
the case for training models to data, we found that several models could fit the data
well because the data did not completely constrain both the transfer function parame-
ters and topology of the models. Thus, we used all trained models to make predictions
with Q2LM, which simulated models to determine what therapeutic perturbation or
combination would be effective at accomplishing a clinical goal. In the course of this
analysis, it became clear that some predictions were ambivalent in that some models
predicted a perturbation would be effective whereas others did not. We investigated
means of experimental design to reduce such ambivalence. However, we found that
while we were able to suggest useful 'rules of thumb' for what conditions would allow
models to produce constrain predictions, at least 10% of the predictions were am-
bivalent. Thus, we conclude that, since such ambivalence is currently unavoidable in
modeling biological systems, it is crucial to explicitly address the ambivalence during
model training and analysis. We demonstrate several means of exploring the general
cause of model ambivalence as well as its effect on model prediction.
5.2 Relationship between cFL and other modeling
formalisms
Models are typically used for two important purposes: (1) to understand biologi-
cal relationships and (2) to predict outcomes in specified conditions. To accomplish
these goals for a variety of applications involving different data and prior knowledge
availability, several modeling approaches have proven useful (Figure 5-2). Correlation-
based approaches such as principle components analysis and partial least squares re-
gression require little prior knowledge and can be used to understand the correlative
relationship between molecular species and phenotypes measured [58, 97, 5]. How-
ever, they do not typically incorporate causative network links that indicate which
upstream species activate downstream species such that predictions of therapeutic
effect do not take into account cellular context [57]. Network inference approaches
(e.g. Bayesian networks and mutual information networks) propose networks of rela-
tionships between species with minimal or no prior knowledge but typically require
large amounts of data to train and do not explicitly take into account cellular context
[123, 160].
On the other end of the spectrum, differential equations (DEs) based on mechanis-
tic representation of molecular interactions require detailed knowledge of biochemical
interactions as well as large amounts of kinetic data to train. Thus, while additional
insights regarding what insights interact are limited, 'these models are well suited to
make detailed predictions regarding how a molecular alteration to an inhibitor or bio-
logic will effect efficacy (e.g. [33]) as well as what aspects of the system are important
for determining efficacy (e.g. [17, 72]). By describing networks with less mechanistic
and time-resolved detail than DEs but incorporating more prior knowledge than a
reverse-engineering approach, logic-based models typically require much less data to
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Figure 5-2: Relationship between cFL and other modeling techniques. Each modeling ap-
proach answers different questions regarding biological data and has specific prior knowledge
and data requirements.
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train than either approach while still providing information regarding hypothesized
network connections and allowing for context-specific prediction of species' states
[124, 102, 103].
5.3 Limitations of cFL modeling
While complementary to other model approaches, cFL modeling has several limita-
tions that should be overcome to further extend its use. As currently formulated,
cFL models are trained only to 'static' data in that only one time point is con-
sidered. Thus, the resultant models represent the early activation of signals while
assuming that later mechanisms of signal attenuation are on a timescale slower than
that reflected by the data. It would be preferable to model these negative feed-
back mechanisms explicitly, but negative feedback frequently leads to oscillations in
discrete simulation procedures. To handle these cases in the case of logic models
constructed based on prior knowledge (Chapter Three), we offer the option of solving
the system of nonlinear equations specifying the network for the root 'nearest' the
last simulation step. While this procedure could be employed in the model train-
ing case, it would greatly decrease computational efficiency. Rather, an attractive
alternative that allows for the annotation of negative feed back as either strong or
weak has been developed for the Boolean logic case [86], and application to the cFL
case would be highly informative for application of the method to study biological
networks involving both intracellular and intercellular regulation in the future.
An additional limitation of the cFL model training approach presented in Chapter
Two is that it cannot add interactions to those deemed feasible by the prior knowledge
network (PKN). If the PKN does not contain an interaction between species that is
necessary to fit the data, the trained models simply return with systematic error
for that data. The scientist must then recognize the error and propose interactions
by manual inspection of the data and literature. These interactions are added to
the PKN, which is subsequently retrained. Methods to automate this process would
be less subjective and potentially less time consuming. One option is to develop a
means to detect systematic error caused by links missing from the PKN during model
training and initiate an additional training process to propose connections from a pre-
determined list or based on correlation between measured species Alternatively, the
Saez-Rodriguez lab at EMBL-EBI recently proposed the addition of links to the prior
knowledge network based on correlation analysis prior to model training [29].
Finally, cFL models are deterministic in that, for a given set of stimuli and pertur-
bations, simulation of a given model will always return identical species' values. Thus,
cFL as currently implemented cannot be used to probabilistically model single cell
data. One alternative for training a PKN to single cell data is the use of a different
mathematical formalism to represent the networks: specifically, a Bayesian network.
While applications of Bayesian network training have typically focussed on network
inference, it is possible to imagine either altering network inference procedures to
incorporate a strong prior that recapitulates the processed prior knowledge network
or developing a new search procedure to evaluate Bayesian networks limited to those
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contained in the prior knowledge network. Work toward the latter is ongoing in the
Sorger laboratory at Harvard Medical School.
5.4 Overcoming computational limitations of cFL
training procedure
CFL model training is currently computationally limited because of the platform used
for implementation as well as the optimization procedure employed. CellNOpt was
initially implemented in MATLAB. While every effort was made to increase compu-
tational efficiency, the training of a cFL model of the size presented in Chapters Two
and Four can take between three and twenty-four hours. If the PKN contains many
possible interactions such that 1000 models must be trained to ensure a sufficient
number of well-fit models, a vast amount of computational time is necessary to ob-
tain the solution pool. Furthermore, if the models are trained in parallel, a sufficient
number of MATLAB licenses must be obtained, representing an additional limitation
to model training.
To overcome the requirement of the proprietary MATLAB platform, CellNOpt has
been implemented as an R packages for both Boolean logic and cFL model training
[144]. Unfortunately, the implementation in R has not yet been optimized for speed.
Although it is unclear if the R version will overcome the computational time require-
ment issues, it will be a viable alternative that alleviates the MATLAB requirement.
If the R version cannot be made more computationally efficient, another programming
platform could be sought. Whichever platform is used, great care should be taken
to ensure that not only does the interface for training models to data remain user
friendly, but also the post-training analysis. One of the great advantages to CellNOpt
in the current MATLAB implementation is the availability of functions for analysis
of trained models' structures and fit to the data as well as the interface to Q2LM for
extended prediction capability. It is crucial to maintain ability to efficiently learn not
only how to train models but also how to analyze them once they have been trained.
Toward improvement of the training optimization procedure (Figure 5-3), the
cFL network has been recast as a regular nonlinear optimization problem (NLP) by
describing the network with equations and trained to data [99]. This procedure first
optimizes the network parameters and then examines what parts of the topology are
necessary, so the model topology and parameters are not considered simultaneously
as in CellNOpt. Additionally, in order to recast the network as an NLP amenable
to training with available solvers, the mathematical form of the relationship between
species must be well established. In the CellNOpt procedure, the genetic algorithm
optimizes based on a comparison of simulated and experimental values. Thus, it is
relatively straight forward to incorporate an alternative simulation procedure into
the CellNOpt but not the NLP procedure. This flexibility is sometimes necessary to
accurately recapitulate data (as exemplified in Chapter Four). If the current CellNOpt
workflow is preferred, improvements in specific aspects should be considered. For
example, a simulated annealing or other global optimizer could be substituted for the
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Figure 5-3: Alternative logic model training procedures. The CellNOpt procedure was
developed and used in this thesis work. Recently, an NLP procedure has been proposed
[99]. A proposed additional alternative is depicted in purple.
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genetic algorithm. Alternatively, the entire genetic algorithm followed by heuristic
refinement procedure could be accomplished using different optimizers and heuristics.
Development toward establishing a more efficient and rigorous workflow for logic
model training is an area of active study in the laboratory of Julio Saez-Rodriguez at
EMBL-EBI as well as several collaborators.
One additional workflow that could be investigated is training the model topology
with Boolean logic methods and subsequently training parameters with cFL methods
(Figure 5-3). In early stages of this work, this procedure was attempted and found
lacking because the optimal cFL parameter values were simply those that recapitu-
lated a Boolean logic gate. However, if the data was thresholded properly to zero
or one for Boolean logic topology training and then the un-thresholded continuous
values used to train cFL parameters, this procedure could still be a viable alternative.
5.5 Concluding remarks
While further work remains toward development of the most rigorous and efficient
optimization protocol, in this thesis we have developed the novel modeling approach,
constrained fuzzy logic. We have demonstrated that cFL models can be trained
to data or constructed directly from prior knowledge and used these models to in-
crease understanding about signaling network responses and make predictions under
a variety of environmental conditions. Ultimately, we hope that development of this
flexible methodology will assist scientists in making self-consistent, informed decisions
for further experiments or choice of therapeutic targets.
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Appendix A
Supporting information for
Chapter 1
A.1 Supplementary Figures
Figure A-1 (facing page): (a.) Example of equation description of logic. Practically, discrete
models are often described by equations. There are several ways to represent logic as
equations. We have shown one possible representation. For the simplest binary case, aij
is 1 if x3 is and activator or xi, -1 if xj is an inhibitor of xi and 0 if xj does not influence
xi. In order to describe multiple activation states of the species, O and aiy can take
on virtually any user-supplied value. (b.) Truth table description of logic. The truth
tables indicate the values of the output species given specific values of each input values.
Only binary (Boolean) truth tables for interactions with two inputs are described. The
Boolean function notation is shown above each gate. All gates shown are monotonic with
the exception of XOR, which has nonmonotonic behavior: increasing input levels may lead
to an increase in output level, but upon further input level increase, a descrease in output
level is observed. The disjunctive normal form (sum-of-products) description of this gate
is shown above this truth table. The alternate conjunctive normal form (product of sums)
is (c.) Continuous or mixed discrete-continous description of logic. Species states are
determined using differential equations. The activation of any given species is determined
by a function (Ga). The specific function used depends on the specific formalism (logic
based ODEs, piecewise-linear, or standardized qualitative dynamical systems, etc.). Each
formalism models decay as a first-order process. (d.) Fuzzy logic description of logic. Given
one or several input species levels, possible output levels are calculated from user-defined
functions. The final output value is calculated based from the possible output levels using
other user-defined functions.
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a. Example equation formalism
x(Q +1) - 0
xi(t) or 0
aixj (t) -6 O>0
jagjxj(t)-6, < 0
7,agjxj (t) -, .j- 0
3
where
x = node state
t = refers to time
a = how node x relates to node x,
0 = threshold for activation for x
c. Continuous or mixed discrete-
continous formalisms
-x =Gi (X,t) 
-yix;
dt
where
x = node state
t = refers to time
y = decay rate of node x1
G = Function describing activation of node x,.
It is dependent on values of other nodes
(denoted by the x vector) and, optionally, time
b. Example 2-Input Truth Tables
AAB
A AND B - C
Inputs Output
A B C
0 0 0
0 1 0
1 0 0
1 1 1
A A ,B
A AND not B 4 C
Inputs Output
A B C
0 0 0
0 1 0
1 0 1
11 0
AVB
A OR B - C
Inputs Output
A B C
0 0 0
0 1 1
1 0 1
(A A -B)V(-A A B)
A XOR B - C
Inputs Output
A B C
0 0 0
0 1 1
1 0 1
1 1 0
d. Fuzzy logic formalism
Input
species' NNO
states
Output
species
state
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Given inputs, calculate
possible output levels.
User-defined
membership functions,
fuzzy operations and
implication methods
used relate possible
output levels to input
species' states.
From possible outputs,
calculate one final output
with user-defined
aggregation method and
defuzzification function
Appendix B
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B.1 Supplementary Methods
B.1.1 HepG2 training and follow-up data phospho-ERK mea-
surement inconsistencies
In the training dataset, ERK was phosphorylated solely under one stimulatory con-
dition (TGFo) and did not increase with increasing MEK phosphorylation. When
compared the raw data between this and the follow-up dataset discussed below, ERK
did indeed respond in many other conditions in the initial training dataset, but sig-
nal intensity was much lower in this experiment, causing many ERK phosphorylation
measurements to be below the noise threshold and recorded as zero during the normal-
ization process. Because of these discrepancies with the phospho-ERK measurements,
we did not include it in our training dataset.
subsectionConstrained fuzzy logic
Prior to implementing constrained fuzzy logic for network training, we investigated
the use of Mamdani [88] and Sugeno [140] fuzzy logic gates with varying number
and functional forms of membership functions. The cFL framework we use in this
work represents each biological interaction with Sugeno gates with normalized Hill
input membership functions and constant output membership functions of zero and
one. Each AND gate is a fuzzy logic rule with an AND operator of "min." In this
formalism, OR gates are evaluated by the "max" defuzzification method that operates
on the outputs of fuzzy logic rules.
The use of normalized Hill functions assumes that species reach the same level of
saturation under activation by any of its possible inputs. Biologically, this assumption
does not always hold. However, during our initial methods development, we deemed
this assumption acceptable as the use of the normalized Hill function did not cause
any noticeable issues during the model training and allowed each parameter to have
a distinct meaning with the sensitivity parameter, k, specifying EC50 and the Hill
coefficient, n, specifying sharpness of transition.
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B.1.2 Simulation
A set of functions was implemented in MATLAB (Mathworks, Inc.) and integrated
into CellNetOptimizer to convert BL models to cFL models and determine the logic
steady state of node states of a given cFL network under given experimental condi-
tions. To calculate the logic steady state, nodes of the network are updated until they
reach a stable state. If the network contains negative feedback, a logic steady state
cannot be computed, similar to the Boolean case [71]. Penalization of not-computed
stated states leads then to the absence of negative feedback in resulting models [70].
To increase the efficiency of the training process, in the HepG2 prior knowledge net-
work we determined the negative interactions that would result in negative feedback
in CellNOpt using the MATLAB (Mathworks, Inc.) software CellNetAnalyzer [126],
and we removed them prior to optimization.
B.1.3 Model Refinement
Model parameters were refined using the MATLAB active-set algorithm, a Sequential
Quadratic Programming method for nonlinear constrained optimization.
http://www.mathworks.com/access/helpdesk/help/toolbox/optin/ug/brnoxzl.html
B.1.4 PLSR model of cytokine release data
Luminex data describing release of 50 cytokines at time zero and three hours after
stimulation was examined. Twenty cytokines were chosen to model based on the
consistency and reliability of the data (e.g. if the data was grossly inconsistent under
similar experimental treatment conditions, it was not considered). Data for these
cytokines were normalized similarly to the phospho-signal dataset [124] except no
data was considered below the lower level of detection because it had already been
filtered for consistency.
A preliminary three-component PLSR model was constructed using DataRail [126]
by regressing the normalized cytokine release data against the signaling data. Five
cytokines (IL1#, IL4, G-CSF, IFN-y, and SDF1Of) were chosen for further study based
on the criteria that the R2 values of the PLSR model for those cytokines be greater
than 0.70. Further analysis suggested that cytokine measurements with lower R2
values were not robust (i.e. varied in measured value even under similar stimulation
and inhibition conditions).
A new PLSR model was then generated with DataRail by regressing the normal-
ized cytokine release data against the signaling data. Three components were chosen
to be optimal by seven-fold cross-validation.
B.1.5 Linking prior knowledge network to cytokine release
nodes
The clustering of the protein signals in principle components space of both a principle
component model of the signals as well as the principle components of the PLSR model
132
was considered when choosing signaling nodes to link to the cytokine release nodes.
If protein signals clustered together consistently, the signal most downstream in the
prior knowledge networks was chosen. Based on this analysis, the following protein
signaling nodes were linked to each cytokine release node: MEK1/2, CREB, GSK3,
c-Jun, Hsp27, IicB, and STAT3.
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B.2 Supplementary Figures
Figure B-i (facing page): Experimental dataset describing HepG2 signaling response. Each
small rectangle represents phosphorylation of the protein indicated on the left at zero and
thirty minutes as measured by Luminex bead-based Elisa. HepG2 cells were exposed to
the inhibitor indicated below the column and stimulated with the ligand indicated above
as described in [5]. Raw intensity (a) and normalized (b) values are shown. Data was
normalized as previously described [124] using DataRail software [126. Briefly, data values
below the background or above the saturation signal of the Luminex instrument were not
included in the training set (grey fill). The absolute difference between the signal at the
time of stimulation and 30 minutes thereafter was divided by the signal at time zero and
transformed using a nonlinear Hill transformation. The resulting value was multiplied by a
Hill-transformed ratio of the value of the signal at 30 minutes to its maximum value across
all conditions. The resulting value was the normalized value. Plots were generated by the
open-source MATLAB toolbox DataRail [126].
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Figure B-2 (facing page): Prior knowledge networks (PKNs). PKNO derived from Ingenuity
and used in the BL methodology validation (a, map without purple dashed arrows) was
first processed to include two-input AND gates (b) and then used with the CeIlNOpt-
cFL methodology to determine the cFL networks representing this dataset. Results of
this analysis led to extension of the PKN to PKN1 (a, purple dashed arrows) which was
processed to include either two-input AND gates (PKN1a, c) or only include AND gates
when an inhibitory interaction was being modeled (PKN1', d). These processed PKNs were
then compared to the HepG2 dataset with CellNOpt-cFL. All maps were generated with a
CelNOpt routine using the graphviz visualization engine (www.graphviz.org) followed by
manual annotation in Adobe Illustrator.
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Figure B-3: Fit of unprocessed cFL networks trained with PKNO. PKNO (Supplementary
Figure B-2a) was processed to include all two-input AND gates (Supplementary Figure B-
2b) and CellNOpt-cFL used to train 90 network models to the HepG2 dataset. The data
is displayed as described in Supplementary Figure B-1, with the exception that the average
simulation result is shown with a dashed blue line and the absolute difference in measured
and average simulated signal level is indicated with a background color ranging from green
(good fit) to red (bad fit). Note that, under the ILla and IL6 stimulation conditions, many
signals are not fit well (as indicated by the red and white coloring). Plots were generated
by CellNOpt.
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Figure B-4: Comparison of MSE and number of parameters of PKN14 and PKN1'. The Cu-
mulative Distribution functions of the MSE and number of final parameters of unprocessed
(a,b) and filtered (c,d) models with or without expansion into all plausible two-input AND
gates are shown. For both the unprocessed and filtered models, the error of the models
expanded with all plausible two-input AND gates is significantly less than those not fully
expanded (p = 4.3x10- 2 from a Kolmogorov-Smirnov two-sided test of the filtered mod-
els). However, both unprocessed and filtered models expanded with all plausible two-input
gates also contained more parameters than those not fully expanded (p = 3.2x10-1 4 from
a Kolmogorov-Smirnov two-sided test of the filtered models). The skewing of the filtered
models (d) is due to the heuristic reduction procedure, which sometimes does not remove
any parameters from the models.
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Figure B-5 (facing page): Filtered cFL network models derived from training the HepG2
dataset to PKN1 processed to include two-input AND gates (PKN1a). The PKN1 (Supple-
mentary Figure B-2a) was processed to include all two-input AND gates (Supplementary
Figure B-2c) and CellNOpt-cFL used to train 191 network models to the HepG2 dataset.
Reduction of family of cFL models indicates that cFL AND gates can be removed without
greatly affecting the resulting refined model score (a and b; b is a portion of the graph shown
in a). The structures of the family of cFL network models trained to the HepG2 dataset are
shown (c). Links colored black were present in all models whereas links colored grey were
present in a fraction of the models (a darker grey indicates that the cFL gate was present
in more models). Filtered cFL network models are shown. Fit to experimental data (d)
is displayed as described in Supplementary Figures B-1 and B-3. Plots were generated by
CelNOpt. Note that, when this PKN1a is used to train the networks, most trained models
include the Ras -to- Map3kl cFL gate. The inclusion of this link is in contrast to the models
obtained when two-input AND gates are only included for inhibitory interactions (Figure
2-5, Supplementary Figure B-6), where only a few models include this link. This difference
is also reflected in the fact that cFL network models processed to include all two-input
AND gates are better able to fit data describing c-Jun activation under TGFa stimulation
(d compared to Supplementary Figures B-7 and B-8). Graphs of cFL network models were
generated a CelNOpt routine using the graphviz visualization engine (www.graphviz.org)
followed by manual annotation in Adobe Illustrator.
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Figure B-6 (facing page): Unprocessed cFL network models derived from training the HepG2
dataset to PKN1*. a) Structures of the family of unprocessed cFL network models obtained
by training the PKN1 (Supplementary Figure B-2d) to the HepG2 dataset. Links colored
black were present in all models whereas links colored grey were present in a fraction
of the models (a darker grey indicates that the cFL gate was present in more models).
Theses models were compared to the randomization controls, both for the determination
of a p-value of the models (Supplementary Table B.1) as well as the investigation of the
influence of the PKN on the model training process (b,c). The graph of the cFL network
models was generated with a CeilNOpt routine using the graphviz visualization engine
(www.graphviz.org) followed by manual annotation in Adobe Illustrator. (b) We compared
unprocessed models derived from a PKN with edges randomly added to those derived from
the original PKN1I. After structure processing (Figure 2-2 Steps 1-2), a model derived
from a PKN with random edges added might have a different number of species as well as
interactions than those derived from the original PKN. Thus, to compare these models, we
further compressed the networks to include only interactions between the treated, measured,
and inhibited species. This treatment allowed us to directly compare models with different
intermediate species. When compared to the original PKN1i, several edges were added
which increased as a function of edges added to the pre-processed PKN, as expected (solid
line). For the trained models, we compared edges present frequently in the family of models
trained to the original PKN1z (i.e. those present in > 25% of the models in a.) to those
trained to each randomly extended PKN (dashed line). The fraction of different edges in
the structures of the trained randomly extended models to those trained to the original
PKN1' increased slightly with increasing number of edges added randomly. (c) Comparing
between the randomly extended PKNs and models derived from them, connections between
treated, measured, and inhibited species that were in the randomly extended PKN but not
the original PKN were often but not always removed during the training process. This is
to be expected, as not all of the randomly added edges would not be inconsistent with the
data, and some might allow the models to fit the data better than the original PKN.
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Figure B-7: Fit of cFL networks trained using the extended PKN1'. The extended prior
knowledge network (Supplementary Figure B-2a) was processed to include all two-input
AND gates only when an inhibitory interaction was modeled (Supplementary Figure B-2d)
and CellNOpt-cFL used to train 243 network models to the HepG2 dataset. The data is
displayed as described in Supplementary Figures B-1 and B-3. Plots were generated by
CelNOpt.
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Figure B-8: Analysis of systematic error in c-Jun under TGFa stimulation. Both the
training and follow-up datasets indicate that c-Jun but not JNK is phosphorylated upon
TGFa stimulation. In PKN1, the only path for c-Jun activation is by JNK activation.
The cFL networks account for this discrepancy in one of two ways: (1) Partial activation
of the JNK node (increasing error) and amplification of this signal to further activate the
c-Jun node (decreasing error). CFL networks that followed this treatment contained Ras
-to- MAP3K1 or P13K -to- MAP3K1 links (blue 'With Crosstalk' case). (2) No activation
of c-Jun under TGFa stimulation, increasing error in only the c-Jun signaling node. CFL
networks that followed this treatment contained neither Ras -to- MAP3K1 nor PI3K -to-
MAP3K1 links (red 'Without Crosstalk' case). No significant differences in ability to fit
the other signals are observed. Each of these treatments of c-Jun activation corresponds
to a different biological explanation. The first treatment corresponds to the explanation
that JNK was partially activated but our measurement did not reflect this while the second
treatment corresponds to the explanation that an interaction we did not include in PKN1
was causing c-Jun to be activated.
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Figure B-9 (facing page): Fit of cFL networks to follow up data. (a) Experimental design of
follow-up dataset describing the HepG2 response to combinations of ligand and inhibition
treatments. (b) Raw data was rescaled using common conditions as described in Prill et
al., in preparation. (see http://wiki.c2b2.columbia.edu/dream/data/scripts/DREAM4/ for
Challenge_3 data scaling scripts). Briefly, a linear correlation the log-normalized signals
under common conditions of the training and validation data was fit. Parameters of this
line were used to scale the log-normalized validation data, which was then transformed
back into the linear range. The resulting rescaled values are shown. (c) CFL networks
were trained to the HepG2 dataset using PKN1'. The data is displayed as described in
Supplementary Figures B-1 and B-3. The filtered models were able to fit the validation
data with an MSE of 0.076 ± 0.005. Some of this error ( 13%) was expected, as these
conditions were similar to the experimental conditions under which the main discrepancies
between the training data and models were observed (phosphorylation of IRS1s and p70s6
under ILla stimulation and MEK inhibition). An additional 25% of the error can be
accounted for by variation in the normalized data of the common conditions of the two
datasets. Plots were generated by CellNOpt (fit to data) and the open-source MATLAB
toolbox DataRail [126] (raw data).
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Figure B-10: Fit of PLSR model of phenotypic cytokine release data. A three-component
PLSR model fit normalized cytokine release data well in most cases except the condition of
TNFa stimulation and Irb inhibition. The data is displayed as described in Supplementary
Figures B-1 and B-3. Plots were generated by CellNOpt.
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Figure B-11 (facing page): Fit of cFL models linking protein signals to phenotypic cytokine
release. Several signaling nodes (MEK1/2, CREB, GSK3, c-Jun, Hsp27, Ib, and STAT3)
were linked to cytokine release nodes (IL1B, IL4, GCSF, IFNg, and SDFla) in an extended
PKN (Table 3, PKN2D) and trained to the HepG2 dataset of both protein signaling and
cytokine release data. The fit of the family of cFL models (a) was similar to other cFL
models for the signaling data but slightly worse than the PLSR model fit to cytokine
release data (Supplementary Figure B-10). A subset of these models had MSEs less than
one standard deviation of the mean MSE of the family of models. Those models were
deemed most reliable because they fit the data very well. The fit of the average prediction
of these models is shown in (b). These average structure for this subset can be found in
Supplementary Figure B-12. The data is displayed as described in Supplementary Figures
B-1 and B-3. Plots were generated by CellNOpt. Because few cFL network models contained
links between MEK1/2, CREB, and GSK3 to cytokine release (Supplementary Table B.3),
these links were removed from the extended prior knowledge network and the resultant
network trained to the data.
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Figure B-12: Structure of filtered cFL models linking protein signals to phenotypic cytokine
release. Several signaling nodes (MEK1/2, CREB, GSK3, c-Jun, Hsp27, IKb, and STAT3)
were linked to cytokine release nodes (IL1B, IL4, G-CSF, IFNg, and SDFla) in an extended
prior knowledge network (Table 3, PKN2D) and trained to the HepG2 dataset of both
protein signaling and cytokine release data. Structures of the subset of 31 filtered cFL
network models with MSE less than one standard deviation from the mean of the entire
family is shown. Links colored black were present in all models whereas links colored grey
were present in a fraction of the models (a darker grey indicates that the cFL gate was
present in more models). Graph of cFL network models was generated a CellNOpt routine
using the graphviz visualization engine (www.graphviz.org) followed by manual annotation
in Adobe Illustrator. Because few cFL network models contained links between MEK1/2,
CREB, and GSK3 to cytokine release (Supplementary Table B.3), these links were removed
from the extended prior knowledge network and the resultant network trained to the data.
The average prediction of these models fit similarly to those in Supplementary Figure B-11
and the models' structures can be found in Figure 2-9.
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Figure B-13 (facing page): Investigating the use of alternate mathematical operators to
evaluate AND and OR gates. The extended prior knowledge network (Supplementary
Figure B-2a) was processed to include all two-input AND gates only when an inhibitory
interaction was modeled (Supplementary Figure B-2d, PKN1) and CellNOpt-cFL used to
train 149 network models to the HepG2 dataset. However, the cFL formalism was altered
slightly so that an AND gate was evaluated using the product operator and an OR operation
evaluated with the sum operator, where the scaling was maintained to between zero and
one by limiting the maximum value of any species to one. Note the similarity of these
results to those obtained with Min/Max operators are used to evaluate AND and OR gates,
respectively (compare Figure 2-4c to part a of this figure, Figure 2-5 to part b, and Figure
2-7 to part c). Reduction of the family of cFL models indicates that a Selection Threshold
of 0.005 is also appropriate in this case. The structures of the family of cFL network models
trained to the HepG2 dataset are shown (b). Links colored black were present in all models
whereas links colored grey were present in a fraction of the models (a darker grey indicates
that the cFL gate was present in more models). Filtered cFL network models are shown.
Fit to experimental data (c) is displayed as described in Supplementary Figures B-1 and
B-3. Plots were generated by CellNOpt.
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Figure B-14: Transfer functions included in the discrete genetic algorithm optimization
process. The discrete genetic algorithm chose one of the transfer functions with the indicated
parameter sets during the optimization process to relate each input species' value to the
output species' value. (a) Transfer functions used to relate species within the network. (b)
Transfer functions used to relate ligand input values to the species immediately downstream
of them.
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B.3 Supplementary Tables
Table B.1: Assessing statistical significance of cFL models derived from PKN1. Data
randomization was accomplished by pairwise exchange of data points. Several types of
network randomization were performed. In "Swap Heads" randomization, the input of
each interaction was randomly exchanged with the input of another interaction while in
"Swap Tails" this process was executed for outputs of each interaction. "Swap Inputs"
randomization involved swapping the inputs of all interactions with a randomly chosen
output node with the inputs of all interactions with another randomly chosen output node.
Finally, completely random networks were generated with the same number of nodes and
edges as the extended prior-knowledge network, at least one edge per node, and no incoming
but at least one outgoing edge for each network input [124]. For the random data case,
P-Values were calculated for each model trained to the real dataset using the Z-score of
the model MSE compared to the distribution of randomized data models' MSEs. For the
random networks case, the distribution of MSEs was not normal as assessed by the Jarque-
Bera test at a > 0.001. In this case, P-value was calculated as the instance of random
models with score less than that of the trained model, of which no instance was observed
for any model.
Randomization Method Average P-Value Maximum P-Value
Randomize Data (n=312) 9.6 x 10- 18x 10 
Swap Heads (n=1027) < 1.0 x 10-3 < 1.0 x 10-3
Swap Tails (n=1059) < 1.0 x 10-3 < 1.0 x 10-3
Swap Inputs (n=1016) < 1.0 x 10-3 < 1.0 x 10-3
Completely Random Model (n=1104) < 1.0 x 10-3 < 1.0 x 10-3
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Table B.2: Test sets for cross validation experiment. In each test case, the measured signal
under one stimulation condition with all inhibitor conditions was used as the test data. The
remaining data was training data.
Stimulation Condition Measured signal left out
1 IGF1 GSK3
2 TGFa GSK3
3 IGF1 Akt
4 TGFa Akt
5 TNFa p53
6 ILla p5 3
7 TNFa IrB
8 ILla InB
9 TGFa CREB
10 ILla CREB
11 TGFa p9ORSK
12 IL1a p9ORSK
13 TGFa Mek
14 ILla Mek
15 TGFa IRSis
16 ILla IRS1s
17 TGFa p70s6K
18 ILla p70s6K
191 IGF1 p70s6K
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Table B.3: Frequency of interactions linking protein signals to phenotypic cytokine release.
Frequency in subset of 31 cFL models with MSEs lower than one standard deviation of the
family of models
Unprocessed Models
Input/Output IL13 IL4 G-CSF IFNy SDFa
MEK1/2 0.26 0.29 0.29 0.32 0.39
IkB 0.84 0.90 0.61 0.77 0.10
STAT3 1.00 1.00 0.94 1.00 0
GSK3 0.29 0.29 0.16 0.39 0.52
CREB 0.26 0.19 0.23 0.16 0.29
c-Jun 0.48 0.55 0.58 0.58 0.64
Hsp27 0.58 0.65 0.71 0.45 0.74
Filtered Models
Input/Output IL1(3 IL4 G-CSF IFNy SDFa
MEK1/2 0.19 0.19 0.19 0.26 0.32
1kB 0.84 0.87 0.61 0.74 0.10
STAT3 1.00 1.00 0.94 1.00 0
GSK3 0.26 0.13 0.13 0.9 .3
CREB 0.19 0.13 0.19 0.06 0.26
c-Jun 0.42 0.45 0.52 0.48 0.52
Hsp27 0.55 0.52 0.61 0.39 0.71
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Table B.4: Experimentally verified and computationally predicted transcription factor
binding sites in relevant genes. Genes were queried in BioBase TRANSFAC [90, 91]
for experimentally verified or computationally predicted transcription factor binding
sites and the March 2006 (NCBI36/hgl8) assembly of UCSC Genome Bioinformatics
(http://genome.ucsc.edu/) for computationally predicted transcription factor binding sites.
Those binding sites listed below were included either because they were binding sites of
phosphorylated proteins measured or transcription factors known to be modulated by phos-
phorylated proteins measured [18, 120, 110]. Notes: STAT1 and STAT3 have similar binding
motifs (BioBase TRANSFAC). C/EBPa is phosphorylated by GSK3 [120]. TALla is phos-
phorylated by ErkI [18] and Akt [110]. Phosphorylation by Akt inhibits TALla repressor
activity [110]. Key: * denotes transcription factor binding site (BioBase TRANSFAC). #
denotes transcription factor binding site in the vicinity of the gene (BioBase TRANSFAC).
+ denotes site computationally predicted (UCSC Genome Bioinformatics).
Gene Transcription Factor Binding Site
1L4 IRF*+, JRF2*
IL/T NFrBi, CREB* C/EBP3*,~STAT1
G-CSF NF.B*+, C/EBPa*, C/EBP3*, TAL1a/E47+
SDF1a STAT+, TAL1a/E47+, e-Jun#, STAT1W
IFN-y IRF1+, IRF2+, STAT3*, NFkB*, CREB*, c-Jun*
IL6 NFpB*, AP-1*, c-Jun*, C/EBP3*, CREB+, IRF1+, IRF2+
IRFI STAT*+, AP-1+, NFnB*
IRF2 CREB+, IRF1*
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Supporting Information for
Chapter 3
C.1 Comparison of cFL and other modeling for-
malisms
Numerous frameworks have been proposed by ourselves and others to formally train a
biological network to data (e.g. artificial neural networks [35], probabilistic graphical
models [160, 79], and logic networks [102, 124]). Our approach here is distinct from
these because we base our models solely on prior knowledge using reasonable default
parameters. While other frameworks could potentially be used in this manner, we
argue that cFL logic models are a more attractive means for quickly and efficiently
constructing a reliable model because they use logic operations that relate naturally
to a linguistic description and yield interpretable results.
The observation that conclusions drawn from cFL models are abstract and species
values must be considered relative to those of other species in the model points to
a limitation of the technique. Thus, if the goal of a study is to predict an absolute
parameter of a system (i.e. most effective Kd of a drug, recommended dose, etc.),
one should use a modeling approach that is able to directly relate to physical prop-
erties (such as differential equations). However, a mechanistic differential equation
model requires more precise knowledge of both the mechanisms and parameters gov-
erning system behavior. While default parameters could be assumed for DEs as we
exemplified for our cFL models here, estimates for DE parameters must be at least
approximately correct because different parameters regimes can yield systems with
very different behavior [73]. Thus, we conclude that while cFL models are limited in
that they can only make qualitative predictions, they require less precise knowledge
of the system, making them an attractive alternative to mechanistic DEs.
Because the quantities resulting from cFL models are abstract, one could raise the
question of whether modeling with ostensibly simpler Boolean or discrete logic would
be sufficient for the analysis we present here. Indeed, cFL models use traditional
AND, OR, and NOT gates to specify the topology of a network, such that tools
developed for either analysis are readily interchangeable. However, the use of cFL is
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justified for several reasons. First, discrete models lack transfer functions such that
analyses similar to that shown in main text Figures 3-6C and D could not easily be
performed with a discrete model. Furthermore, analysis with cFL is no more difficult
than one with discrete logic because of the simplicity of the cFL formalism and ease of
specifying a model and its transfer functions in Q2LM. Moreover, cFL modeling allows
one to explore the effects of the amount of perturbation, different implementations
of perturbations, and the effect of noise in the transfer function parameters. Such
explorations allow one to ascertain whether the predictions are robust to variations
of the model, which if confirmed, increases confidence in their reliability.
C.2 Supplemental Experimental Methods
To validate the Q2LM model, we measured the ability of wild-type granulocyte colony-
stimulating factor (gGCSF) or a mutant form (G43, D113H mutation) to promote
hematopoiesis in 5-fluorouracil (5FU)-treated mice, similar to previously reported
methods [100, 136]. Briefly, B6D2F1 mice (Jackson Laboratories) were divided into
seven groups of five mice each (n=35). One group of animals served as a control
group and received no 5FU or colony stimulating factor. The rest of the groups were
treated with 150 mg/kg 5FU for 24 hours prior to treatment with colony stimulating
factor (gGCSF or G43, injected i.p in phosphate buffered saline, supplemented with
0.1% BSA) for 9 days. Daily doses of 25 or 50 microg/kg of gGCSF or 25, 50, or
100 microg/kg were administered separately to a group of animals. After dosing of
colony stimulating factor was completed, animals were sacrificed and blood collected
by cardiac puncture. After hemolysing red blood cells using a standard lysis solution
(10 mM potassium bicarbonate, 150 mM ammonium chloride, 0.1 mM EDTA, pH
8.0), white blood cells were concentrated and cell count performed with a Coulter
counter (Beckman Coulter Instruments). Results are expressed in Main Text Figure
3-6 as an average cell count plus standard deviation.
C.3 Relationship between cFL and mechanistic ODEs
C.3.1 Introduction
While others have explored the relationship between stoichiometric maps and logic
gates [71, 131], these derivations point out the relationship between logic models
and ordinary differential equations (ODEs) based on mass balances. A mass balance
is a basic engineering concept based on the law of conservation of mass. A mass
balance simply translates the statement "the rate of change of a species' mass in a
defined system equals the rate of entry plus the rate of generation minus the rate of
consumption and the rate of exit" into an ordinary differential equation.
The first major concept used in the derivations below is that the updating scheme
in a logic model simulation is analogous to steady-state solution of an ODE. In the
simulation of a logic model, each node is updated based solely on its input nodes'
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Figure C-1: Binding of GCSF to its recepter. (a) graphical depiction for development of
the mass balance (b) logic gate representation of this interaction
a) ------------------------------------- b)
kf GCSF Rk rYR C
C
states at the previous time step and the concept of time is not considered. In an ODE
framework, this is akin to evaluating each species as if it were at psuedo-steady state.
The figures depicting these systems (Figures C-1, C-3, and C-6) also point out
important distinctions between the interpretation of an mechanistic ODE and that
of a logic model. In the graphics that motivate development of an ODE, an arrow
generally indicates that the molecular species at the 'head' or 'input' of the arrow
undergoes some change (i.e. is internalized, becomes bound, gets degraded, etc.).
However, in a logic model, these arrows indicate only that the value of one species
affects the value of another. Thus, we should understand the arrows in logic models
not as indication of what happens to the input species, but rather as indications that
the value of the input species (as determined by other nodes) results in some change
to the output species' value.
C.3.2 Receptor Binding
In a mechanistic ODE modeled with mass action kinetics, a mass balance on
bound receptor [C] depicted in Figure C-1 can be written with Equation C.1:
dtC] = kf[R] [GCSF] - k,[C] - kendocyt[C] (C.1)
Due to the relationship between the updating scheme of a logic model and steady
state described in Section C.3.1, we set the derivative in Equation C.1 to zero and
solve for the steady state value of [C] (Css).
0 = k5 RssGCSFss - krCss - keniocytCss (C.2)
Css k + ! RssGCSFss (C.3)kr + kenjocyt
From Equation C.3, we note that the pseudo-steady state value of [C] (Css) is
a function of the product of Rss and GCSFSS. This dependence is plotted as a
heat map in Figure C-2a. From this plot, it is clear that this relationship between
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Figure C-2: Heat map of CSS as a function of varying amounts of GCSFss and Rss. 'Truth
tables' of binding as modeled by (a) Equation C.3, (b) Boolean logic AND gate, (c) cFL
AND gate evaluated with the min operator, and (d) cFL AND gate evaluated by the prod
operator. For evaluation of Equation C.3 values of Receptor and GCSF were considered to
be scaled between zero and one. For cFL evaluation, transfer functions with a gain of 1,
EC 5 0 of 0.5, and hill coefficient of 3 were assumed. The truth table in (a) could be directly
replicated with cFL by using a linear transfer function with slope = 1 and intercept = 0.
a) Steady State Mass b) Boolean Logic cFL AND gate cFL AND gate
Balance Truth Table AND gate with "min" operator with 'prod" operator
0.8 1A 0.8 08
Ro- R R u R 0. 0.i
0.4 040.4 04
0.2 0 002 02
0 02 0.40.6 0.8 1 0 1 0 0-20.40.6 0.8 1 0 02 0-40.6 0.8 1 0
GCSF GCSF GCSF GCSF
species corresponds to an AND gate in logic terms. A heat map of the Boolean
logic AND gate truth table (Figure C-2b) is a very abstract representation, but the
cFL AND gates shown (Figure C-2 c and d) demonstrate a closer relationship to
the 'biochemical truth table.' Thus, we see that the AND gate relating pNR and
bloodGCSF to pNboundGCSF is directly related to the steady-state solution of
the mechanistic ODE based on mass action kinetics. Additionally, the mass-balance
concept of "losing" [C] due to endocytosis does not change the functional form of the
relationship of its steady state value to Rss and GCSFS.
162
C.3.3 Receptor Degradation
To model endosomal degradation, we do not explicitly model all of the processes
that occur mechanistically (endocytosis of both bound and unbound receptors, dis-
association, etc). Rather, we use the abstract concept of "Substance" (Subst) shown
in Figure C-3 to lump all processes into one mass balance (equation C.4):
dSubstdt = Substi, - Substjegraed - SubStrecyded (CA)dt
Using a "fraction degraded" constant (fdeg) to relate Substi and Substdegrajed,
we obtain
dSubstdbt = Substin - fdegSubstin - SubStrecycjed (C.5)dt
Again, we use the steady state description and set the derivative in Equation C.5
to zero and solve for the steady state value of SUbstrecyled.
Substrectyded = Substjn(1 - fdeg) (C.6)
From Equation C.6, we again note that the steady state value of SUbStrecyded
is a function of the product of Substin and (1 - feeg). In logic terms, the product
again corresponds to an AND gate truth table where "1-" in 1 - feg indicates
inhibition (Figure C-4). Thus, the AND NOT gate relating pNboundGCSF and
pNdegGCSF to pNrecGCSF is related to the steady-state solution of an abstracted
ODE describing the mass balance of these entities. In this case, the mass-balance
concept of "losing" substance due to degradation did change the functional form of
the relationship of the amount of substance recycled because this 'loss' is reflected in
the logic gate by the inhibition of recycling by degradation.
Figure C-3: Degradation of bound receptor. (a) graphical depiction for development of the
mass balance (b) logic gate representation of this interaction
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Figure C-4: Heat map of Substrecycled as a function of varying amounts of Substi, and fdeg.
'Truth tables' of recycling and degradation as modeled by (a) Equation C.6, (b) Boolean
logic AND gate, (c) cFL AND gate evaluated with the min operator, and (d) cFL AND
gate evaluated by the prod operator. Equations evaluated as described in Figure C-2
a) Steady State Massb) Boolean Logic C) cFL AND gate d) cFL AND gate
Balance Truth Table AND gate with "min' operator with "prod" operator
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fracjdegraded frac-degraded fracdegraded fracdegraded
In Equation C.5, we assumed that "fraction degraded" was a constant for the
derivation of Equation C.6. However, in Figure C-3b, it is clear that the Substegrajed
species depends on Substn in the logic description. Thus, when we plot the level of
SUbstrecycled as a function of only Substi, we notice dissimilarities in the resulting
relationship (Figure C-5). These dissimilarities are caused by the fact that the amount
of faction of substance degraded is dependent on Substjn in the logic case, while it is
a constant in Equation C.6. It is unclear which assumption is correct in the actual
biological system, and we can model the relationship specified by Equation C.6 in a
logic model by not having an additional 'degradation' species and instead modelling
the logic as a direct interaction between Substjn and Substrecycled the 'gain' of the
transfer function relating them analogous to 1 - feg. However, this further level of
abstraction hinders our ability to alter the 'degradation' species directly. Additionally,
it is unclear if fde, is actually independent of the amount of substance presence in
the biological setting. Nonetheless, we repeated the work presented in the main text
and found that the interpretation of the results is the same regardless of the logic
description used for the endosomal degradation process.
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Figure C-5: Substrecycled as a function of varying amounts of Substi, modeled by (a) Equa-
tion C.6, (b) cFL AND gate evaluated with the min operator, and (c) cFL AND gate
evaluated by the prod operator. In the derivation based on mass balances (a), the variable
fdeg is considered a constant. In those derived from the logic gate, we vary the gain of the
transfer function relating Substi, and Substdegraded and consider this gain to be fedg
a) Biochem function b) cFL with min AND gate C) cFL with prod AND gate
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C.3.4 Amount of GCSF in the blood: an example where the
logic gate and mass-balance are not analogous
Figure C-6: Processes affecting GCSF in the blood. (a) graphical depiction for development
of the mass balance (b) logic gate representation of this interaction
recycled GCSF b)
doseGCSF (recGCSF) recGCSF
-....... 
-. --. N doseGCSF clearance
bloodGCSF
Nl~non-speciic
clearance bOdGS.. .......... .. . c.. bloodG:CSF
boundGCSF
We now turn to an example where the relationship between the proper logic gate
and mass-balance based ODE is not analogous. A simplified mass balance for GCSF in
the blood (Figure C-6) is shown in Equations C.7 - C.8. The 'logic' of the summation
in Equation C.8 would normally be an OR gate. However, in the construction of our
logic model, we found that an AND gate was necessary to correctly model the logic
of the bloodGCSF species because presence or absence of all of the input species to
this gate can limit the value of bloodGCSF. In this case the mass balance and logic
gate are not analogous. Perhaps one clue that they will not be directly related lies
in Equations C.7 - C.8. In these equations, the two terms denoting the 'appearance'
of GCSF in the blood were not dependent on a species. Rather, they were further
abstracted and given as rate constants independent of other species. Additionally, the
contribution of 'binding' is abstracted and modeled as simply a lumped rate rather
than including the biochemical steps of association and dissociation. This abstraction
at the level of rates of processes serves as an indication that this mass balance does not
describe relationships between species we include in our logic model and bloodGCSF,
and thus, it will not be directly relatable to our logic model.
dGCSFeioo
di = kdose + krec - kbnGCSFBjioo - kcearanceGCSFBoM (C.7)
GCSFnioodss = kdose + krec (C.8)
kedearance + kudnC
In order to correctly deduce the logic describing the bloodGCSF species, we in-
stead turn to truth tables describing how we believe the species to relate to other
species' values. We first recognize that initially, only the dose and clearance values
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determine the value of bloodGCSF (because at the beginning of the simulation, re-
cycling has not yet been calculated and is thus the initial value of Not-A-Number).
Thus, we will initially determine how bloodGCSF depends on the dose and clearance
species (Figure C-7a) by examining the truth table for the dependence of bloodGCSF
on limiting values (i.e. zero and one) of each input species (Figure C-7c). We first
note that dose is required for bloodGCSF to be 'on'. Thus, we deduce that when
dose is zero, bloodGCSF is also zero (Figure C-7d). Next, we note that bloodGCSF
is limited by clearance. Thus, we fill in the remaining two entries for the truth table
(Figure C-7e). This gate corresponds to an AND NOT gate (Figure C-7b).
Next, we consider how bloodGCSF will depend on recycling after its value has
been calculated (Figure C-7f and h). The dependence on dose and clearance remains
the same, so we can fill in many entries in the truth table (Figure C-7i). Finally, we
note that recycling is now required for bloodGCSF to remain 'on'. Thus, we can fill
in the remaining two entries of the truth table (Figure C-7j) and ascertain that the
recycling species should be an input to the AND gate (Figure C-7g).
From this example, we see the importance of considering both the interactions be-
tween the species as well as how the species will be treated during simulation. As
it is sometimes difficult to anticipate all potential factors that should be considered,
we emphasize the importance of model validation at the onset of a project as well
as repeatedly returning to plots of how the species' values evolve in the course of
simulation to check that no artifacts have arisen. For the GCSF example, during the
course of analysis, we found that the inclusion of an additional node, 'bodyGCSF'
(Main Text Figure 3-5b), was necessary in order to ensure that the model behaved
properly under a few conditions where boundGCSF was fixed as a stimulation per-
turbation (Main Text Figure 3-6b). Such cases underscore the importance of model
validation and highlight the benefit of being able to easily 'follow the logic' during
model simulation to enable facile model troubleshooting.
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Figure C-7: Determining the logic controlling the bloodGCSF node.
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Figure C-8: Simulation Procedure Pseudo-Code
Main Simulation:
Set initial value of species to NaN
Set stimuli values based on scenario file
While species' values haven't converged or the number of steps is less than the
maximum
Calculate the value of all species given the value of their inputs (using transfer
functions)
Evaluate AND Logic
Evaluate OR Logic
Overwrite stimulated species' values with maximum of their simulated value or that
given in the scenario file
Multiply inhibited species' values by their percent inhibition
Store species' values
Solution for oscillating species:
It a species had not converged in some condition
For those conditions
Set initial guess of solver to be equal to the final value for species that stabilized
and the average of some predefined number of simulation steps for those
that didn't stabilize
Solve system of equations specifying network (a file with that system of
equations is written by Q2LM for both min/max and sum/prod when the
model is loaded)
Store solution as final value
C.4 Simulation Procedure for Determining Steady
State Value of Oscillating Species
Figure C-8 describes the procedure developed to calculate the steady state of oscil-
lating species by solving a system of equations. To solve the system of nonlinear
equations for cases when species' values are observed to oscillate, we use the fsolve
function in MATLAB. This function requires a default initial guess for species values.
Depending on the value of the initial guess, the solver will return one of multiple
possible roots. In order to return the root corresponding to the steady state of the
simulation, the initial guess for each species is determined from the simulated values.
Basing the initial guess on simulated species' value is key, as the solution to the equa-
tions using a default initial guess not based on simulation results can vary greatly
depending on the default initial guess chosen.
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D.1 Supplementary Figures
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Figure D-1: Larger view of prior knowledge network in Figure 4-2
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Figure D-2: Larger view of data in Figure 4-2.
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Figure D-3: Larger view of trained models in Figure 4-2
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Figure D-5: Dependence of kept models' features on solution pool size. (a) Of 993 models
trained to data in Supplementary Figure D-2, only the 120 best fit models were used for
further analysis. (b) To determine the affect of pool size on features of kept models, smaller
pools were randomly chosen from the full pool and the affect on MSE range of kept models
calculated. The plot indicated that, while the kept models would be better fit for larger
pools, the effect was incremental after a pool size of 700. The variability in structure was
calculated as the standard deviation in each 'bit' indicating if a specific interaction was
kept. This result indicates that the topological variance decreased slightly at a pool size of
700, likely because enough solutions had been obtained such that a structural variant that
resulted in a slightly better fit was a major component of the best-fit 120 models. We also
investigated the influence of keeping more 'well-fit' models with a fixed total pool size of
993. We found that, for the number used in this work (120), only a slight increase in MSE
was observed, whereas a much larger increase would be observed in more models were kept,
as expected.
a.) Protocol for choosing best fit models from initial solution pool Number Kept
Run CellNOpt __ Calculate MSE of
993 times filtered models
7
Pool Size
Rank MSEs _ Keep 120 modelswith lowest scores
b.) Dependence of measures of kept models on processing protocol
Dependence of MSE increase and structure variation
on Pool Size when Number Kept is fixed at 120
(mean and standard deviation of 100 pools chosen
randomly from initial 993 models)
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Figure D-6: Results of 10-fold cross validation in which the data was divided into ten
random subsets and the optimization procedure performed to obtain a family of at least
350 models from training data comprising nine of the ten subsets; the remaining subset was
considered a test set. The fit of these families of models to their respective training and
test sets was then plotted as a function of the selection threshold. As expected, on average
the ability of the trained models to fit the test sets was slightly worse than, but comparable
to, the ability to fit the training sets (R 2 = 0.79 for the training set and R 2 = 0.71 for the
test set), providing a first indication that the models were predictive.
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Figure D-7: Experimental data of phosphorylation of protein signals 30 minutes post stim-
ulation. Relative fold change of signal post stimulation compared to basal value. Relative
fold change has been scaled such that the maximum for each signal is one. Yellow and blue
coloring scales according to magnitude of increase or decrease, respectively.
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Figure D-8: Trained Models' Structures clustered based on Hamming distance
Interactions in Filtered Trained Models
White = present; Black = Absent
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Figure D-9: Correlation between interaction presence/absense in trained filtered Models'
Structures. NaNs have been replace with zero for visualization.
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Figure D-10 (facing page): (a) All metrics for evaluating how well constrained models were.
(b) Examples of 'good' and 'bad' metrics. Metrics are distributions indicating either how
constrained the model topology (as measured by the average of the bitstings cross models
for both unprocessed and filtered models), parameters (as measured by inner quartile range
(iqr) of summary 'sensitivity parameter', g, n, or EC5o), or predictions (as measured by iqr)
were. Negligilbe differences were observed for distributions of the topology and while some
of the iqr of the individual parameters were different, few were statistically significant as
evaluated by a Mam-Whitney test. For the predictions, all were statistically significantly
different. Thus, we conclude that any additional data over that of single ligand doses was
not helpful in further constraining the models in terms of topology and parameters, although
having at least ligand doses was helpful in constraining the predictions.
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Figure D-11: Original Training Conditions Necessary to Constrain Models - In Silico Results
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Figure D-12: Influence of Model Pair Threshold Parameter on Experimental Design
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Figure D-13: Experimental Design Validation Data. Because the 'Booleanizer' method
was not general enough for this data set, relative fold change of signal post stimulation
compared to basal value was scaled by dividing each signal by an empirically determined
value representing the average of the maximum and minimum increase of the signal under
'maximally' stimulating conditions (TGFa=1 and lLla=1 and any inhibition). Any value
greater than one was set equal to one and these values used for subsequent model training.
Yellow and blue coloring scales according to magnitude of increase or decrease, respectively.
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Figure D-14: All distributions (as in Supplementary Figure D-10) for in silico investigation
of effectiveness of designed conditions. We found that models trained to the various subsets
did not differ significantly in how constrained the model topologies were. A few subsets did
differ in terms of how constrained predicted species values were, and these subsets seemed
to also feature more constrained EC50 parameters but less constrained Hill coefficients.
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D.2 Supplementary Tables
Table D.1: Hypotheses suggested by gates removed during CellNOpt-cFL analysis
Hypothesis Evidence in cFL Evidence in data
Models
Map3kl -+ Isk Map3kl -- Isk gate is cJun and not Ib are phos-
crosstalk is incon- present in only 13% of fil- phorylated upon growth fac-
sistent with the tered models tor stimulation. Removal of
data. this crosstalk allows the two
pathways to be decoupled.
TSC is mainly Erk -+ TSC1/2 and Akt ILla stimulation results
phosphorylated -+ TSC1/2 gates are in Ikk activation, which
via by Irk or present in few unpro- then results in MTORC1-
p9ORSK cessed models dependent phosphorylation
of p70s6k (inhibition of Mek
did not ablate ILla-induced
phosphorylation). Activa-
tion of TSC1/2 through
p9ORSK allows for inde-
pendent modulation of this
pathway through P13K
Inhibition of Mek MeklactB and p38actB Few data values are negative
and p38 did not were not connected to upon Mek and p38 inhibi-
affect basal phos- downstream species tion
phorylation levels
Inhibition of mtorclB and pi3kB were Several signals have negative
MTORC1 and connected to several values upon MTORC1 and
P13K affected downstream species in P13K inhibition
basal phospho- many models
rylation levels of
several signals
187
Table D.2: Combination conditions predicted to differentiate between trained models (pre-
dicted to distinguish between 5116 of 5151 model pairs)
Stimuli Inhibitors
IGF1 = 0.6 Map3k7 + p38
IGF1 = 0.6 MTORC1 + Mek
IGF1 = 0.8 Map3k7 + P13K
IGF1 = 0.8 P13K
IGF1 = 1 p38
TGFa = 0.2 P13K + Mek
TGFa = 0.4 P13K + p38
TGFa = 0.8 P13K + p38
TGFa = 0.4 + ILla = 0.4 p38
Table D.3: Combination conditions predicted to distinguish between trained models where
only full stimulation and inhibition conditions were considered (predicted to distinguish
between 5041 of 5151 model pairs).
Stimuli Inhibitors
ILla Map3k7
ILla P13K + Mek
TNFa Map3k7 + Mek I
IGF1 MTORC1 + Mek
IGF1 P13K + Mek
TGFa Mp3OC + P13K
TGFa MTORC1 + P13K]
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Appendix E
Constrained fuzzy logic to link
signaling and transcriptional
regulation
E.1 Motivation
This thesis focussed on using cFL to model activation of signal transduction networks.
These signal transduction networks result in phenotypic changes through interac-
tions with cytoskelatal proteins, secretion and cleavage of autocrine and paracrine
cytokines, and activation of transcription factors. Transcription factors form com-
plexes that bind to DNA, resulting in alteration in transcribed genes. The transcribed
genes are then translated into proteins, which act to change cellular phenotype. In
this appendix, we present a proof of principle study for the use of logic models to de-
termine consistency between an expanded prior knowledge network linking signaling
proteins to the transcription factors hypothesized to be responsible for a measured
transcriptional response and condition-specific data describing activation of signaling
proteins and hypothesized transcription factors.
E.2 Data
HepG2 cells were stimulated with various inflammatory and growth ligands and
prosphorylation of several downstream signaling proteins measured by BioPlex af-
ter 30 minutes (Figure E-1). Additionally, gene expression after stimulation with the
same ligands for 4 hours was measured with mRNA-seq (Figure E-2).
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Figure E-1: Signaling Data
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E.3 Results
For each stimulation condition, transcription factors (TFs) responsible for the ob-
served gene expression changes were hypothesized by calculating over-representation
of predicted transcription factor targets in the differentially expressed genes (Figure
E-3) with a Fisher Exact test and Benjamini-Hochberg multiple hypothesis correc-
tion. Predicted TF targets were obtained by determining if the gene contained the TF
binding motif in DNase hypersensitive regions 5kb upstream and 1kb downstream the
transcription start site. DNase hypersensitivity data was obtained from ENCODE for
un-stimulated HepG2 cells [22]. TF binding motifs were obtained from TRANSFAC
[90, 91].
In order to link the hypothesized transcription factors to the measured protein sig-
nals, the Prize Collecting Steiner Forest (PCSF) algorithm developed in the Fraenkel
lab was used [54, 150]. Briefly, this algorithm seeks to connect detected proteins
with edges from a protein protein interaction network by balancing the penalty of ex-
cluding nodes with the cost of including additional edges. In this work, we used the
log-2 transformed score of the edge in the STRING protein-protein interaction net-
work as edge costs [142]. We used the maximum across conditions, log-2 transformed
multiple-hypothesis corrected p-value from the Fisher Exact test as node penalties
for the transcription factors. The root ('dummy') node was connected to measured
signals and stimulated receptors such that the algorithm sought to create the most
parsimonious network possible that connected TFs to measured signals or stimulated
receptors.
The PCSF result was combined with our PKN of the signaling network (Figure
E-4) and the resulting enhanced PKN trained to the data of signaling response and
transcription factors hypothesized to be responsible for the observed gene expression
changes (Figure E-5).
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5
The results of the cFL training analysis indicate that, although most edges in our
enhanced PKN were not inconsistent with the data (i.e. most edges are either grey or
back in trained cFL models; Figure E-5), they were insufficient to describe the data
(i.e. the fit to the data indicates much systematic error; Figure E-6).
However, by examining the fit the data more closely ( Figure E-6), we are better
able to determine what condition-specific overrepresentation of transcription factor
targets was consistent with our general picture. For example, the relatively low error
in proteins that form AP1 dimers (i.e. jun, atf, creb, and fos) indicates that they
were activated by the expected pathways. The error in NFcB overrepresentation
in conditions with TGFa stimulation indicates that either this was a false positive,
or TGFa activated the NFncB pathway through mechanisms not included in our
prior knowledge network. Finally, the improved fit despite similar overrepresentation
patterns of the Bach1 and Elf1 transcription factors over Bach2 and Elf2 indicate that
the placement of Bach1 and Elf1 in the network was more consistent with condition-
specific data than that of Bach2 and Elf2.
The analysis presented here suffered from an apparent lack of specificity in the
TF target lists when calculating over-representation of TF targets in the differentially
expressed genes such that many over-represented TFs were false positives. More
specific lists could be obtained by collection of differential DNase hypersensitivity data
or incorporation of additional data types and sources in the designation of a gene as a
TF target. Alternatively, the calculation of overrepresentation could be circumvented
by linking differentially expressed genes to the protein-protein interaction network
through the TF target list and using the enhanced interaction network and gene
expression data directly in the PCSF algorithm.
Thus, we conclude that cFL training of a prior knowledge network linking protein
and transcriptional regulation is useful in systematically determining if condition
specific hypotheses are consistent with our general picture, but further development
is necessary to fully evaluate the ability of this methodology to provide additional
insight to this type of analysis.
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Figure E-6: Fit of cFL models linking signaling and transcriptional regulation
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